var title_f41_40_42624="Echinostomiasis adult worm";
var content_f41_40_42624=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56568&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56568&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 606px\">",
"   <div class=\"ttl\">",
"    Echinostomiasis adult worm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 586px; height: 269px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Adult of",
"    <em>",
"     E. revolutum",
"    </em>",
"    , stained with carmine. Structures illustrated in this figure include: oral sucker (OS), armed collar (CL), cirrus sac (CS), ventral sucker, or acetabulum (AC), uterus containing eggs (UT), ovary (OV), paired testes (TE), and vitelline glands (VT). This species has been recorded from humans in Taiwan.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Echinostomiasis. Available at:",
"     <a href=\"file://dpd.cdc.gov/dpdx/html/Echinostomiasis.htm\" target=\"_blank\">",
"      file://dpd.cdc.gov/dpdx/html/Echinostomiasis.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42624=[""].join("\n");
var outline_f41_40_42624=null;
var title_f41_40_42625="Burn hand eschr dig";
var content_f41_40_42625=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F64145&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F64145&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 543px\">",
"   <div class=\"ttl\">",
"    Conventional escharotomy with digital escharotomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 523px; height: 561px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42625=[""].join("\n");
var outline_f41_40_42625=null;
var title_f41_40_42626="Photo birth 2";
var content_f41_40_42626=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F64939&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F64939&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Delivery sequence from crowning through birth of the newborn",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 290px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Late crowning. Notice that the fetal head is appearing face down. This is the normal OA position.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wolters Kluwer. Copyright &copy;2009.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42626=[""].join("\n");
var outline_f41_40_42626=null;
var title_f41_40_42627="UC cecal patch";
var content_f41_40_42627=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53637&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53637&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    \"Cecal patch\" in ulcerative colitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 349px; height: 463px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Periappendiceal inflammation is identified in approximately 15 percent of patients with left sided UC.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Athos Bousvaros, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42627=[""].join("\n");
var outline_f41_40_42627=null;
var title_f41_40_42628="Total parenteral nutrition: Drug information";
var content_f41_40_42628=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Total parenteral nutrition: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?1/4/1092?source=see_link\">",
"    see \"Total parenteral nutrition: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F2422245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Caloric Agent;",
"     </li>",
"     <li>",
"      Intravenous Nutritional Therapy",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F2422260\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Nutritional supplementation: I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Total calories:",
"     </b>",
"     Calculate using Harris-Benedict equation or based on stress level as indicated below:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:2em;\">",
"     <i>",
"      Harris-Benedict Equation (BEE):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Females: 655.1 + [(9.56 x W) + (1.85 x H) - (4.68 x A)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Males: 66.47 + [(13.75 x W) + (5  x H) - (6.76 x A)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Then multiply BEE x (activity factor) x (stress factor)",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:8em;\">",
"     W = weight in kg; H = height in cm; A = age in years",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Activity factor = 1.2 sedentary, 1.3 normal activity, 1.4 active, 1.5 very active",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Stress factor = 1.5 for trauma, stressed, or surgical patients and underweight (to promote weight gain); 2.0 for severe burn patients",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Stress level:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Normal/mild stress level: 20-25 kcal/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Moderate stress level: 25-30 kcal/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Severe stress level: 30-40 kcal/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Pregnant women in second or third trimester: Add an additional 300 kcal/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Fluid:",
"     </b>",
"     mL/day = 30-40 mL/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Carbohydrate (dextrose):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     5 g/kg/day or 3.5 mg/kg/minute (maximum rate: 4-7 mg/kg/minute)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Minimum recommended amount: 400 calories/day or 100 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Protein (amino acids):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Maintenance: 0.8-1 g/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Normal/mild stress level: 1-1.2 g/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Moderate stress level: 1.2-1.5 g/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Severe stress level: 1.5-2 g/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Burn patients (severe): Increase protein until significant wound healing achieved",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Solid organ transplant: Perioperative: 1.5-2 g/kg/day",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:6em;\">",
"     Renal failure:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Acute (severely malnourished or hypercatabolic): 1.5-1.8 g/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Chronic, with dialysis: 1.2-1.3 g/kg/day",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:8em;\">",
"     Chronic, without dialysis: 0.6-0.8 g/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Continuous hemofiltration: &ge;1 g/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hepatic failure:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Acute management when other treatments have failed:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     With encephalopathy: 0.6-1 g/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Without encephalopathy: 1-1.5 g/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Chronic encephalopathy: Use branch chain amino acid enriched diets only if unresponsive to pharmacotherapy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Pregnant women in second or third trimester: Add an additional 10-14 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Fat:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Initial: 20% to 40 % of total calories (maximum: 60% of total calories or 2.5 g/kg/day);",
"     <b>",
"      Note:",
"     </b>",
"     Monitor triglycerides while receiving intralipids.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Safe for use in pregnancy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.V. lipids are safe in adults with pancreatitis if triglyceride levels &lt;400 mg/dL",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F2422259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Nutritional supplementation: Children: I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Give within 5-7 days if unable to meet needs orally or with enteral nutrition:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Total calories:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &lt;6 months: 85-105 kcal/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     6-12 months: 80-100 kcal/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     1-7 years: 75-90 kcal/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     7-12 years: 50-75 kcal/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     12-18 years: 30-50 kcal/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Fluid:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     2-10 kg: 100 mL/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &gt;10-20 kg: 1000 mL for 10 kg plus 50 mL/kg for each kg &gt;10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &gt;20 kg: 1500 mL for 10 kg plus 20 mL/kg for each kg &gt;20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Carbohydrate (dextrose):",
"     </b>",
"     40% to 50% of caloric intake",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &lt;1 year: Initial: 6-8 mg/kg/minute; goal: 10-14 mg/kg/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     1-10 years: Initial: 10% to 12.5%; daily increase: 5% increments (maximum: 15 mg/kg/minute)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &gt;10 years: Initial: 10% to 15%; daily increase: 5% increments (maximum: 8.5 mg/kg/minute)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Protein (amino acids):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     1-12 months: Initial: 2-3 g/kg/day; daily increase: 1 g/kg/day (maximum: 3 g/kg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     1-10 years: Initial: 1-2 g/kg/day; daily increase: 1 g/kg/day (maximum: 2-2.5 g/kg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &gt;10 years: Initial: 0.8-1.5 g/kg/day; daily increase: 1 g/kg/day (maximum: 1.5-2 g/kg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Fat:",
"     </b>",
"     Initial: 1 g/kg/day; daily increase: 1 g/kg/day (maximum: 3 g/kg/day);",
"     <b>",
"      Note:",
"     </b>",
"     Monitor triglycerides while receiving intralipids.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F3062237\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F2422285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling. TPN is usually compounded from optimal combinations of macronutrients (water, protein, dextrose, and lipids) and micronutrients (electrolytes, trace elements, and vitamins) to meet the specific nutritional requirements of a patient. Individual hospitals may have designated standard TPN formulas. There are a few commercially-available amino acids with electrolytes solutions; however, these products may not meet an individual's specific nutrition requirements.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F2422281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For I.V. administration only, usually via a central venous catheter; can be administered by continuous infusion over 24 hours or cyclic infusion over 12-14 hours. Cyclic infusion is used with a tapering-up period at the beginning and a tapering-down period at the end to avoid hyper-/hypoglycemia. For infants &lt;2 years, taper over 1-2 hours. Change tubing after each infusion. Hang fat emulsion higher than other fluids (has low specific gravity and could run up into other lines). Infuse via pump using either peripheral or central venous line.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F2422257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See detailed reference.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F2422246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Infusion of nutrient solutions into the bloodstream to support nutritional needs during a time when patient is unable to absorb nutrients via the gastrointestinal tract, cannot take adequate nutrition orally or enterally, or have had (or are expected to have) inadequate oral intake for 7-14 days.",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F5978077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F2422252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined (unless noted).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Endocrine &amp; metabolic: Fluid overload, hypercapnia, hyperglycemia, hyper-/hypokalemia, hyper-/hypophosphatemia, metabolic bone disease, nonanion gap metabolic acidosis, refeeding syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hepatic: Cholestasis, cirrhosis (&lt;1%), gallstones, liver function tests increased, pancreatitis, steatosis, triglycerides increased",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Renal: Azotemia, BUN increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Miscellaneous: Bacteremia, catheter-induced infection, exit-site infections",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F2422247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Varies by composition:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lipid-containing formulations are contraindicated in patients with hypersensitivity to fat emulsion or any component of the formulation; severe egg or legume (soybean) allergies; pathologic hyperlipidemia, lipoid nephrosis, pancreatitis with hyperlipemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dextrose is contraindicated in patients with hypersensitivity to corn or corn products; hypertonic solutions in patients with intracranial or intraspinal hemorrhage; glucose-galactose malabsorption syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amino acids are contraindicated in patients with hypersensitivity to one or more amino acids; severe liver disease or hepatic coma",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F2422248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Refeeding syndrome: Use with caution in patients at risk for refeeding syndrome. Refeeding syndrome is a medical emergency; it can consist of electrolyte disturbances (eg, potassium, phosphorus), respiratory distress, and cardiac arrhythmias, resulting in cardiopulmonary arrest. It is usually seen in patients with long-standing or severe malnutrition; initiate cautiously; approach goals slowly. Do not overfeed patients; caloric replacement should match as closely as possible to intake.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes or insulin resistance.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution and limit protein in patients with hepatic disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Volume overload: Use with caution in patients who may be sensitive to volume overload (eg, HF, renal failure, hepatic failure).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abrupt withdrawal: If TPN is discontinued abruptly, infuse 10% dextrose at same rate and monitor blood glucose for hypoglycemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Monitoring: Monitor fluid and electrolyte status carefully.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14446377\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Indications for special nutrition support are the same in pregnant women as in nonpregnant patients. Additional calories and protein may be required (ASPEN, 2002).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F2870146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Electrolytes: Sodium, potassium, chloride, and bicarbonate should be monitored frequently upon initiation and until stable; phosphate should be monitored closely in patients with pulmonary disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Efficacy: Nutrition and outcome parameters should be measured serially.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Glucose: In patients with diabetes or patients with glucose intolerance risk factors, monitor closely. Monitor frequently upon initiation of therapy and with any changes in insulin dose or renal function.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Line site: Monitor for signs and symptoms of infection.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liver function tests: Monitor periodically.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Triglycerides: Before initiation of lipid therapy and at least weekly during therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Refeeding syndrome: Patients at risk should have phosphorus, magnesium, potassium, and glucose levels monitored closely at initiation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Bone densitometry: Perform upon initiation of long-term therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Vitamin A status: Should be carefully monitored in patients with chronic renal failure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Neonates: Sodium, calcium and phosphate should be monitored closely. Frequent (some advise daily) platelet counts should be performed in neonatal patients receiving parenteral lipids.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      ASPEN Board of Directors and the Clinical Guidelines Task Force, \"Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients,\"",
"      <i>",
"       JPEN J Parenter Enteral Nutr",
"      </i>",
"      , 2002, 26(1 Suppl):1-138.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dersch D and Schoen J, \"Weight-Based Ordering: An Evaluation of Increased Guideline Use in Hospital Total Parenteral Nutrition Dosing,\"",
"      <i>",
"       Nutr Clin Pract",
"      </i>",
"      , 2002, 17(5):296-303.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fulford A, Scolapio JS, and Aranda-Michel J, \"Parenteral Nutrition-Associated Hepatotoxicity,\"",
"      <i>",
"       Nutr Clin Pract",
"      </i>",
"      , 2004, 19(3):274-83.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Howard L, \"Enteral and Parenteral Nutrition Therapy,\"",
"      <i>",
"       Harrison&rsquo;s Principles of Internal Medicine",
"      </i>",
"      , 14th ed, Chapter 78, Fauci AS, Braunwald E, Isselbacher KJ, et al, eds, New York, NY: McGraw-Hill, 1998, 472-80.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ireton-Jones C, DeLegge MH, Epperson LA, et al, \"Management of the Home Parenteral Nutrition Patient,\"",
"      <i>",
"       Nutr Clin Pract",
"      </i>",
"      , 2003, 18(4):310-17.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Martindale RG, McClave SA, Vanek VW, et al, \"Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.),\"",
"      <i>",
"       JPEN J Parenter Enteral Nutr",
"      </i>",
"      , 2007, 33(3):277-316.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/40/42628/abstract-text/19398613/pubmed\" id=\"19398613\" target=\"_blank\">",
"        19398613",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mattox T,  \"Parenteral Nutrition,\"",
"      <i>",
"       Pharmacotherapy: A Pathophysiologic Approach",
"      </i>",
"      , 4th ed, Chapter 128, Dipiro JT, Talbert RL, Yee GC, et al, eds, Stamford, CT: Appleton &amp; Lange, 1999, 2247-65.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mayhew SL and Gonzalez ER, \"Neonatal Nutrition: A Focus on Parenteral Nutrition and Early Enteral Nutrition,\"",
"      <i>",
"       Nutr Clin Pract",
"      </i>",
"      , 2003, 18(5):406-13.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mirtallo J, Canada T, Johnson D, et al, \"Safe Practices for Parenteral Nutrition,\"",
"      <i>",
"       JPEN J Parenter Enteral Nutr",
"      </i>",
"      , 2004, 28(6):S39-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/40/42628/abstract-text/15568296/pubmed\" id=\"15568296\" target=\"_blank\">",
"        15568296",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      U.S. Pharmacopeial Convention, Inc, U.S. Pharmacopeia 27, Chapter &lt;797&gt; Pharmaceutical Compounding &mdash; Sterile Preparations. Rockville, MD: U.S. Pharmacopeial Convention, Inc, 2003, 2350-70.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10307 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.25.216.6-3FB984B900-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42628=[""].join("\n");
var outline_f41_40_42628=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2422245\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2422260\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2422259\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3062237\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2422285\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2422281\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2422257\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2422246\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5978077\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2422252\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2422247\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2422248\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14446377\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2870146\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10307\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10307|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?1/4/1092?source=related_link\">",
"      Total parenteral nutrition: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_40_42629="Alglucosidase alfa: Pediatric drug information";
var content_f41_40_42629=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Alglucosidase alfa: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?43/44/44741?source=see_link\">",
"    see \"Alglucosidase alfa: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/56/3972?source=see_link\">",
"    see \"Alglucosidase alfa: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708603\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information. For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F2932456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lumizyme&reg;;",
"     </li>",
"     <li>",
"      Myozyme&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F10304109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Myozyme&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F3269346\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Enzyme",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F3269355\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?43/44/44741?source=see_link\">",
"      see \"Alglucosidase alfa: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Pompe disease:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infantile-onset: Myozyme&reg;: Infants &ge;1 month, Children, and Adolescents: I.V.: 20 mg/kg over ~4 hours every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Late-onset (noninfantile): Lumizyme&reg;: Children &ge;8 years, Adolescents, and Adults: I.V.: 20 mg/kg over ~4 hours every 2 weeks",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F2932616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lumizyme&reg;: 50 mg [contains mannitol, polysorbate 80; derived from or manufactured using Chinese hamster ovary cells]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Myozyme&reg;: 50 mg [contains mannitol, polysorbate 80; derived from or manufactured using Chinese hamster ovary cells]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F2932458\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11216815\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As a requirement of the REMS program, access to this medication is restricted. Lumizyme&reg; is available only through Lumizyme&reg; ACE (Alglucosidase Alfa Control and Education) program; only trained and certified prescribers and healthcare facilities enrolled in the program may prescribe, dispense, or administer Lumizyme&reg;. Patients must be enrolled in and meet all the conditions of the program to receive therapy. For enrollment, call 1-800-745-4447.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Access to Myozyme&reg; is restricted by the manufacturer, and allowed only to patients &lt;8 years of age with infantile-onset or late-onset Pompe disease (who are restricted from access to Lumizyme&reg;) or to patients of any age with a diagnosis of infantile-onset Pompe disease or evidence of cardiac hypertrophy. To obtain Myozyme&reg;, call 1-800-745-4447; no formal distribution program is established, but availability is controlled by Genzyme.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F3269356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Visually inspect the powder in the vial for particulate matter prior to reconstitution. After vial reaches room temperature, reconstitute each vial with 10.3 mL SWI. Inject slowly down internal side wall of vial (do not inject into powder; avoid foaming). Roll and tilt gently; do not invert, swirl, or shake. Resulting solution contains 5 mg/mL. Visually inspect the solution following reconstitution for particulate matter. To make final infusion, add the desired dose amount of reconstituted solution to 50-1000 mL NS (volume determined by patient's weight; see product labeling for complete details) to make a final concentration of 0.5-4 mg/mL. Do not use filter needle for preparation. Remove airspace from infusion bag prior to admixture to minimize particle formation due to sensitivity of drug to air-liquid interfaces. Do not shake. Final solutions for infusion should be used immediately if possible, but may be stored for up to 24 hours between 2&deg;C and 8&deg;C (36&deg;F and 46&deg;F); do not freeze. Protect from light.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Infuse over ~4 hours; initiate at 1 mg/kg/hour. If tolerated, increase by 2 mg/kg/hour every 30 minutes to a maximum rate of 7 mg/kg/hour. Decrease rate or temporarily hold for infusion reactions. Infuse through a low protein-binding, 0.2 micron in-line filter. Do not administer products with visualized particulate matter.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F2932602\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Stable in NS; do not infuse with other products.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F3269352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Store vials between 2&deg;C and 8&deg;C (36&deg;F and 46&deg;F); do not freeze. Protect from light. Allow vials to reach room temperature prior to reconstitution. Final solutions for infusion should be used immediately if possible, but may be stored for up to 24 hours between 2&deg;C and 8&deg;C (36&deg;F and 46&deg;F); do not freeze. Protect from light.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F3269347\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Myozyme&reg;: Replacement therapy of alpha-glucosidase (GAA) for infantile-onset Pompe disease [FDA approved in pediatric patients (age not specified)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lumizyme&reg;: Replacement therapy of alpha-glucosidase (GAA) for late-onset (noninfantile) Pompe disease without evidence of cardiac hypertrophy (FDA approved in ages &ge;8 years and adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F2933646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Alglucosidase alfa may be confused with agalsidase alfa, agalsidase beta, alglucerase",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F2932594\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, flushing, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Fever, pain (postprocedural)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Diaper dermatitis, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Constipation, diarrhea, gastroenteritis, gastroesophageal reflux, oral candidiasis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Anemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Catheter-related infections",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Myalgia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Hearing impairment, otitis media",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchiolitis, cough, nasopharyngitis, oxygen saturation decreased, pharyngitis, pneumonia, respiratory distress, respiratory failure, rhinorrhea, upper respiratory tract infection, tachypnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Antibodies to alglucosidase alfa (may affect efficacy), infusion reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Abdominal pain, agitation, anaphylaxis (7%), angioedema, aortic dissection, apnea, blurred vision, bronchospasm, cardiac arrest, cardiorespiratory failure, cerebrovascular accident, chest discomfort/pain, conjunctivitis, constipation, coronary artery disease, cyanosis, dyspepsia, dyspnea, dehydration, ear discomfort, edema, epistaxis, erythema, face edema, facial erythema, fatigue, fluid overload, flushing, headache, hemothorax, hyperhidrosis, hyper-/hypotension, hyperparathyroidism, hypersensitivity, hypokalemia, infusion-related reactions, intervertebral disc protrusion, insomnia, irritability, lacrimation increased, livedo reticularis, lymphadenopathy, malaise, muscle spasm, musculoskeletal stiffness, nephrolithiasis, nausea, nephrotic syndrome (secondary to membranous glomerulonephritis), pain, pallor, periorbital edema, peripheral edema, pharyngeal edema, pneumothorax, proteinuria, pruritus, respiratory syncytial virus infection, restlessness, retching, rhinitis, rigors, sepsis, skin necrosis/ulceration, somnolence, stridor, tremor, vertigo, wheezing",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F3269349\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Hypersensitivity to alglucosidase alfa or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F6915304\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Systemic immune mediated and severe cutaneous reactions have been reported. Patients should be monitored for the development of systemic immune-complex mediated reactions involving the skin and other organs during therapy. Nephrotic syndrome secondary to membranous glomerulonephritis has also been observed.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F3269350\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Life-threatening anaphylactic reactions have been observed in some patients during and within 3 hours after infusions. Therefore, appropriate medical support should be readily available when alglucosidase alfa is administered.",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     Reactions have included anaphylactic shock, cardiac arrest, respiratory distress, hypotension, bradycardia, hypoxia, bronchospasm, throat tightness, dyspnea, angioedema, and urticaria. Experience from clinical trials and expanded access programs has shown approximately 14% of patients treated with alglucosidase alfa develop allergic reaction involving at least 2 of the 3 following body systems: Cardiovascular, respiratory, or cutaneous. If anaphylactic or other severe allergic reaction occurs, immediately discontinue administration and provide appropriate medical treatment. Use extreme caution if readministration is attempted. Patients who develop IgE antibodies to alglucosidase alfa may be at a higher risk for occurrence of anaphylaxis and severe allergic reactions.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Patients with compromised cardiac or respiratory function may be at risk of serious acute exacerbation of their cardiac or respiratory compromise due to infusion reactions and may require additional monitoring.",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; acute cardiorespiratory failure requiring intubation and inotropic support has been reported up to 72 hours postinfusion in patients with infantile-onset Pompe disease with underlying cardiac hypertrophy which may possibly be secondary to intravenous fluid overload from drug administration.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Infusion-related reactions are common; reactions may occur at any time during administration or for up to 2 hours postinfusion; discontinue immediately for severe hypersensitivity or anaphylactic reaction; mild-to-moderate reactions may be managed by reducing the infusion rate and/or administering antihistamines and/or antipyretics. Appropriate medical support for the management of infusion reactions should be readily available. Use caution with subsequent infusions; infusion reactions have occurred despite premedication with antihistamines, antipyretics, and/or steroids. Patients with acute underlying illness are at greater risk for infusion reactions. Although less common, delayed onset (within 48 hours after administration) infusion reactions have also occurred.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Cardiac arrhythmias (including ventricular fibrillation, ventricular tachycardia, and bradycardia) have been observed in patients with cardiac hypertrophy in patients undergoing general anesthesia during central venous catheter placement; relationship not well established; use caution.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Injection contains polysorbate 80 (Tween 80&reg;) which may cause allergic reactions in susceptible individuals. In premature neonates, thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported after receiving parenteral products containing polysorbate 80 (Alade, 1986; CDC, 1984). Infusion of polysorbate 80-containing solutions through polyvinyl chloride tubing may cause DEHP to leach into the solution; in immature animals, exposure to DEHP may adversely affect the development of the male reproductive tract.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Lumizyme&reg; is available only through a restricted distribution program due to the potential risk of rapid disease progression in patients &lt;8 years of age",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Only health care providers enrolled in the program may prescribe, dispense, or administer Lumizyme&reg; (Lumizyme ACE Program&reg; 1-800-745-4447).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298706\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6217680\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F2932583\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F2932584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Animal reproduction studies have not demonstrated teratogenicity or fertility impairment. Limited information is available related to use of alglucosidase alfa in pregnant women (deVries 2011).  A registry has been established for Pompe patients; women of childbearing potential are encouraged to enroll in the registry (www.pomperegistry.com or 1-800-745-4447).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F3269357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Liver enzymes (baseline and periodically; elevation may be due to disease process); vital signs during and following infusion; immune mediated reactions; volume overload; periodic urinalysis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     The manufacturer recommends monitoring for IgG antibody formation every 3 months for 2 years, then annually. Consider testing if patient develops allergic or other suspected immune mediated reaction. No commercial tests are available; however, sampling kits can be obtained by contacting Genzyme Corporation at 1-800-745-4447.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F3269353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Alglucosidase alfa is a recombinant form of the enzyme acid alpha-glucosidase (GAA), which is required for glycogen cleavage. Due to an inherited GAA deficiency, glycogen accumulates in the tissues of patients, leading to progressive muscle weakness. In infantile-onset Pompe disease, glycogen accumulates in cardiac and skeletal muscles and hepatic tissue, leading to cardiomyopathy and respiratory failure. Juvenile- and adult-onset Pompe disease are limited to glycogen accumulation in skeletal muscle, leading to respiratory failure. Alglucosidase alfa binds to mannose-6-phosphate receptors on the cell surface and becomes internalized and transported to lysosomes, resulting in increased enzymatic activity and glycogen cleavage.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F3269354\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      ss",
"     </sub>",
"     : Infants 1-7 months: 80-147 mL/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Infants 1-7 months and adults: 2-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Clearance:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants 1-7 months: 24-25 mL/hour/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 601 mL/hour",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F3269358\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/56/3972?source=see_link\">",
"      see \"Alglucosidase alfa: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     This medication can only be administered by intravenous infusion. Report immediately any redness, swelling, pain, or burning at infusion site or any adverse response during infusion (eg, respiratory difficulty, facial edema, pain, restlessness, tremor, wheezing). Report rash, diarrhea, or constipation; nausea or vomiting; change in appetite; mouth sores; respiratory distress, cough, or respiratory tract infection; or other adverse response that occurs between infusions.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F3269359\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Patients with sustained positive IgG antibody titers (&ge;12,800) to alglucosidase alfa may have poorer clinical response. Most patients (89%) develop antibodies within the first 3 months of therapy; concern is with patients with sustained high (&ge;12,800) antibody titers. Patients developing a decreased motor function should be tested for neutralization of enzyme uptake or activity. Infusion reactions are more common in antibody-positive patients. Patients with moderate-to-severe or recurrent reactions with suspected mast-cell activation may be tested for alglucosidase alfa-specific IgE antibodies.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Alade SL, Brown RE, and Paquet A Jr, \"Polysorbate 80 and E-Ferol Toxicity,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1986, 77(4):593-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/40/42629/abstract-text/3960626/pubmed\" id=\"3960626\" target=\"_blank\">",
"        3960626",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control (CDC), \"Unusual Syndrome With Fatalities Among Premature Infants: Association With a New Intravenous Vitamin E Product,\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 1984, 33(14):198-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/40/42629/abstract-text/6423951/pubmed\" id=\"6423951\" target=\"_blank\">",
"        6423951",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      de Vries JM, Brugma JD, Ozkan L, et al, \"First Experience With Enzyme Replacement Therapy During Pregnancy and Lactation in Pompe Disease,\"",
"      <i>",
"       Mol Genet Metab",
"      </i>",
"      , 2011, 104(4):552-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/40/42629/abstract-text/21967859/pubmed\" id=\"21967859\" target=\"_blank\">",
"        21967859",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kishnani PS, Corzo D, Nicolino M, et al, \"Recombinant Human Acid [Alpha]-Glucosidase: Major Clinical Benefits in Infantile-Onset Pompe Disease,\"",
"      <i>",
"       Neurology",
"      </i>",
"      , 2007, 68(2):99-109.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/40/42629/abstract-text/17151339/pubmed\" id=\"17151339\" target=\"_blank\">",
"        17151339",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kishnani PS, Nicolino M, Voit T, et al, \"Chinese Hamster Ovary Cell-Derived Recombinant Human Acid Alpha-Glucosidase in Infantile-Onset Pompe Disease,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2006, 149(1):89-97.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/40/42629/abstract-text/16860134/pubmed\" id=\"16860134\" target=\"_blank\">",
"        16860134",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schoser B, Hill V, and Raben N, \"Therapeutic Approaches in Glycogen Storage Disease Type II/Pompe Disease,\"",
"      <i>",
"       Neurotherapeutics",
"      </i>",
"      , 2008, 5(4):569-78.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/40/42629/abstract-text/19019308/pubmed\" id=\"19019308\" target=\"_blank\">",
"        19019308",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13091 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-125.69.132.100-32DA4B247A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42629=[""].join("\n");
var outline_f41_40_42629=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708603\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2932456\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10304109\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269346\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269355\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2932616\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2932458\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11216815\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269356\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2932602\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269352\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269347\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2933646\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2932594\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269349\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6915304\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269350\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298706\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6217680\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2932583\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2932584\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269357\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269353\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269354\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269358\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3269359\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13091\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13091|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?43/44/44741?source=related_link\">",
"      Alglucosidase alfa: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/56/3972?source=related_link\">",
"      Alglucosidase alfa: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_40_42630="Dermoscopy colors";
var content_f41_40_42630=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F71482&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F71482&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 625px\">",
"   <div class=\"ttl\">",
"    Colors seen under dermoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 605px; height: 263px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEHAl0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAON+LdvBd+DktruGOe2m1XS45YpVDJIpv7cFWB4IIOCDVKXwD4IiUNJ4R8OgEhf+QZD1P/AAGtL4of8ixbf9hjSv8A04W9bOARTQmcuPh54L/6FDw7/wCCyH/4mj/hXngv/oUPDv8A4LIf/ia6iimI5f8A4V54L/6FDw7/AOCyH/4mj/hXvgr/AKFDw7/4LIP/AImuoo60Acx/wrzwX/0KHh3/AMFkP/xNH/CvPBf/AEKHh3/wWQf/ABNdRRQBy/8AwrzwXn/kUPDv/gsh/wDiaP8AhXngvt4Q8Of+CyH/AOJrqKUUAcv/AMK88Ff9Ch4d/wDBZB/8TSf8K88Ff9Ch4c/8FkH/AMTXU0UAcv8A8K88F/8AQoeHf/BZB/8AE0f8K88F/wDQoeHf/BZB/wDE11FFAHL/APCvPBf/AEKHh3/wWQf/ABNH/CvPBf8A0KHh3/wWQf8AxNdRRQBy/wDwrzwX/wBCh4d/8FkP/wATQfh54K7eD/Dv/gsg/wDia6g0GgDl/wDhXngrP/IoeHf/AAWQf/E0q/DvwXz/AMUh4c/8FkH/AMTXT9aBxQBy5+Hngsf8yh4d/wDBZB/8TR/wrzwX/wBCh4d/8FkH/wATXUUUAcv/AMK88Ff9Ch4d/wDBZB/8TQfh54K/6E/w7/4LIf8A4muopAME+9AHMf8ACvPBf/QoeHf/AAWQ/wDxNA+Hfgs/8yh4d/8ABZB/8TXUnnpRRoBy3/CvPBYP/In+Hf8AwWQ//E0v/CvfBXP/ABR/hz/wWQf/ABNdTmgYNAjlh8O/BWB/xSHhzP8A2DIP/iaUfDzwSeng/wAOf+CyD/4mupHApvU8cUAcu3w78F/9Ch4c/wDBZB/8TSf8K78F/wDQoeHP/BZB/wDE11XI5PNJj3oA5YfDvwWf+ZQ8O/8Agsh/+Jo/4V54Lz/yKHh3/wAFkP8A8TXQXd5b2aeZcyqi+/euZg8WXd+5/szSJpFIyhkO0Ef3vpVRi5bIuMJSV0Tf8K88F/8AQoeHP/BZD/8AE0D4d+Cz08H+Hf8AwWQ//E1g3GseJNTuJbYalp2gywnLRyIQ5HY7m4IPtWS8kOr6mF1PxPqOqxIu14bQ/ZbIN7spy30rRUJMv2T6mp4r+H/g42wex0XwrY3URyTNYxCPHuAvWsXw9pvhS6XE3gvwjeQxsY5LmxtreVUIHfC8Z9K25vD/AIPe0+z3ehW0tqx3HLOefXOc1D4Z0zwVompPf+DdIL3cga3ljti2xeed4Y4z/Sn7NWtZjWita5aGhfDsxsy+DdHfacbU0aIk/QbeadZ+G/AtxMVl8CaTZxgZ8260m3QH2+7XVQNeySZjt44gRk7CMg9xUOs2d5dabPBLaw30UiENA743fQ4qORbEtR2KX/Cv/BBZQPCPhwsw3Af2ZByP++aUfDzwX/0KHh3/AMFkH/xNQ6c9z5FrFfWUskNo4eGSNiskRAxsZR1Hb0xXS29/bT8JKoYfwtwaUoOJDi1oef8AxH8CeEbT4d+Krm08K6DBcw6TdyRSxadCroywuQykLkEEAgivHfCeleHpPCujPcaHpUszWULO72kbMzGMZJJGSSa+gfibcwP8N/GMSTxNINGvcoGBI/cP2r5Y8Par5egaYmfu2sQ6/wCyK+c4gpTqU4KDa16HfgXyyfMjvP7H8M/9C9o3/gFF/wDE11Pwes9MtPinD/Zen2dlu0a88z7NCse/E9pjO0DOMn868q/tj3P516B8ALz7X8U+udujXX6z2teRlGHqwxkJSk2tevkzqxU4uk0kdV4+1vx7pnxLs/C+i6nD9j8TFX0+8lhiL6aIfmuQF24kynI35649607T4sXFz42n8P6f4Y1TULSz1JdKur+NJWaN+hmdVh8sRg9SZAcHIXFem3Gm2Nzf2l9cWdtLe2m8W9xJErSQ7xhtjEZXI4OOtULrwt4fu9Yj1a70LSp9VjZXS8ls42mVl+6Q5G4EYGDnivtTxz508CePtU0qx8GaxrWp6tqFrFoOq3l3C1y8huGjuXClgTgkAAAnoPYV3l78bLnTra6fUfDMYktrWz1GX7NqPmxpaXDBd5fyh86ll+QAgjJDYFepWnhrQrMW4tNF0yAW8bww+Vaxr5cbkl0XA4ViSSBwSeajs/Cfh2xsLuxstA0m3sbzi5t4bONI5/8AfUDDfjQB5z4e+Na694otNEsPD8puLm5uNjvdBVFlHGHS6J24w+cBenH3jXo3gvWpfEXhfT9WuLa3tZbpC7Q294l3GnzEYEqfK/TqPpUtp4c0SyukurPRtNt7lLcWiSxWqI6wjpECBkIMD5enFXNOsLTTLKKz021t7OzhGI4LeMRxoM5wFAAH4UAeKeDviZq83hqbXfEc88Y0rSxdf2esMYl1Xcdv2jIUgRBiFAj5ByW6ha6bT/iTq93PYWZ8Jyw399etZwfaJZ7eFwLZ5g4aa3RyAYyrfu+Oo3cA92dA0cwWsJ0nTzDao8dvGbZNsKONrqgx8oI4IHUVDpXhbw/pBjOk6FpViY5DMn2azji2SFShcbQMNtJXPXBI6UAeUeMPi9qUema9baTZW0NymnXl1YalBLNJExgZVY/vbZEcgMT8hkXcu0kZBrpL7x1rGma3e2VxpUM2og6bClrHqINsr3MlwgZZPs6v0jUtkH0AGCW7CHwh4ahuri5h8PaPHc3Kus8qWUQeUP8AfDHblg3fPXvUtl4Z0GwjRLHRNLtkQoyLDaRoFKMzIQAONrO5HoWJHU0AUPCHiuLXLYpfR2+n6ot1dWZsxciTe8D7HaMkKXXoc7RjIyBXTVRh0jTYblLiHT7OO4R5JFlSBQytIQZGBxkFiAWPfHOavUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcl8UP+RYtv+wxpX/pwt62c1j/ABQ/5Fi2/wCwxpX/AKcLetgjmmhMbPIIoXkKs4VS21Rkn6Usbb41cAgMM4IwaC6qeSB9TUbXMI5aWMDuSwxVahZktLWPJ4l0ZH2f2lbM4JyEbd0+lV7vxPDbwidLC/mtjx5qx7QfwOD+lNQk+g1Tk9kdB3oPFcpH4506W4NtDb3bXW3eEKbRt9cnimHxtbvK8VrZyTvGAZir/KgPTnvVujUXQr2M1ujrgKXvVWwvob6JWhb5iMlCeRUOuanFpNg1xKNzFhHFGOTI56KBWdnexCi2+U0MjJG5d3pkZpQpPQGuK07wZZ6jv1PxFaMdWuOZGWZlKrnhOD0FWD4D0tAwtrvV7YMCGEV62CD9c4qnGN7XLcYLS51pUjOQRik7VgaD4YttGiSKO+1O7VWDA3dwZDkdPyrf6/SpatsZu3QKKq3eoWlnJGl1cJE0hIQMfvH0pVvbZk3CdMepNFna4WLNFMSaJ8bZEORxzT+MZHNHqFrBRQDk0jMqqWYhVHUk8CkAtB45qhc6raxQmRZBMR0CH+vQVw2qeKNd1FtuiRRRRrnLL8+B33MflArWnRnU2LhSlI9Hz+H1rPk1WBmZLRhO6sUOw5AI615cdT8T3cDQpIl6yH5pY1Kr9M9K0PCFvoyIsepPd2WpbiHSScqAc9iOCK6Xg3GPNJ39Db2Cirt3O5ivdQwGlgyn+yhrP1DxeNPlWK5027kckgmPGP15qK606wZmitZL+6nIyUhuG4+rZwKwrrwprlgTqGitCt0hLi2llaUv/wADbv8ApWdOnTk7SdhRUG9TZ03xRqkiLJeaU8cTyMFJyDt/hJzwK6bTNVttQ3xxkx3CDLwyDa4HrjuPccVyeheLb29jNnqOmbNTjX97EWCr+RNR39nqSsJoLFo44jvjRJQzKe5jft/ung050LOzVvmJwvurHaDUrIXgs/tlt9rPSHzV3/lnNWTzXjeu3mnTwTPqOnJJqs2I4LuJBFLG2eGlA5DL1yODiu+0mPW102NrbXLTVC6jFxLEOvf7p5+lZSouKTYpUeVXudPk4rP1XU4rN1hDA3LqWEeeQv8AePoK5zWLLStPuRf6nPcahqrp5SIshUv7BF4Arm7HQNWmvlxHJAkrl2jkbJAzwXJJJA7Lmrp0E9W7IIU47tnQyLfapcbbS2UKx+aa4OQR6qo6D69a3o1i0OzWFHe5u5T8qsfnlb+gH5AVS1WK30LSpr2S7MUip1bGHfHAA+vas3QZLGaFbbT9QF5dzLm9vN4LID1RfTJ4A7U3HmjeOw3eS02Kes6Dd+KdXVr+Q3Gl2n3oQcRyP3Vf72O5PetE+J/C2ixiz82CAxfJ5CR5KkdsAdam8TeJrDw3pJVWRdoEcSKc49/w61h6Tqc97ZrDpFqIbdRkSyxkvJnksfqea3hCU4LmVo/cVGLklzbHVW9rBqcYuXCrGwyqpwQD61w/jvS20KFr/SNQnju2OBFHwzDv07e+KxvFR8Q+FAt8kzRWMp2ySR4Plk92U9AfWtrwF4RGs2f9s6zfvePcA7VilDAL/tEd/at1SVFe1lK8exXJ7Nc99CjoHijS9RsRHHoWrNNFje1tIzOCO5I5roYvF9sECtHrKDoTJbtkfpWpqfhyW2UXOj5MkQz5QOxnA7Ajv9eKl07UNUuLdprWa2uok4eKcGOVW7qccA/UVhOVKb5oLT1IcoPVI4HWfGdjYagLrQ9Wv21EYV7W7QiGYfzH1rpNJ1SPx9bSQlrfTyn+siX57j6gnhR7jJrn/iD4gfW7Gewj8NzyiM7ZLsdI29iK89066No9vcx+fFqdqcwTLwWUdUcf1rup4SNWldaS+83jGMo9mej+MPCmkaf4I8Xo9s6ajb6PeTQ3LSEtMnkPnnvzwR718k2Oq+XZW6Z+7Gq9fQV9HeMPEeq6x4D1m6X99bNYXSM8eG8otA4YHuARmvkxIHKKQTgjNeFmWGbaVVkTU4PV3Os/tj3/AFr2T9k+8+1/FS85zs0Wfv6z29fOHkP6mvev2MoynxT1PceujTf+j4K4KWHhCakjOc5NWZ6J8R/HnjHS/GfjtNJ1K8h0zQG02RNtvaNbQRzKplM+9fOfPO0RknOc4GK2LP4hz6P4v8cSG7S/jk1Kxg06zvLm4AxJbbiII44ZnJJwSqoOuSR39Wv/AAf4a1HVDqWoeHdGutRJVjdT2UTykqAFO8rnIAGOeMCn3/hbw/qP2k6hoWlXRuZFmn8+zjfzXUbVZsj5mA4BPIFdZiec+GfjHP4pPh+z0Tw8g1fVY7mV4L6+MEMCwuVYCQRMzsSOmwYHXFYnhv4iajp3xj8R+HLxZbya/wBUggt1uL11tbJRb7nCOykFifuoACx64r1y48G+GLjTodPuPDmiy2ELtLHbPYxNGjt95lUrgE9yOtSt4V8PMHDaDpJDyxztmzj5kjGEc8feUcA9QOlAEXhDXZdftb+ae1trY219NaKsF7HdB1jbAYlOEY90PzL0Nb1VdP06y01JU0+ztrRJZWnkWCJYw8jHLOQByxPU9TVqgD5x8JfE3xlqel+DbW7uP9Nk1C0k1K9+zIFubS4kVYkA27VJLSqSoBH2c9N3O/rXxQ1DxB4S1p7DRdT021a1kltdTjW5TaUlVdru0KIrMCSNkj9CCRXsMej6ZHY2tlHp1mlnaMj28CwKI4WU5UouMKQeQR0qivhDw0t3d3S+HtHF1dqVuJhZRb5gSCQ7bcsCQCc9wKAOJ1L4sfYfEd3py6XFdWkaXvlXdvNPteS2iaRo2Z7dY8/IynZJIVI5FPj+IeoT3tnZahpX9nXUs+myr9kvlnV4Lp3UBy8IwR5bblUfRx1rtP8AhEfDf9oz3/8Awj+j/b7jf51z9ij8yTeCr7m25O4MwOeoJ9azvEd1oukavpVs3h83+o3YBiW1tYmeKK3wRISxX5YzIMBctl/lUkmgDM8EePr3xDqWmW9/okNhDqllPfWkkV6Z2KxSIjCRTGu0nzFIwW464PFRaz43v9O8T3el2Gni/uJdUttOgjubxYIkMlo85bKwswH7sgg7zzkY+7XY2Vlpdva2t5aadDAsFuwg2WmySKJ8MyKm0MuSqkpgHIGRkU6LT9Mu5ItQ/s63M8jpdLLLbBJQ4QqrncAyuEYrzggEjjkUAYmleLLnU/AD+IbXR5Zr1VmH9nQy7y8kUjRsqvtGRlDg7c47Z4rj4fiD4g1DxRoUdjZ6Wtq8F+b6zN3MjK0Jtzz5tqkiuqy5CFVDb+SMA107634bf4Yyaw+kK3hyWJpXsDbRnerSHcDHnYSWJJ55znrWyvg/w0tpaWq+HdGFtaSGa3hFjFshkJyXRduFbIHI5oA4PUfivf2XhXTNafQbMtf6f/akdit9cS3AtxGjlyIrVwoy2NzFV+6SykkLFYfEfWYbrxLqF3YW1xokF9p0Fqv2rZLAt1Ha4BAiwR+/ZyS2Q3yDjDD0TUPCvh7UbWzttQ0HSbu3skCWsU9nG6QKAAAgIwowAMDHQUTeFfD08sss2g6TJLLbi0kd7OMl4RjEROOU+VflPHA9KAOPvfiRfNrFxpui6HbXlxDe3loWm1Ewpi3hikZiRE5yfN27ccFeTycaPgHxvd+JruCG+0eLT1u9Lg1e1aO888tDKSAHBRdrjAOBuHPWui0/w3oWmpGmnaLploke8osFrHGF3KFbGBxkKoPqFA7VW1qfR/COjvqv9nRolpDFZxR2cCCQoXCRQJ0AG5lAXIUZ7UAc7ffEC8t7HxHqsejW76Los81o8jX5W4kmjwMeV5ZVULMBuMmdvzY6AwH4h6omtw6E/h+zbW5L37GY4tTL265tXuFYyGIN0TDDZkA5AbgHqoPD+i38/wDa954bsYNVuYSkz3NrC1wFZdrRu67gePlIDEEccirOm+G9D0uO3TTNG0yzS3kaaFbe1SMRyMpVnUKBhipKkjkgkUAcDJ8Vbqy+03Oq6BHFpsU+p2yy218ZpXeyWVn/AHZiUBWETYO7IOMjHNS6H8T72+lsEvvDN1ZLeX1taRTv9oSJlmjlbcrTQRlmUxgFQMfOpDGuxkh0WCxur4aXEEsZLic5svLbzCG8103KMl8tlxw248nNUdC8NeENQ8NxyWPhjR4dN1aKG6ktjp8KrKCN6eYoGCRu98HOKAOWufipeyRO+kaBbXYjt9Tu5DLqRiXyrK48klSIm3F8ggcAZxnvW94V8cnUbq/t/EFnZ6M1vDZ3Ebm+EqSJdFxEpZkTEm5CpUZGSME10Nt4c0S1hENro+mwwiKSAJHaoqiORg0iYA+6xALDoSMmodU0bRE8m9udMQvbyQOjW9uzPmPcsWVjGWVPMYgEELktxjIANuiiigAooooAKKKKAOT+KH/IsW3/AGGNK/8AThb1sZwaxvih/wAixbf9hjSv/Thb1sU0JmPHpM815cTX140kTsRHFGNoVe2T60N4es5pFNyDNEvKo3AB98da2TRjFWpsr2j7kFtZWttGI7e3ijQdAqAYpt9ZRXixrNnCNuGPp/KrNFLmZHM+5X+w2vy/6PFwMZ21OEQJs2KFxjbjjHpUNxe21t/x8Txx/wC81Zh8UaOJ5IPtTeZGQGHlnBz6etWo1JbJlKMnsZk3g1LWKQ6Hf3VnMeVy+5VOc4Ge1WdN0K9fWRqmv3i3MkK7bWFF2xw56t7t2zRN420NI5DFcPPKnBijjO7P48D61x2o+JrvXG+zPpsF+S26Kztrvt/fkYY6DsDXRTpVp6NfM3j7SSserDOB3HrUF7eQ2URkuXCgdB3Y+gHc15ZdJfWMQmgtbvTpJcRpFHeHMjdgASc1c0XwdqNwv2zxHcS/ayOMzE7B/jT+qxiuactPxJdFJXbNrUPEGtSTO2nWDm2ReVijMsmf9rsPoM1lP4q8SxxLB/ZFxLPMSIt8PlvgdSRnpW1/YNvaKbm21W6WSJDlDcEJt78dvrXFWut6vcandXXh2aRLY/IZL3NwzY6lAB09q2p0oSvypNLuXCMXrY37iz1y7sS2o2scaY3Nhd8g9wegrmbzxFqVzG9ppUT3VuuEaaWIZyPTGM4qW9bWtVaON9f1S6urhgqWMMAtkY9Tuz0X15zXQW3i210m6XRdV0gQXka5xEu6MD13AVulyrZPyNIvTRXKfhe0RolRNTje++9NEXKPn/cbg/UV0ohvbbkXrW4XpuTA/PvVO90m08S+XKtvpUbr/q5hkyL9CMVWC3eg3ccHiJWv7B/kS73E7PZh2+tc8rTfn2M3aWxYudR1uyE1w2qaayFeGlXIQj2HWud0nxJc63qTrrGoQxJGdsW9THBICeoXv+JrvRpeiyQgwQwLGeTgnB+tZXidrGXSprS0to764KbY4kUbUJ4BLHgAVNOUG+Vx1/IUHHa2pSeOwvJzCt3Lfqp5EbDax/uoo4/E1M95a2Ui2dyBPcdYtKs/m2/7Ujf48VyXhvRdUgmFhpNwsMX/AC8TheNx6qhrtLTSx4ViaV9QtRHIdzGdQHY/73U1tVhGD5b38i5pLRO5KdMvNWVTqMKJb/wW0R2og9yOSaytX8CxPAwsDNDIfmXc+9c/jWjp/jqx1C8ms9PRr2eEfMISOvoKzPFfjaTQgo1G6t7C6lBMNsR5jAerY6VlB14yslYmEarlaKKGi6l4m0V5LeVbWZFwDC/ysv8AtD1FbsXiBJQTqKXoI+95cR2gexFeLa58UdSudUt7pRHJc2gwrQx7Y5ATyGB5IrvPDXxgt9aiS3ma00i5A2sJkZ9x9VAHT611VsPK3PypvrY6a2FqRXM4F/xDa+EdQtm1Gxnjh1KH5wJ5HUTgdY3z69PrXQeF4NK1bSl1LwnczWMuNrxBy6q3910bP6VlvP4X1l/s+p6615cTL8qSJ5aD3AwMfiaxLTQ9Q8Ia1J9gaSWydfNCwyYaRO5HqRmslTU48rk1JbX2MlBSja9n5nX6oiWs0Wp3lrCNUgO0FRlJM+npVqfTkuQZopPsMr4aR7X5dx7+1V5NOXxDpUctjq1xIkgyPMIypHY8dRUdlNf6XOtrrMYlgX7tyh4H++KytdaPVdDK11vqX4ItK0C0m1GUb7sDCvIdztnoF+tUo77xNuef7PZpLdkeRalS8qL6uc4FT315Y2zJq+rTJHaRcWcbjJlkP8QXv6AfU1XvvFFtYQzSo4ludheQ45Qdce2KiMZSeiu/MlRb6alWXRJrzUCdZv8Az5FG6UIMhAf4R7n2Fc9448Q6D4PtA9npSRXrfKgYFNw75wea43Vvi3Jp8E0duomu5WLE4+UE9Mnv9K82utSvtf1qKbW7ie4VDliFJCf7IHavToYWbfvvRdD1KGDl8VXRLodBP8QrufUDfT6dbSIp4jYEIPToetVbr4meL57oTwajLAqkBY7aILGPQYx/Op5dEi1e4h+zW8tvaJkySYwZfQAf1rStfDptoVWLcqZ3bRjAPuO9d0qVN7nfFU18MDh7+61jU7hpdUkvpxMw3szFgT24q7p+seIPB0hTTb2905SwYiMgoT6kdK7W40i+eBQ9xBbRo2RsU7z+P0qpc+HkltwTIstxGxKTH+Jf7rDv9aOSm426Fc/NGzivuNTSvjr4itoR9rSyviF6umwk+uRWVrfxPv8AW777dFENNugu1haN8so/281l3Xhk3VwHgtI0hC/MpJwW9cCrdp4LtD+8liVXP3RGDgH6GojhqVOXNFGPsaLd+Sxv6X8YNSs9Hewn0yzc7doZhwV9xnmuc/4Sa3lkMl8GcE712Db5Z9AB2rYbwsVSFprS0vIQCvzLtcKO1ctq+gG2uJDb/uLYgssMh3YbB+XPpV04Qi24dR/VsO3pGx0mrzwP4P8AEF1o92AjWU6TwZ5ZWiYZ/WvD7S13WkLY6op/SuinuprfSr4R+ZCZraVWQ5AZShzTNKtVbTLMknmFD0/2RXzPEU+SUGctbDKM1Z3VjF+x/wCzXtX7I8PlfFS+4xnRp/8A0fb15z9jTONx/wC+a9Z/ZhhSH4p3Gxi2dGuM5XH/AC3tq8DDVnKokc2IpKNNs+q6KKK9Q80KKKKACmTqXhkUDJZSMbiuePUcj60+mTmQQyGBUeUKdiu21S2OASAcD3wfoaAPF9C+GOvaPbQvZWugQSWWo2t9bW/nAtN5ayoyzXMdrGzfLL8paORsgksd3GRe/DjX7q+GnXuj6JqFzcWGpObq4kl+zWctxeGRXjbyiWlUPkD5DwcNVvQvGXjG5tPAOqXEFneXN1ol/dzQ/wBotDFdKgtSJZAsO1ZBucBArAbvvDJrqT8Up5NMvtTttCVtPs7e0md5b3Y7G5iR41ChCOGkUMSQAMsM/doAxYvhVrMXjVtVn1CO/TzRIl69xHFcAeT5flsPsryMnX5ROqkHO0Ec2bL4P20Fv4WZtP0Nr7TdDlsry4aLc8t2Y4FilDlMkIY5MMcFQwCjsN6w+IU7eJbPQdT0mC2vn1GTT7iSC+86GIi0NyrK5jUtkAKVIUgnPPfFf4vXM2lXGoadoFtLBZ2kd5dmfUvKIWSaSJBFiJvMJ8skk7RyBkmgBNN+HOpWU8n2vTvD2qyS2MFtDqF1M4uNPZLVYWSEGFsoWUvkMh+dsg1mn4X+JW8UeG79pNCWLSX0/wD0iEKk5jhjRZULfZzI+7D4/fKuCAVq/pnj3UfD91qp1iye80iTWtSghuheNJOnkxyTbBCUwE2xMow/X+HHNaKfE+6gmtINT0O2inuX05k+zaj56LBeTeUru3lrtZSCduCD2agC/wD8IZqP/Cn/APhFPOtP7R+zeT5m5vKzv3dducY9q5k/DDVr34iz6zrK6KdJne9juVtERJLm2mjZFR1W3DswyhJeZwSCQBwK1E8ca3qfxH0vTNHtbIaYJdRtrlZbvHm+Q9uPMBETEFRIcICAxY5IwDWh8T/iMfBBJi0+LUvKtjd3EKyTiaOLdt3YSCRAvDfNI6DIxmgDh4fhxr/iXwfZ3t9OratJdRNLb38axCe0gjaKFJFlhlCtyZiGjbDSMMAgEb+k/C2SGOb+1ILW9C6Cmm20c14WeKYS3LbllWBAgCzKqyLGGUAgL6p4c1jULj4kRQPf3b2japqaCFpmKbFgtii7c4wpZiB2ycdauaz4uufD/i/xOAy3ZJsIbSynmnwXeOZmEaRRSuWITJCpyFySMUAanwy8J3/hjw/qOn3SaZZedKWgGnJHuRSirud0hhV3yDg+WDjAJbrXDx/B7UJ9KSzu7Pw5CI4rOGUxM8g1F4rqKSS5nDRjEjRpIuPnJ81gXwa39L+LbX2n6fKdCaO71SJTp1ubk/6RMLkwSxkmMFfLO1ySPutkgEEVGfi7Ow1y4h8MX0mm6dFfulztuFVmtVckSOYBEgcxsAVkcg4BUHgAGz8UfBFz4l0HSNP0RrSC30+4WQ2MgjS3ljCMiphoZUAXIIBjYcdAcEed3vwx1e71X+x102zk8rQLW2j1a+uGkNhILq5fdbutugeRFZcACLaNvY8+g33jvWNP1HTItQ8PW1pYXgic30t5M0MQkfaqMyW7KsnI4dlXLKA7ZONPxj4uutE1S307TdNt726eyuNRkN1efZY0hhKBsNsfc+XHGAMZJYUAcXrnwx1a8ubmR4NC1eCafUXW01KRxFC1w6NHcACJgZVCsMYH3uGHNVrP4T6zB4r0fU7m7t7mK0FgQ6XKRSW3kRRo6RlrV3ZGKMdokiDByCOSTvfDbV9Q8T+NvEWrXCSppsaWyWcZ1GXESSW0MwU2+0RliJSS5JYH5RkDNVT8XZ2GuXEPhi+k03Tor90udtwqs1qrkiRzAIkDmNgCsjkHAKg8AANL+Elmtn4Vg1bT9HvBYtK2p+Yhk+1Eo6x/eX5wpYYDYC9qzNN+EN9p2hWlrZnSYLttKt7S/kjZ1Fzcx3MUpkY7Mv8AKjgM3PIGAOm0/wARr0anDYanphsLmK7szILK8FwjwzxTOoYtCDuHlHKAA8qQ+M5wZfidqNtqUXiO/wBP2aZPoKXVnp9rfPcGXzrqKON5VWPCN84B2iQgZAyeCAdT4H8FX+g+OdX1Z7XSrexvBMdyOtxdOzyhxmX7PG4Tg5R3l/hAICjOff8Aw81S48Y3WpJHpB83UGvV1ZpJPtwhMOz7Lt2Y8vPH38Y/gzzV3RviJq+qanp2mDwrJa392br/AI/Jp7aIJB5B8xTLbrIysJyP9WMMhHQ7hRT4na9P9ma28K2DR3cF9c2xk1hlLR2jhJN4EB2klhtAznuRQB2Pw68Lw+E/CGlab5Fql/FZwRXs0Az58qRqhYsQGYfLgZ6AAYAGK6avKU+JV+0WpXun6Nc3tus9sD50reVaRyWUU+4+RbySAZkwch+cksq4A9E0XWbLVreI213ZzXBt4riSK3nEmxZFyjdAdrYOCQMgdKANKiiigDkvih/yLFt/2GNK/wDThb1sGsH4uTfZ/BizEqvl6ppb5Y4Axf2559qyZbvxFrYik0yOK3tEOWeQlfP/AN3vt961p03PyRShzdTs8jONy59M02WeKFC00scaD+J2AH61wc2lXn/MU0rSpCPW4ct/KsXUZ57m6SLT/DdrcfZwXMjuZlibHBC9PzrojhebZlRo36ndzeLNLVysErTjO0PGPkyOvzdK43UfHmravcT2vhmwIgiB828c/KoHXB6VleHoLLWo2uZnur2Rn2tbswiUMOCGI+VVHoK7C8GlWlru1zVLOK1iXcLG2IEYx7Dlj9a6HRpUHZq7NVCMHtc4SxhtbuSa51G7tpGIzILuWRicegXgVJb6GmvZuhp62ulwfL5sBZZJQOuCTwPrXWpDe+M7WMJYPo2iA5XzBtluPTj+FfrWd4o8NXfhnTJdX0jU22WqmR7S8JaGTA9PWuiNdOXLe0nsuxqqi2vqRWNvpkZS2tNA1SSMjKyXCnacduvT3qLWYLMKvlaLqVhddUubAfMhHt3HtVdNf8UzaFHqviLUrLSIZQrpbbsSbT0yO1c/q3xPt7BVSO8uLwHIMttLsdD64PBFUoTctNX6s1p0Ks9Yxudp4U1m5m1NhrEiJcRII7e5uoth299q9Nx7nNdNqd7YW0JlubqW5foEDcE/QV8w6548vdXv3lmlmkjUgReaw3AD1xxVW58T30qbI7mRN33m385+tazwCk1Lb0OqnlMqnvN2PdfEst1r89rpFhYRFpzuZA2CsY6l2HQdsV0kdrrOi6dBbtfaJp0AGyNYYWJUD0z9418xaF4r17w/dyz6Xc3QJ+R22lga27b4mayk0j/Znub6U4M04Z3+gHYewpVMJN2jC1l+YVMud+VSVketa/qlzb28ktrrWsS3RBKyJ5ccY9z6D8as+BviRoEOk+RqU5hvwxM28bmdj3J714Dq934k1u7Et9HKiyHIQgqMf7tVYNH1m5nMgUboj8wLbWx6Zq1glOHJJG31HDuFpSd/I+ptW8U6e1m9xFHaxQgZNxNIqfkBya4bVfiYunBItPvrfV0kwv2YKXBz2ya8WuvDt/dSqVZkUcHzn3H8AK0LLwdcJGXN6xYdo06fnShgYQdnqiYYGhF2bbPSrHxTqSQYvNNWzsD8xEkW5QD0HB4FYviX4gIYmghummWM7kigTYhPua5QaDf7jHI91MMZbe4VfpVu28PSuVTyooiO5O6upUILWyNfq2GT1uadp8U/FY0822lWlvCcYWWOLc4H48fjXH6nH4l1edrnVb55JWHL3d10HoBnj8K9As/D1vBCyStIzOP3jZ6/T0FSW2l6TZMClqrNjq43EfnUqFNO6Wo1CEXenGx5/pllqenypNY3ccc/QtBIwOfrirB0HUdSuzPdXU008hyXKk8+7NXpkckRiKxqBkdBxULj93lELBeCD1FVzRTvYvnexxsPgYR2bnzvMu2YbfNchFHfpVK78H6jDKJYFgaeLBHkSlW/DNdoN53yjCInJ4yPxrQUSzRK0REbcEZHWhza3M1Ud9zzCDUte04kRXM8iRZLQSjOD3BU9a1tM8bz/aLaewEtpNC+4xLITFn2U/dzzkDiuq1W1eWVTJAslynzK4H61yuq6EuoXYntCtrfqM7SvySex96ajF6pGqnCppNXPVvDPi2LUz9p0NYbbUy4a5sJXwk+P4kPZq9ECT+JNPRpI/sNvIMEhg0hHcZ7elfOOg6Va6tK1mbpdK1pfu2t0cRzn1ik45Poeani17xn4PvJLeIXwjDEGJwxBPtmuCvhYyl7jtJdzgrZdGq26EtV0e57lcaZpXhy7ZoZDLqTxmXzryTcLaJer5P3Bz+NeGfEHxIur2k/9nSPZeGjIyrMFxNqsoPzNnrsB/Cppr6fUdGkufGGoQxabC4kk0yGUm5vZP4RKTyFHp0HauLuHvfGWum8uQLe2XbFBBCuERB92OMdv8mtMLhmpXk7hh8J7F809ya18Ov5FsyybdSuACgPIgj7s3vjpXbeH9PtNLtTawTGUkmSV36E45Jos9KfToVEcZlZMbo1OcexPerRsJbi1YSMsSMApUc7QOevvXbKfROyOpybld7l2CSB5iihhtUMRt2gg9xRd7iQluVU+lRWmDNIZZZJ3ZVUt0Ax0+tUpJgshOT524hge3PBrLl1Em1qzTt4yUJkOSOME9fesq5kfOUUom7buxwa3bmJoplDEFdu7cOh4rPa2eaLyoriP7PnfyPmFEX1HzW1Q21geC2WU/vJHOBk4Gakt5d9zLDexyQXKHDAtVyULNYx26jy0iwwk6luc1RH+m381zc3KzOTyEGAB6Ur33DmblrsWnuGgk2Ih29d3U1V1HdeRbFiV3dd24gZ2596vRTpIRtyBt43Uy8gEkaGM7ZOQp/+t6UloxOWmhxvinTluPBGqeZsuGhtpZRvXayYQ4K/T9a4vRLfdotgfW3jP/jor0XxcWHhzWfOHzjS54l29MCJq5Dw7b7vD+mHHW2jP/jor5riO8nD5nPOV5pvsVvs1emfs4R+X8U5PfRrn/0fbVxn2b2rv/gDF5fxT6ddGuv/AEfa14GEjaqv66GGJlek/wCup9KUUUV7J5IUUUUAFFFNkRZY3jkUMjgqykZBB6igDKsfDGg6e7NYaJpdqzeYWMNpGhPmbRJnA/i2Jn12jPQVh3ms+E9L0fXAunRiK00gaheWK6eYnktEWREBR1UHiF0CtjAA6AiuY0D4ceIrI+H7XUdciutI0+6Uy2jO7L5FuB9jEYIwHDKGc9yeCdq1kf8ACotSjsriNbPw7c3d14ck0g3czsslrORcASxnyiWDCZEY5UhV/i4FAHqNv4X8M3GgQWCeHtJ/shmFylk1lF5KuR97y8bd3PWsfxL8MvD/AIgn083EKW1pZKEjtbaztVTaH3kBzEZEBPUI6559TmXwN4OXwrrWsS2cNla6beQWix29qNoE0auJZGXAGW3J83JOOa4LUPhNrdzY6vbRDQ4Lm4tL+BtTWWT7RqTTtmP7SPL+UJ/vScgYwOKAPYhpGmh0YafZ7kna5U+SuVlYENIOOGIZgW6kE+tZk3hzwxpWh6jCvh3Tk02Yebd2ttpqyCfHPMSITIfQYJ9KZr3hOxvfBWreH9Ogiso7yCVVaMbcSsCRKSOS27DFjkk8nNefa98NfFWu6feR6vrVneSzaTcpGsrSbIdQuAFcodpKwKgKqAM/M3HNAHVXH/CEWkFnFDoWmyx2esx2EUcOnxgWt4xXDKGAAIymWXngYziuk1vwzoOvSxS65oml6lLEpSN7y0jmKKeoBYHANedXPwtefVdVDaT4eNle65Fqj3PInmhDIzwSJ5WCMhj98gluQMk1Qv8A4UamIpoLe08P39jnUI7KyvZJEh05Z5t8UsIWNsOq8bQFxgbXFAHr0Ok6bBdC5h0+zjuA7yCVIVDBnADNnGckKoJ77R6VlxWHhjxhpS376ZpuqWN9sk33NmrCXZuClg65JXLAZHGTjrXC3Pw98Qf2tJEk2l3mlXOq6dqdzcXU0gnb7PHEkieWIyrbvK3Alx1wR3re+HXg258M+C7vQ/sulabcFXjS90wndNkELNIPLTDjI4y3T71AFuHTNBj8daXp9raNbTaPYSXdpbQRRx2kYmkKM4AGfM+Vh6YdupPGvJ4S8OS391fSeH9Ie9ukeO4uGsozJMrrtZXbblgRwQeo4ryMfCHW30q8t4YPD+kSyafa2kn2CVmF/JFN5jvOXgx+8HB3LJ77xkVu+FfhdLZ32hPrEFjNY2P29pLN5lnjDTG3KeWqW8MYQGF227BtYgjJ6AHol34a0K91K11C80XTLjULUKtvcy2sbSwhTlQjkZXBJIweM1LrOhaRriQprel2GopC2+Nbu3SYI3qu4HB9xXkVt8EoF0+CK4sNCkuP7EvLOZyhPmXsjqYZiSmTsG8Bj8y5G0elp/hx4lm8faRrk82i7LK5t5GuYtqXEkSQiN0c/ZzI7E7uTOFIwNgIzQB6F4Z1fSb/AMM2/iXTbGW3ttVjiuWCWuZ33KqIXWMMSQoUZ5wF64FM1rwN4c1aLVjJpFjb3uqW01rcahb20aXRWVCjESbSc4PfP41h2/grUY/g7pfhNprT+0bWC0ieQO3lExSIzYO3OMIccenSsP8A4VFFcX7TXsOm5u9R1WXUJosiaa1uvN8qPdtBJUuhwTgFcgk9QD0PSPCug6PZQWum6Np1tDDIsyLFaxpiUDAk4A+fBPzdeTWTYaX4Sg8T6poNl4b02C7exS6u3jsYUjnimkddrEDLEtCSQRjp17ch/wAK31yfTLS6119H1/WjfLcaha3bulnexRwNDEjEo5G3IlwUYb2b2am2vwu1iKzkY31iL+HTrZLCRWkK293BdXE6DkZ8kCVI89Sobj1APS9J8NaFo5iOkaLplgYt5j+y2scWzft342gY3bEz67Vz0FTpouloIgmm2SiJJY4wIEGxZCDIo44DEAsO+BnNeN+I/g/q+ow6e/2q1vJjbS/bkedIcXcspkknieS2nKkltoKhGARMNxitib4SQXesR3+pWek3kza619cy3C+ZJPZ/ZmQQsSnzfvNrFD8vGevFAHfXvg/wzfQiG98O6NcxBlYJNYxOuVQIpwV6hFVR6BQOgq1DY6boi6jfxQrbiUCa5cZPEcYUYHOAFQYVRjqcZJz4zqvwc1u5g0qH7XaT29paNapAt0kP2XFxJIjwyPazFW2Oi5QRkeWPmIxjeu/hQ1xey3Zj0v7Zc6rf3F1cspMktpPBKixMdvzAM6MUPy8EjnqAep6feQajYW17ZyeZbXMSzRPgjcjAEHB5HBHWrFcT8PdC1jw3pWi6UdO8PWGn29s6Xi2DuzTTARhJV/doPmxIXyCc7cE8121AHE/GONpvArRIod31LTFCkZyTf2/GK5nxLrfjSytY7ezstONyccwEyNGo7lScDiun+MEgh8E+Y0jRKmp6YxkUZK4v7fkDvis6001ZbZ7i+We208ncIHb99cn+9KevP92uvDSUdZK6NaTS1kjndF1HS72ESPLe6tqrffW4IgUN6bTwB+dbOtWuoLpnkGdIbm4GyCwscBQe7O/UgDr0qh4sHh2Kza88UMkNq37qCKFSZHb0QLyTXiepeKdT0S9e50iJo9N34jS9uN07gdAcHIHtXpUqKrO8Xb1OunRnVfNTR9AaJ4K0DRrNEu9sswG52ll+UnqTjOK4jxD8SvBVlqy2tnDHLFbPvZoY+JpFPyrnH3Qec15J4n+JOua/YG0la3srdxhxADvcehYnpXL6botxeODGvk246zSg4+gHU1rSwkpScqruzrp5fL4qzPd/E3xgsoYIpbe9a/mdSTBb/u1i47sRz+FeVeJPF+teKo47eMXv2NTuMJmZwT6kkCprfwhIm1ojbyxON4uJuMewXrmta20O5KGGWTYh6urDpjsK6qeFp09TqhQp0bOC1ORt7C51C4jjuLySSZ/+WUZMhUDuT0/CtqDwaDkXFrdHH8TOFP5V2enwWemw7dOtVR1GN23GfcmrSMbgKY5Vc55I6mtOZLSKNpTk1qcdF4bsraE4sFY44LZJz6e9LHoM006N9hgghT5RuPzH3Irt4BtYrjdnjFQXT+ZvSBkUhwg45J9eaaqu+hF+VEFlZwizw4zIvDFFwuaJNLthIs0CtFcryknXmrGnySNDK8jE26vtVyOtSS3K/Z3EKsWGTzxuqHKV9GF0zKuLaXz3kuN8rbeMcZ9cVb2RCFmdDFBuBUSnk/Wp7VpZER/MDoT8w7getQJK7SiVUMwjJKgjPNDlfQhK2qLcYVY96qCpHG3FM+0RqdhVj2wDUdjBIsW+6ARixbav8OaNQuYbBonIB8xjjA5wO5pdbF3Vrlt4YCuQu1jVWYi2nVIVWSZlLAdMD1Jqzc3SQWkrRnzP3YkRlHU+gFZlzBMkVq7lknmXeUIy3t+lEfMzk+xaju2aJWUBSw5DdF+tLBHFcRCXcVU8/WolszdTRrFP5bkZYNyffipLRSbs2yJJuX5QpXkn6UaJXQKViSOYRyCMqOSDmklv5IkaUx+ZAr7G2nkfT6U4Wpj1Bo5z8yNiUDqvfFU2jmkZ44FJjfJAPYdzSVnqPmb2LnloXD4DD7xx0IqtZz3F1dTJlRHtzt6EDOKLSO4luoo7cMx3BET1zwKtWNv5uranCqgXVnG5VYzxK6jgD15oukEnYrwpcM0yzSODDjAI55OOKfc2sEiEXL8s3Unac+xqLz7p0t4b0CK/ky0zZ+5gZ2/Wlt5JJrZp9m/dGUVwuQDnqKeu5N1e5karo6yxiISmfI4WT7w9CDWhbav42sraKDTNVj8hQAougshX255rQhADRt2IGQR+dLdrbsrYHIolJS0krltKW6OVn8OXGtai154l1Rr28b+GNQoH1xW9Y2NvpzRqoVXjG1SR936U7SmV2Z5HCLlgFXvjp/OpZWcXIRk8yRxn6Cqcm/dWwc1lY0bOxZLO7vC5SGEZyT94+lVVkSezlX7q4yQByfSnXCyTIElfbEq7mBPyjjvTNPZHs3ktnJB4yR27msl3I5u4QW7QL5bkLzvYk9KJIYZd9wEVnC7gfX3qxcR7dIbe6CZidpPHHam6fYzDTp2Vcx20LM2TgHHJpp9Rc9tSrc3Ms9owdCUXpt5496IbmNLTgAKqlRnjJPameHtQh1S2lliieNQ/lnJ+9xnIq7JbJe2s9jdpFAmFnWQdVXtk/hQ/d0sJyIGin+xTRkFCAMBhhmyOMe1VLZS32OIWzRzfOs8nTOcbR749a0rK6i1Is6mRolBWM46gdKoQW7yX0MMnmi5d8lz25+79Kae4ua1myU2NxFbySArhMgbhgk9cUyMiRAyPmNVDlipwh/ipNTfUb/WSuoLLZW0Mh8uEjJcdiSOuRUGqgm5EaiRAuGTB4FCTdrgnojK8TySjwpqz3G145rC6ELjt+7b+dZfhe33eGdJOOtpCf/HBW541to4/CWrujlgdPm2r0Cny2zj2qHwhBnwnop9bKA/+Q1r5vP1dw+ZhV92a9Bn2f2rs/glH5fxTj466Nd/+j7SsX7P7V03wjj8v4p2/vo15/wCj7SvDw8bVF/XQ568v3bO18S/FvSPD+ua1p11pWszJoz2qX13BHC0URuADFgGQSNnODtQkY+mevbxNoK6lLp7a3pgv4t3mWxu4/NTau45XORhfmOR05rzbxj8GD4i8WeItZGrWEH9s/ZRuk0rzbqy8lVXNvP5o8tmxydp7elW7j4L6TeyeMZdSuhc3OvqiRXbWy/abMLGEO2Uklt2AWxtzyDXqHnHcWnjHwzeQJPaeI9GnhedLVZIr6JlaZuVjBDYLnBwvU4p7+K/DqKGfXtJUGSWEE3kY+eMZkXr1UcsOoHXFeb3vwWfUrXV5dT1+NtYvIrKO2urWw8mO1NqR5biIyNuY4IJLAYJAAqvo/wAB7XTb+4uP7dlmjfS5rOKJ7biK6mgSGa6zv5LhMleOvWgD06z8X+Gr2K6lsvEOj3EdpEJ7h4r2JxDHjO9yG+Vcc5PFbME0VxBHNbyJLDIodJEYMrKRkEEdQRXlWnfCBtPcSW+tQGRfCy+Gx5umpKhYPu89kZirDjHlkEe9enaTatY6VZ2jukjW8KRF0iESsVUDIQcKOOg4HSgDg9L+MHhvU9H8N6hbR6hjXb8afBbtEolik3AbpBuwEG5DkE8SLxzW14i8d6Npuk6zcadfafql9pab57GC8QyJ8wXDgZK8nuK5TQ/gvpukWujGHUZW1CxeyaScxfJKLd1Y7Y93yNIEjVjk8RpxxzXtfgwLe0u7P+2vNt2tpba1klS6klt1kkVyMNcmIj5RkLEmSAeMcgHow8VeHjqN1YDXtJN9aq73FsLyPzIVUZYuucqAOpPSoYfF+h3kaSaVqlhqam6jtHNpewuI3c4AYlxz/sjLHsDXFap8K9R1TxHcalqHiqa4iYXqwxSQzMYkuIXjCYM/lAIHGNkaE7eSc5rUk+HCHV7O9j1FY1t49MjES23B+xvI3Xdxu8zHT5dvfsAdVpHiXQtZuprbR9a0y/uYV3SRWt1HK6D1YKSQPrWZbeNtLPjDUvDt9dWVlfW8kMdtHNdosl2XjD/IhwTjdjjNUvCvgJNAu/D06Xyy/wBk6fc2JAt9nnedLHJv+8cYMZ45zuzkd6mufD661XxFqN2dYt4tL1C7sry4thYkzlrbYUVZ/MwoLICfkJwSARnNAGrrvjvR7HS9RuNMvtP1W7sJIo57S3vELxl5Vj+cLkrgseo7YrUbxRoC3d9atrmlC6sUaW7hN3Hvt0UZZpFzlQB1JxivONJ+DA0+xks/7aE0SW6WtrLIly8sUazxTbSHuWiwfKAOyNOcHjGDt2Xw18u9jjvtTiudFt5b6aC0FnsmJu94kEs287wBI+MKp6ZJxQB3k97awG28+5gi+0uIoN8gXzXILBVz944UnA7A+lcX4u+J2i+HpfEll5kM2s6NYLffYnuEiNyCjvsTktkKmW+XgMp5zVTwj8Mf7B1nRtSuNbnv5rK3ZZxJCFFzPhkSf7x2lYnaPAzldvPy82fGHgK61688Rta6xDaWuvaYmnXUclmZnXYJdjowkUDmY5BU5xwR1oA6EeMPDJ0ybUh4i0Y6dDL5Ml0L6Lykk/uM+7Ab2JzWg2q6cmlf2o9/aLpnl+b9rMyiHZ/e35xj3zXB+K/heNa1m41S01ZrC6a5guIAiSosZjhaEgmKWNzlW4KsuMY5GQduHwasPw8HhiN7I/IV3yQzyRbjJvLbWn83qcj97kHBB4xQA1PiT4Sk1+w0qHXdNlkvoHngnjvIWhcrIqeWG38uSxwoBzsb0q9N458JQCIzeKNCjEuPLL6hCN+VVhjLc5V0P0ZT3Fc5p3gDV7O8068bxMLq6gt7myna6tZJg9vNJG5SMtOXUr5QAZ3k6nOaz9e+FN7qPg7SPDll4meysLPSf7MmjWCVY522BTPsinj+Y4J2uZFO7kHrQB1mlePvDeo6vqmlx6rZw3+n3gsXhmuYleRyEwUXdkgtIEHAO8FcZFXtT8W+HNKGdT8QaRZAu8X+kXscfzpjevzMOV3Lkdtwz1rkJfhreiG+gttdt0hmv7XVoPMsC7xXcAgALESgPGRBymAfm+9xTrH4azpfNe6jrMV1cyLqXmFLLy1LXghBKgyNgL5J4ychuoxyAdto+vaPrbXC6NqthqDWzBJxaXKSmJjnAbaTtPB6+hrSrk/Cvg1PD+qw3kd2soj0a00ny1h2Z8hpD5mcn73mfd7Y6nPHWUAFFFFABRRRQAUUUUAcV8YYppvBBitZPKuH1PTFjkxnYxv7cA49jXkHxD8U6t4MnjtLvXU1LUGAP2R48sqn+IsOF+lepfH27k0/4XajewkiW2u7CZCOoK3sBH8q+PnkvNV1Ge7u3lubmR/Mlkc7mYntmvVyyk6jfY9PLsOqt5T+FHW6j40uL/TZ55hM+szjyluWwI7eI9Y4V7MeAW61m2Wgysqi/g3ysN2zksB2zz1ra8M6FMLiO71CNU2r+5jHIjz/AF9669Ykd/KLpFngZOCfxr3bRpbHs+7BONNWRxVn4bdHQRQ2drzy7jzH/wABXW2OmxWaB0Jml6CR+309KvLYFWG9gTwFqYqqlDIwVQeB61Eqt9EZKVzOvNi3SoATKV5aTkKKsaZHtXPlKpVsMRzn6Vamt4brZ5qgkdGB5FMlkET+TAD5adSepPrUOV1YLjL2Fpon2AkZ59xVS1X7LvmWIiPhVU+vc1YnuR9oMUe75ce1TyhpohESA6tlTSTaWo2upHpt1JNOVkGAPm4GOKragtokoLRMZMfMV9Klt9iySoZ98/AbjAx6VFqUJkcsSNnQE/xGnpzE3vuX5Qv9mQrG6fMN4j7sucZFUoY2jBkXdtX7qN0DdzTr1jY2tndOgMAcQbs884JxS306TapcW0ORHt8xCD/CeOaEStWWbaQXcYiCqkrH5wnAPvTIZFMcVrGFEu/cQBjAqKBP7Ot5by5T9yqBduemeM/jVaNfMu5LxSSHTcpA6LQrPXoFzSUGUrGi5LttX86zdQji1GHyoW8zyZCrN90qc8itHRN8RjkYszncy+o9KpaTp8unaVeu6os7Heu452n6d85pJ2Ym7+hLMoto7Z9rN8u1VX2p7sNRu7K6tjufJXawxyKsALPaWcs8JB/5aJGcYPse2RU+gvbXGpzWUR8tzbSQRhv4CykA59cmk5WTdtjOUn0M/TraGTUbCzjBF00kpmnB5AAOOfyq/wCAtSvrjVLn+1Uhe6tIJXgmIClm7AnpWf4V0y50vS1guJS1xGDt77T9atI/2LTriWWUBj8iuRnBPt3pTtJOJnKN1YyPC11Lc32tTXkjSzFv3zkcB2z8o+gxzV22tWO5jkqB1B7VPp1lbaXoC28TAy3UrSyyNw8jAdPpipLa+C2YuTEQJBhfQDOM03Lsax0GJdQ2mopAs8Yu0YEBRkxt2zVW1triG/MolMkznkrxkmpn0mAa5JqMrCHzGDEHu3tRrWpXOjaDPPYhRqElwI9zqDsjxkkfjQ2vs7sH3sT3lnBM5WdAzRfeOdpzSz3DB4LdEC20Hyxqo42//XqnpWpLqMgWXaJ3jzNzgbsVo6Ynl6hFaSgb2O0E9DSemjGmlqV5rVRLld/ynjB4wfWo7uKZbeU24Ri2Cwzg5BzxW7NapG0jSbVgQnzDnk1g6wqh0bzNsSjEb/3z1yR9KITuw9omrEen2kixO9wMB2yADzWgbFbhzOlxErwELtDfOBjpipdLjZot8gUsqFio6Hjg1jaRbg67dMykGKFVUj+Jic5PrTu22KctC7rEJOlyQwlRvwzM5xjn1qzvt47GE24DQKpUHH33PU/StjVLW0n0fySxTaAzMBnPtWEtxCNTi08wGNEbZ87ZOQNxP61nGfMtDNO7uQeIGjZ7TzWwCoCr6nvWvY3H/EhnihRg08UkTK3YdOKzNVtxq1t9qsUbNtIyuhHPbirGllo9Kt2lEmQ7YVxztJ4BqpWcEGj0ZS0C3tNMihtCwjlc7gvX8/yqLU2W3mms13NNMCGmJysYPCjHcVDpiQHxfLZ7w13brLNcOc4VT0/EA1ozW1tc6vHtmwZ8GKPru29M1TdpXZV7sozLLoGj7WH+kSSohEZ3Y3c8fl+tTXDPDFAHkMcjyDzJeuzJ5/KqXh/z7+zkfVJftDxSbxu6xMGI2/pmrGp38MOlfbNomg+0pFKh6hSCSf0qm9bDiiQThoRPJJJN+9dkZ+cKDgH9CapeU2qv9rt0823aRJAwk27VB5WujggtriCaKaERwSRGAbONoYcEVmeHbJdF0GCwuZVaWNmQt2IJ61PMrO24a/CYfiySK48N+IIYlfNrptwx9OUI/rWh4Kt8+DdBOOthbn/yGtQ+MJ44/C3iSGCEKzafOJJM8tiNv0rc8CW+fA/h0466dbn/AMhLXz+dq7gc2Ifvr0H/AGb2ra+Gkfl/FOz99Gvf/R9nSfZvarvgWLy/inp/vo19/wCj7OvHoxtNHLVd4M9ioooruOMKKKKACo7mRoreWRI2ldELCNerEDoPrUlMnljghkmnkSOKNS7u7AKqgZJJPQCgDxy0+JuozeHdP1B9e8JrNeXEEV2vkPt0MOkjH7UDPuJ3IIxkRDcefStHwv468Q6/cxRxDSIoY7B76S4+zysLlUuZYg0SlxtSRI1dSSdu7o2eL9h8X/DF63h+dNQsbfTNVtbid7m7vYo/skkXk4hkGSociccbgRjvnjsZPEeiRanbabJrOmpqNyoeC1a6QSyqRkFUzlgQOwoA8kl+J/iqw8NW2oXtrpN3LfaNZ6tEba3eJbQTSKj+Z5k2HVQ4bO6McckD5hZ074tX0VtY3WuvolvYXEWoBbxJo2SaaERGFFMU8qKzB3Hl72YlOK9I8aeK9L8I6LcX+q3tlbyLDJJbw3NykJuXRd2xC3UngcA9elO0/wAVaPdTWFnLqenwatdwJOmntdJ5+GXdwmQxGM847UAeZRfETxfe2tvd2X9gQxPJo9uY5bSZ2Ml9HEWbcJhhUaTIGCSOMg8nt/B3i17wCw1+W2/tc6jeWEX2S3kWOfyGOX2kv5Y24zuYjJwDyBWjN458JQRCWbxRoUcTAEO+oQgEEAjnd3BBHsRSweJPCl41zqUGs6HO2mxlZ7pLqJzaxuQSGcH5FYovUgHaPSgDh/iP8R9Z8N+NItHsLTT1t/IimRr6WGL7WzOVZI3luItpUAfdWU5YZA4zm6h8VdVs5vE8Zu/D7zabloUhQTQxp9qji3TTJckqQr5KvHEd2cZCHPsGl6lY6tZR3mlXtte2kmdk9tKsiNj0ZSQaxNW1fwjrdpqWm6hrOk3ENoVkvYRfIpg2OCDJtYFMMB1xzxQB5lqfxa1y0tT9nbRb21GoSWia9BGiWMqrBHIAoluo13bnZM+cRmM4BPA2NJ+IWp6nfJb6lfeHdDc2VvMlnM/nS6i0kRZjbSpOqlQflBUSHI+me+tfFejXz2P9l6jZahDdzvbrPa3kLorpG0hB+fLHC9FDEZyQFBIyrH4i6Be6/qtnb6npcmmabZQ3c+ppfxtCjSSSIY2I+VSPLU8t/GOB3APNrX4uX9nJ4MsoTZyfbLfSlu7aaMmUfaVjy6SyXXmyAb+vlScghnzk1B4Q1K/0bzNT0uGO4ks9HeeWF1LGSBdTuDKFwR8+zcV68gDBr2lfFXh5re3nXXtJMFyu6CQXke2UbwmVOcMN7KvHdgOprH1Txh4E1jSruwvfFegyWd0n2eZU1aNCwcH5dyuCMjPQg9aAIYPEd9qXw11zxDJFFHE9vd3OnqnmRs1sqt5TOQwYMwG/KlcBhjBGawPhZb3Go+OvFOs6h/Z80sS2ltC/2VjcRI1pBLsWZpGIT5zlcZZiWz2ruZPEugWV3Lo9vqml/wBqWsRI01LqMTKFTcB5edw+XB6dOapweM7JPh5p3ivUlis4Lyygu/Ikuoo8NKisIxJKyIT82ASVz7UAefal8U9YtdW1SC2n0G8ktby/tv7Miic3UEUEMjpcyt5uNhZFUjYud3BzxTvGXxH8UeHbfR/Mj0RZNRs2vUnmVIYA2E22++e6iG7kkuCTgjEfBNemabN4f0lbpbO8soVuL+UTZugc3TZd05bh8AnYOgHTFJaeMPDV5a3dzaeItGntrRBJcyxXsTJCp6M5DYUH1NAHmN18Vdatr3XIxFpV3PaWktxBp9hsunG1VP72WO4JTbuJIaFQcYVz1p/h74jeJ9em0uys5PDwlvtSa0W9AjuEEa2kkxzFBdybWDR45l5BBwK7Vvib4TbVWsLbWdPuZTZG9ieK9g8ucBnBRGLgFxsbOcADkkc43IfEuiy6hb6edV09NUuIlmSxa6jM5UjIIQMSRjuMj0NAHmXgTxdrGs/EOwfVdX02zgv9GhddOKOBcSpNcrJ9n3S4DjYGY7WOzap6bjreIvFGsWPjO+0zR/sSSzXun2ay3YmmRFljnZm8sSKMjyx93bnuTwR3Gi+JdC12WWLRNa0zUpIlDyJZ3ccxRT0JCk4BrWoA5v4fa3ea/wCHPtWprbrexXd1Zym3VljcwzvFuVWJKg7M4JOM9TXSUUUAFFFFAHm37RUTT/CHWIUIV5J7JAT2JvIRXgPhzRf7MsImwGdm5dh95vb2r6E+P67/AIWakvPzXVgOP+v2CvH5VePToxIiM6gKoz0r28rly05ep62XfDJCRQNHfRIHZ0kj3sT/ADpdSgRomD5MhYY2jccentVaCeaC68tZfNXPlFsdDjoPUU2XfFGLmJmEqSEMc444wMevWvUSd0dvMrbmxbMYbVUlyzYz83b2qrqLKb1FkZREygKWGVz3q9KEkt0lYEZTLKO5qk9ypsJLi2VHMIJIcZwB1FZre438JUe4aSdhbeY0MKnARSSfermkzRXlt57YUodpz1qITSrYvPpsZKXSskin+EnB4p2j2i2VqYJGDSlg7/jVO1mVF6WLN8v2SE3oXcpZUYd8mryRyPCZgoxj5QTyTiq2ow3H2KWJUJG8MDjjiquoTz2mhQvFhpH4Df3fU1nurIiTMqOGY+LvNYukbkFg/BzjkVsa0Pss1lFIVxKmY0J7E9aYsMn/AAj0GpXtuzRMGCzDqwH9atT2FrqraddXE/k3EMAiyvIkTORkHocVTlqvIlvS6DxFatNp0OniPEaziYKx5BxjFUrC1kN2jEEiGM7uOpz0zW7rCF1ilwVXzBgn06c0ls4kfVbS2Ba6tbUXUQP3WOCdp/KoVR8uglJRVzCklea+1XT58PBBIjMo53jjAH51EL9tHsrKDyzI8zNx/dTdxmpdIjj8ttTk/d29xGJnOeS57Vce1h1SS3u/9VFF97ceetatqLsxXZtzWLQac09vjzQysfp3FYemXR1ePUNNk3I3JVh1B9a6+ON4omUEMu0Mme4rFsdOjsdee8HEcgJx9R/jXNCas7ijJtM57wjpd7Bb6sbrf5sF1CoBYkOCDk/yrRsooY9Umu4s7WYArjoRwa6Kd/kdkPDMrAdwQa5TxHaX1zqn2DTLdlikl86WQqcHIHerjNzk76A01e50M8KtM0kcq+UpLEnsPesq9kgvrT7RbQM8UFwH8luN4wav6rC41SaCNi6taKsmOhYL/wDWrm9Ciuvs+8qy/OAc9hSprS9xXVrkt/avJZaIXbF2JHcnP8OMBf1/SnXFsxk0+ybJK7Q3bPetjVLc/wBq2ML8TAApx+JqG6uZJtcFksBCLH5skxHI74FWptpJAmit4qika9sAqHaWbIP8OPWtBCt/KYjEHcKDlxwxqq7S3ekrcIvmTPJtUHsKis9RmtLt4V8ozAANIw6nP3E+lTZuNl0KvoVo9Ji09ry9upUSKHLtwTnJ4WhCb+W0vrJWEZYEezZ6f/Xrc1yOK9sZLeUAvITv2nsBn86woJn0y20220/eY/OO87fmAq4ycld7iuX9avVvpLizQMbu3HmvGvXkVFq+nXV5o1u0O1pginHbJXkCsdkli1i91eGTc8kwSR84xwAPwwMV11rqFmSIftGbqVQ4iJ6cdqUlyJKIrdhugx+RHbwspBECq4bj5u9Sb4HknkgK7485HpWTpV5ctrc1vduMSI7rjkIAeP0zVe1dIryRlkR3jRkba+Q+TxxU8rbbCxdtNSmeKVVQ/ZllVEY/xc81Bfae39s6vfwyhmkBlij7qxwGx+ANR3H7/VrKOL93ZRAYOeC2OW/OqnhaK5l1qSY7nXIV2I4zk5quVRTltoLpcvrP9gktbSNi005W5mGcYB4HFWJrqT7C1wx4eRgo6d+DTNV0OafxhPfvnyHMYQ+gC9BWVcz3k/itdLdQdPLbYlxj5V5LZ/OhJS2C5qnR4w+p3VkjLe6sgjmkc8IvG7A7ZxzVK5jjg1fTzHKrC1IRQPvE9vwqxr1466vpsVu+2OZznHJbA+6P1rL+xPe2WpalaSeZLFN91iFKcdzRDu3uVFLc0b+X7Pq2nNZbPKdpDKONm45BLY6+tUv7N+x+Hbma+aOXDqQB0wO5/E1di077X4egt4bhH8rInYDAI64B79evep4bSGDQXW9kDwOcllOcjPAo5raBpuVUu5pvCcuo3JG2ObZ5Y4Ddh+FMu5F1XTrwRbYhAyRKZGx83v8Ayq1LeRQzW+mWlktxYtEsvQgA9j9RVa9sLfUra6jjOw3Mwlk29Aw9uw4pre7Q9Sp4kZ4vA2tQSov259Luhg8EBUJY+/ygj8a7D4fW+fAPhk+umWp/8hLXFfEbSr2+0XULsSLHbWOlXALBuZD5TA/nXpfw4gLfDvwscddKtP8A0SleDmyTlGzOHEv30yz9mpfC0fl/FPS/fRb/AP8AR9lWx9mPpVPR4/L+Kej++jah/wCj7KvLhG0jlm7o9JoooroMAooooAKKKZPKsMMkr7tqKWO0EnA9AOtAHnWhfDa5sLXRLa81m3uodH0670y12WJjYxTLEqlyZGBZfKOSAA27ouOc/Tfg+un6tp90usfaLeD7A80Ey3IDyWsccauix3KRgkRKRvSTB9RxXN6b8Y9a1CLVFsTpN00cdlJazm2EYUz3kcDLJHHdSkELIGwzRuD1T137j4g61aT/ANn6lfaBp0kWq3Onzaxc20gtQI4Y5EAiMwId/MwAZP4DjJIFAHT+OPBd34g1F73TNWg0+afTZ9Kn8+y+0gxSEEsmJE2OOeeQe44rFsfhSLPxPDqa6t59qtxb3b2swuf9dFGiBlCXKxD7gI3xuRyMkYAqeG9euPDP7N+gavZG1E9vptoA13nylDMiEtgg4AYnqOlZOqfFvUrLS7lor/RbqRb6S2tNSgtB9iv1SGNzsMl3GqsGcr/rH3FTtBIIAB2ejfDmHTdK8KWQvY5F0GxuLPd9mCiYyoqmTG75TwSRznceaz2+FKjTtJgg1ZI7jTdMsLGGQ2YKNLayiVZXTf8AMrMOUz3PzZ5rnIPi5q9ybGSKTQopp7TS7iPSXjdru9a6x5iwkSDGzJOdje+Otc/rupS6qbe6uBiTd5WPMkk4j8RQoOZGZuijjOB0AAAAAPYdB8B6dbGS61+30zWdWkv5NRF09giiCVtg/cqxcxj92h+8SSMk5rgdT+D95p/hzVodLvV1SX7HNbWEM7XHmRiSVXIJkuTDj5eQsaZwDkd6Oo/GnVINR16OwGm3kFrYX91b77YRSRSW7KAsqLcu+Dkg70hJwCBg8dr4o8U+J/D2o2enSw6bd3Wrp5OmvFbSCOO680ApLmQlkWJt+RsyIpDxkKACK4+F8uo6hNqGs60kt7c3EstybOzMEZRrKS0VUUyMUIEm7cWbJGOO1O8+E17qMTNqXiKI3MVrY2to9pYyWqxC1kkdCwSfcc+YQdjJjGQR0ro/iH4ouvD13oltDe6XpcF+8ol1LU4mkghKICqbRImXck4y4+6epwK8m8G/EbWdC0DwbollaacluNLsGT7bLDEbwScP5byXEZG0DA2xy5bg4yKAPUPB/wAO00DXLLVJryC4uLeC7jYJFMd8k8kTmXdNNK4bEZB+Y53k8dDQt/hRFF4bj0r+00Zk8NTeHhN9kGcyY/fY3djztzzn71VIvGPi290/RLm2k0K3/tXXbjSIxJZzS+UkTXY8w4mXJIt1G3juc/MAuBqvxE8Tx+Ep7rVF0mVL3R9TuYUs47i2eKS0kjjOZFm3EPvJ+Uoy8fMetAHTX3wv1G+8S2eo3Xiiaa1s7n7RBbSRTHyx5LReWB5/lAfMTuEW/sWINXPF3hrUbb4MJ4O0e1l1W7bTI9IWZDHCq4iCec4dxheMkLubngHrVWz+IksPjrWtN1i/0pNN0+O4nK2cQuJEiiGS0rpOzxsBnKtAuTwCTXpVrcR3drDcW7b4ZkEiNgjKkZBwfagDz29+HF5PrMk0euRR6W2rvrP2U2JaXzmhMTL5vmY28kj5M9sntXm+FCtpujW8OrJHPpWmWdjDIbMMjyW0qSrI6b+VZk5TPf72ea9PooA4LVPBet6pd3F1da7pwuLzS5dKvPL0xwjRsXKtGDOSjDfzksDj+Gq1p8NprXUItmsxnSxf22pywGy/ftPDGiDbNv8AljPlqduwnqA2DivRqKAOI8F+Al8MTaBIt+Lj+ytGOk4Fvs83MiP5n3jj7n3efvda7eiigAooooAKKKKAPP8A48f8kzvu/wDpun/+lsFeMyxzs6QSBdjgFSo+7x+tez/Hbn4aXoIz/pun8Zxn/TYK8d0uIzMzyg748pHmQscZxXs5X8MmengHaLIoLYh9zSiSRASgAxj3pbeOPUFeaUFgGGT0+btV2JIUmePzVadkJCj/ABqS3iClLdmEZf5wMcNXpc1tT0m9LIna3by0ZOQF2lSORWZpVkZJNQjkwsboeo7iruqXcxuLdYl2RDarj1z0p2o7vKEUG4tICGbHQdB+NQm7epF0xdMiWG38tG81HJbIHQ1TsWL6hP5nReh9a0YFm0+yDpHmQsFVT09CaX7AVmdwoHGWGOvrj2p8yu3cUZaFvQXOpziKfKEqWX047Gq2pacJIjbyMwETZwDjj0pUM9tqmjwWo2+YxaZ+2Oy0eK1ntvN3dZSGyD0FZ/bVupEXzSsZmsW+s3WuW25gvh2JVSGBSAiKPUdcn1psdlOkKbQzOvylSPujP+FS6hc3seimazYM8a7gCAc/XNT3OuPB4Uj1i1gD3DzJHKpH3XI9PwrT3rJIF7uiKHjfULyw0rwu0DlRJcTeZu4VsEYVvwyatadLOPF2oTQKB9qtwijqAu3jH0zVsQQeK/DEKXuY1ScSgAfcYcHHsRW1BDDBIjqi5wEDegHAqXNQjyta6kpXRyjyxWlybAwq1tbAxqjHLMdvWpIUx4fht4huu5G85YW4Lqp5A/Ct+40lH1I3yBd8i4VcdGxgnNY2vafdWt/aXVqjOkCjGPUnBpxnGVkCfQ3o9UFhoDXFzG7paxKz4GWCscDj2qxaINSkhWEqY/vZHHFULWWPU9KZ48GK5RreaM9UYHkH8eRW3ploLKzjWP53CgHHBrmlZX7jhpqi3NYQJB+6Cq44ODyPeqkzSQwyIIvMlUAjJ5P0q4pkd1+XYxBVc9/aqwcyoyTBo5oyQwznpWMbgot6N3OR1q/ntdRsNnClg9xkcPk42/TFTa9a3H2KzWzDh1vgWA/u7OM/SukksYriAFolkAIJdl4XHeny28wZWjdPvhySO9dCqrS3QmzZDbhXndpFDShQdxHI47elR3SwsiRALluM+gPrVi4SY7wsUYLckqeeOwpmqae8ulSwWVwkd8wU+aBuCDPIHvjisuZXGo9WUIhFbbIoFYxjhQB1NUYIvDx1eRbR5ZtQh5lcnMbNjov0NbYsbuQGO3x5RiJdgQXHGMjuPwrltH8M/wBmGSW4uQ0jZwqn/HrW0Gne7JbvK1yroWlai2oXDXMbxIXd2lduHJbIx+HFdFPbG4ZZYApMEgbGMY7c+1cvJpniS2ukW3uTPZOdyndwR+NdHNci0tZ/PZ0aRAGKdPxrSbejTLtfYjudGthaXVvbFvs8x3NITnD57Vz+oaKJtYi1SxnTyIl3SMG5i2Dk4/CpY7q60jTXInSe1lLDnnbkYH0PNHh7TsWsggmd4J1ZHRucKR61SvFNtgnyljRWsfElpcX1kDbXMgaGXB+ZR/eX61Ha+EbPQoprq7v8vMPLjdzhU9+OprS8PeHm0aaWNFykiMTs6L6VPLpEl/p91Yaq2E3boXU5wMVLnZ2i9BczeiKb6G50WAW97BcFcq7wEMCM8EH+dbenBLVTC0IUKu4OBgk9OareGNHGh6A0cU6zTTSFiD0jHpitmBrVkebUJSsajlVHJPasqlTdboEnJO4xBgxh/m2nOTVHVdKtVkluYx+/WM/OOoz1q417Co2qHaPOFLjkioJH80v5KsyAcjGRj3rKLady3Qlucjp2kXd/dWl6zFFs5m2kr94Y/wATWpf+FIUs47OS7NtDcHe69ZHYnrXRWt/HHgrFsRQPk64xUcsv2qYSmNwi9GK5J+ta+2m35GclUva1jO8Rx6fo/hmbT9O8yS4aLaZMZKg8Y4rD8O6dnQHjuHAQfvFVzhmH+yvUj3rW1LXv+ET0u41OeCKeSV9mx+dyk4/lWdd6fOPFA1m5cRac1q0ceCR8mcjAPT/61XC6TXzv3IjdKxQ8NSXwv7n+0ZDHaKP3cSrhiPSlvY5ZPD96yQ+TLIGRWjbB6jnGfTNM/tiS71ic2Nr5qyYSID7w7ZA7/Spta09ZrJRrEoiWFg7cEMMZAQ+h5rd6SuzfoZJlmX4ceKbaV/MdNPuMBjyF8pq9k+GMGfhr4SOOukWh/wDIKV4p4hm0fTvA2tGae4N5PZXFssag8P5RILegJxX0D8Kogfhf4PPHOjWf/ohK8TNI3qJnnYuS5k0aH2eseCPZ8U9D99G1H/0fY12HkD2/Oubuk2fFPw/050XUun/XexrzFGxxt3R2FVdR1Kx01IX1G9trRZpVgiaeVYxJI33UXJ5Y9gOTXzt8WvAfiDV/iJrGiaJp9z/YvimO3vrq+RT5UE1tHMAjNjapZvKPJ5/lkWvhvxVrvhuDxHrOkatb+ItT8VaYZ4zaP5sFvbR7BKVK5C5LnJGOmc1ZJ9VUV4LZzeOdR1LRLfWba9uGs/FN7ZjUZtHi81bJY/3VwCYtqZJOJFABxjnmuZ8HP8QPCfwx8O6Xo9rrkEkd/cR6okmnHfZqXdo/JxbSl0fJZnCS4OANoPAB9QUV5l8PtU8V3Wp6DF4kur2YvpUz3XlaO8FpJMs5VXaSVY5I5NmP3flgEZYcYr02gAorxTw/4g1DSfhDpWk6fpnieDXbWGKOUR6TPEYf3gDNvktpVYDPIRJGxkgcEiPQfEPjS5ttOXxPP4k0u03Xatd6dov2i4mdZgIhIhtiVUxnIbyU3f7PSgD1y8t9L8TaRJBK0N9p8kmG8qbKl4pOm5T1V0wRnqpB7itOvJ/hM/iGy1BtM1izv7DTRPqEtmFtcx3Ba8mYtM5XMZAZSi/KGBzubO1ZvEWqeLk8bXFrZSavFF9utIrO3t9NWSzmtGCefNLcGM7HUmXA3r9xPlYNmgDuNFbQrnV9XvdHurS5v2ZLe/a3uBKUaMEKjqCQhGTxgH1rarzn4cWWpeHvhADeXF99vS1nuAl5DGjW7fMcBQi8Z+b5snLHnGBXH6LrPizW7PSZs6prGnySaNcTTahoyReVM1ypn8lTCu6NY/m8zB24BD9wAe7VRudKs7rVbLUbiEvd2QkW3cu2E3gBjtztJIGMkZAJA6nPh1z4s8crci0hvdaGuzadfXE9hJpCLFbyxzwrH9nJhzKoV2yd7g8HjpXTxf8ACcWHiG4VtY1jUbK01m0tI0n0+BUubWSFGlkZo4VOEd2G5SANmDnmgD1iivBNJ174n3Gn6kbxruC/+zp+4/s6RzBMbmJSYSbRI2QRtJkebMcAMGwCav6lbeJR4x0x9V1HxJJYaTrE8EOoW+mRySvDJZxsrMqQFSvmNJHvVABzkgjIAPZby8tbJYmvLmG3WWRYYzK4QO7HCqM9Sew6mp647xN/yUbwZ9q/489l95e77v2rZH5f/AvL+0479feuJhPxCuBYySa5rkH2u11KeVF0y2xbyQyKLeMboCRvVicNktt+XFAHs9Q2d3b31rHc2U8VxbyDKSwuHRh6gjg143b6/wDESfxfpUdzFNZ2Mn2BmjNnM0UqPGhuN5S1k2OHMgG6aILtGQRknDj1bxtoGgeHLDQ9N1+CW3toTJCbIvDNunbepAtZGDBOu6aHAKlQ3OQD6GoryMXXjY3sstxNqV1aXV9q9o1jLp0XlRW8YmNs4xGGO7bGAWYq4YcEnNVtCufHET2czSalDaW97pVmNNXTIkhNvJbQfaGOIg4CO0nKsAhUg8DAAPXrO8tr6EzWVxDcRB2QvC4ddykqy5HcEEEdiCKnrznRdZt9I8X+J0jhuZ7e/wBbt7OGOAKR9pNqjTMMkfKqrufHdW4JzXo1ABRRRQAUUUUAFFFFAHBfHNQ/w3u0b7rX2ng9uPt0FeU2fk6d4g0uHa8quhd1blVJJC5/HmvUPj+C3ws1EDqbuwH/AJOwV5bp9kD9lna4CJHtZ9x/EV6+W/BJv+tD0cErwaKenWeqDX5ZNUUlQpYuQAHPoMdqb4qvRaWyXlmdrR/u177T3rpbiVj9ruHZnManA7DvxWPLpH9qWELnCoZRKQ3Q16CnqnLod0dCTQ1OqWMElz8zblkZ34JqXTmFxaoZmbeHbyS3BcDkil1C5ittPdHAeLlykfAJAwAPasi7vpb6w0Bnj8ry7htzL2Ycbaqzk9NidmdLDqq3z7LhVP2eNnOB97HP50qXTXbi5hQxxSwsgHUoQeaYNKjWS4uIxuSUZ8sdR65rJ1DVbnQL3SEtYfkZWadJfUtgKPwrJRUnaO4mtdCzo2pyvfSW1wylxueNjjt1A/Cp5Gl1Pw1qskbb7uBGkgzzkKfmA/Cs+4tYbPxPDEZcGf8Afxq3Uoe31610ei6Z9lWeFWLRu24N02g8YpzaS5kDf2jD8I3EmoaMk6ogYjaydVOKsaWljeadqNlav5izdARjYc8Ef0Nauk2MVk09pHHiHLBccfWofDOgPo95qC3TrJHLCfIKDBI6r/hUyqRfM/uFUkloXodMjs4IIIQRC43Anv2OfxrV8i3i+UplFxzVayRzNGkxOwD5T2GeaXVbjdqZFi6rD5ag5HIcVzyblKzDVvlQ25RCUWCRiQTkFcYp9wsEmjmCXJd+D6mpp4ZpIpJETfIyEgAd6xLG/llkCSW/zHhQB0PvRFX+Q1Dmdg0PSfshkSNiyl9/I6cVuRyfZQ5bBkz9KjsLW8ufMAUgAdTxz7VyWp3/AIxt9UFp/wAIrKwdtscgYsrD64wKr+JKzZfNFOzZ0OpQ3F8Ungd/MQ8bTVmK0v3iheaNROf9bub5h7n8Kv2Gh3drp8Zv5IoZ2Xc6RsWC/j3qh4juL6y0mSawDXU0fOwgnd9azU+Z8sTJ1VzXpMwNT8V2NjMtmlveXEhPl+ZCP3ZOeme9dLp9sbi1WRo5oCV3eVIefrXL6H8RrrVLf7Cvh62hljIElwrjYvuFxwa65dRuTseYxA9AVORV1ISirctn6h+9eqVird+Z8kMAAZjlsfpUsFu0VpczhvliyDj+I5qPy42y7Tg7/uqvJJqpr+pXel6Sun2EDPdXj480jcqA9aizdorc1ndR5YlYaYZPFGn6tDfSwi3BDRKTiTPHPas/xFbve+NftEc6w6ZCQV3tjeSOQPxrp7DymtF3Y3KAvXqagvNHhv5Y47hlihQ7m2rktzn8K0jU5ZXfTQwkuWTbOWntbq1uRNq8zwxeZlFQ5yOwHp2roRpFtdBbiCUmNhiVH9Mc1L4ttIdThRI5WUo+MjnA9qqyuNPsF0uygmZyMtI/zOw9MVTm5JNaMcVKduUwk020vIpZdNuTNpjM0bRyLzx7envV7S7KPTLF0iGEBLcdMfjSzQy6fZL59r9khZhGihcEsec4rU0a104RfaL+6IA6RjlmPsKc6jUddUdXs1CHM3cWO5F6H2y+WUjLnP8AEPSqeoalp2m6e95qc7RQphFRBl5HPQAVp30VpJd3NzYtiMxnMRXGBjqPxp2mXvhHxRZxxzsiPEMslwAuG6GsuZJc1nYxqTVNXijnbDX7W+e3S23qZBllIBKj3961bpAYcrERGDxg9T602/g8K21wzaZEXm6GWMALkcVuQwpLZIJZVA/uryTVSnHeKsjaNTlipNNHOkBSCYghByOcn8aPtR5WV5EYk52rgAfTvV1rrTrIsxtbjHQMrcA+vNFlOs28rB9reQFN8rE4GelS5X1sbOo3rbQxdE1iSa+vI57Dy0hj3xyScknOMemKmju7ktI7SS+UxyVzwPQ10z28kMse9YwCuNoXHPoKypt9zIsSeWXDYZFwoz7j1qudSeiIpVIyb6lRrRtRbY9t9otkkDfvVBQMOh9jWgwgMLjV7dbp0yiWzZ+Wq+o2N/EA88sfls4VIoz1P0FWdduEg1C2uYebSQtCzDn5wealyu0jGpBTklFmBY6NdLK9xaBbFY8yZXjYoPX1qGbUILmK9trsPcCJ/NkeUgtL/te3PaupnmXyLqKUCVJ02go3ODWBZ6HGLWWO5lUtKNmAvJXritoTv70jB8zfvaHN6vY2+peDvGGoXduryLplw8aleFbymIf616d8M7zZ8N/Ca56aTaD/AMgpXIeMLQ2Pw28S20MQjX+zLkksMEjymOD+VW/h7ebfAPhlc9NMtR/5CWvMx0+edzgxa95HpH273rLsp/O+Kei89NG1H/0fY1l/bv8Aao8Lz+d8U9L56aNf/wDo+yrhOU9UooooAKKKKACiimTxiaGSJiwV1KkqxBGR2I6GgDhPEXxR0bStOuZoLfUp7y3ltlezm0+6tpfLmnWLzArxbmUZbGAQSAucsK0pfiF4bhN4Jry6jazEZuQ9hcKYC6I6K4MfyswkQKp+YsdoBYEDm9N+Cvh/T4L1IL/UxJcwwwmZVtkkXyplmR8pCN7h0Ul5N5b+LNdFN4DsLiw1mC7v9Rnm1We3uprpmjWVJ4EiWORNqBQwMKNjbjOeMHFACP8AEfwykUTfar1pJJZYRbppt004eNVZ1aER+YpCurcqODnpWbZfE3Sn8SXlrc3Sf2U0VjJY3cNtM6P9oBwZJACiAnYBu29cc9q938Nbka5p97YeItUhl8y6nv8AUC0Ju5nljijUKDCYwAsQHCrgAYrSt/hnoVrpFxplq95DaTx2MRVZFyotGDR4JU8kj5ic57YoA1ovFfh/UI4YheRyJdR3J8uSFwNkDbJ94ZflCsdp3Y5OOa87HxLvtPWxie0stNs4tJfVnik0268tLfc3kReZGGEOIlG5yrDd8oTPFdAfhybm88YTT3MdqNdmjiCwlpBHafKZkAO3a8x8zdjIG5T82Od3xL4J03xAdU+1y3UQ1DTP7KlEDKoWHczZXKnDZY9cj2oA5nwl4h8L6Z4o8QW8umafpGpNqktmtzaaW8S3IVBLiSdV2NIcudpbJ9OedwfEvws1nbXUd7dywXMXnwtFp1y/mRBVZpABGTsUMoZvuqTtJB4qOX4dWE2sTXtxqeqy20l8+pCwZohAtw0fl+YCIw5wOgLkZ5xTp/h5YnTdGtbHVNW0+TS9O/slLm2eLzZbbailH3RsvPlqdyhSD0IoAszePdDYXy2FxLdvaQNM8yWlw1qmIfOAe4SNkXKFTjJPzDAJIBs6R4x0nVNQWwtJLma7Cr5rQ2dw9vExjEm1p/LEanawOGIPI4yQKwZ/hVos1+tybu+REsm0+KKJLePZCYDCF8xYhK4CkkK7sucHHAxFrHwstL67e8t9Yvra9FobKKQQW4McZi8o5dI1lf5SSA8hUNg44AABNaeM9J1DTbGfxBbrcNezyXml21rp017L9njfEVwUjVypI2sHwAN4A5FSeJviPpNloviBtIuRNqmn2V5NAs1tMLeaW3jZmRZMBJNpXDBGJGD0xWpqXg+3nv7C90vUtQ0W6s7X7Ej2HkkNBkERsssbrgFeCADyeayLr4XaTdQ3dtNqOrHTpUvFgsvMjEVobpXWZ4/3e7OJHxvZgu44GOKAF0Tx8pt9duNdhnWGx1H7JGdP0+4uSE+ywTFpBGrkcytycDAHfroTfEbwvFJbKNRllWdLd1lgs55o0FwQIfMkRCse8kY3kZzWRrXwk0PV1lW4u78CS7e8dSsEqFmhihIKSxOuNsKEHG4EkgjOKxL/AOFd9b3Gnab4fvGt9AQ6ebxprxWef7IyFSYRb8ttjQZWVB0JU4wQDsZviN4Wg+2NNqMiRWkU0zzNaTiJ0hOJTFJs2y7SeQhY1reHvEml+IftQ0uaZntXVJo57aW3kQsu5SUkVWwQcg4wexrix8GPDSLq0cDzwwajDPC6x21oHiWXO7ZN5Hndzjc7DHGCMV1c3hW3fWbrU4r/AFK2uLm5triVYJgiv5KlVjPGSjA/MCefagDas7O2sYTDZW8NvEXZykKBF3MSzNgdySST3JJqeiigAooooAKKKKACiiigDgvjlD9p+HF1AOst9pyfnfQCvINbtpo7WKziI3cDdnJ616x8f2kT4V6k8JIlW6sChHY/bYMV5d4bs5ZNMsbq8LGS3jZ2z1YD+tevlrcYSl5npYF2izaT/kEs6xsGWJQ5P8ZH9ay9G1BHe5hmwqgYWNeSKl8L6tLrMF2kqqIkkAVQMDrUGoeH7qDxVtC+Xa3CeZ5g6Be9d6SUnGR0p9CoNNluLNIUBZmuOQDyiE8ULp0mnvHpd/lC9z5gkb+8ev4VW1Vrme41ywtsJcfZBOrqTkDIIGexwK6EW9zqFjost5HIZyqtIep9zVuVlq9BuWupm6bJdWvid443z8u1l68djTddtJ7XxjZSbXmsb5QkqPkhXH8Snsehrtkhsm1GZxbvGWiVAccnHeq0iy3F6tvOwW1Cll45V/7wNYKt7yaXQjmvsZN9oMsvjGzv5ZI2it4AoA/iABx/OujMarGmw7wB933HrRbDT4FZtUvBbQRfM8hOAo9Ce1U4NX0nWHlfQ5J51WTYJGQqp9x61k5Snp2K3fKaE/7u1QLHuLZ3DHNEdrcRxp9o3Qx4yomOAo/wqSO68gkb41bGAW5rNZ/tk7vfmRpgOo7n0+lZ2ZoqcpX7FkzRF1COGiB4cdCR6U4wQgO6sxy2QT61RkgmV1lkjSJRnZGDnHvinR/uyPtLylGOVwP6VduxulFLRm3YzSxwytyxxkKe/tmsuS4e5m8zy/KK8kAdake6gcBWZmbHG4bcD6VJHNbiIK2SBx7moStrYxSs3K25uw6rDb2wbKh1XOM8k+lcbb/FDV7jXBZR6Mi24fYzSllYf7WPStSaKGQAt+6U8nnk1Vuzpvmq/mu0aj7qjLk0qcKavzRuRDCU27yTZNNq0t/c+bOxeXONkWQgH1/pWlHKz2jPJGRGchccE+tYllqWnrKFghljXB3Oxy34dhWrJfW9zbLFaxyocY+9n9aJxtokVUoqNlGNjGtdP0y1a4+xwy4kbGG6g5yefrV5be3eHe85E+AoWNchQO5NLdwSwWgigVgGyQQMnb606xeO1t2jhLs7ja/mDCj6VbldXNbWjeLK8MUkJeRWSZBnc4ONv1p9xLNcWvlxKY1HQjkk06KyIQ+Tum2/MY/4R71gR+N9Ns/EA0a4+0Ldb9uRCSoP1ppOd+XWwOon73Y1LdGiC+dJ84yQpGP1okiuxG0ts0sy5yQgzWumnT6pNFNatHJERndkBcdsVDqenS2bsZrnyWX5v3JPPtgVPtE3bqH1iEnbqzGtLa5nuo1XzGmYtmMDkYGR9M1Y04ajYJNNHA4vJuTJIpbA9B6UzStVvo7+O1tjFDcTvtVnXcd3bNbfmeI7xmjaEERv88kfC5+p64pzk4uztYdaTi+V2scsHV9Xubi4eaSMYKiVsnf3A9vetFpdLFvueOQybCVBJXD+h9qvPo+25k2AypGAztFzkt2zUPiP4f8A9v2dubW9ubcdXAfHP+134odSm7czsR7elFJNszIPtE0ZSMCV8ZJHYVfl020i069ubiJftoYRLtQfP0OffGetWtM8Dv4ft0TT9Ta4kbgmVuW+npSxWs2nh1kSIbeNpbezn0+lKVRN+5IJV41H7jE8M6KZNSWeZAllEuWDgEHiqd5epK+qfZwJbddoSQHb39a2L6LUdR0VomntoYh87xRDkjsDWOdJS4wn2toIUDSSsVGEYYABPqTUqV25SZMaylJyqMueH7K/1K7e3uJImsTCVePAIAI4Gf71TaPDaxveyWgki063ZUUv1kdeDVTTo0tzb2STuk14heabcNyIOyj8OvvT79gNMhhSTyoTPhSecjPLNQ/ela+hEpe0m1fRk174ih06WzutVYR291N5cSkcnHTFauoaDp2tKb3RbiFJ1+/sIKMf9oDoa8/8X6TqOqW2jppuy7nsb7zRggh0IIYKTxxxx1q/o+kpperXl3pd1KguI8SRZOQ2Odw6ZHPSm6UeVSi7M5mmpXg7Md4ige3szDqE8VmxdU8xG+XPUDNYvha21GxjvNNYJe288nmImN2Cf4lPauitPDY1+Ka21RJ2guIyWctjYR91vzqWDS7PRore0jdrmVGWNzG53KTwMe1aKrFR5N2djqQi7btGbNp93ZSYaCbcBlXwfmx2x3q/bNfQPJI0TxSovmK5XgH0Oa3NRW50+5jj+0mVBhY0cfMMiq9x9uuoNsPziQbdsjZyMcis/aN2bF9Z50k0tTjfiDqt5P4K8RG5Kyg6dcqGz6xNk8Vm+B7zb4K8Prnpp9uP/Ia1P40sGl8EeJHeYIYtMuJPKHUfu24rlvCF1t8KaKN+MWUI6f8ATNa48byqSSOLMYx5oqHY737bWn8PJ/O+Kll7aLff+j7OuGN2M/fH5Gun+EUol+Kdvht2NGvP/R9pXEec4tDfG3jGPQ/Hvit/HF7rttY2UUDaNZ6dffYxLEUzLMuZIxO4fAKEsRnAUjONS1+IPiWTxPrNjYJp48OaFplrfXNxfwTSX7RyWxkzsjba77gMj5R1Gecj2migR852Hxs8UX+neIbnTLPSNQTSrS31NXWDYZbZmxKCiXMoR1GTy+RtIZQeB2fhv4iazq8HhzUZzo9jp2vavPBZQ3EE/nzWag+WQV3KJTtLZbauMYr0zWtLtNb0m70zUo2lsruNoZo1kaMuhGCNykEZHHBqXT7O306wtrKyiWG0tolhhjXoiKAFUfQAUAWKKKKAPAvh9qXiPSfh14d8QyJ9qvdTksbNbi/169vRMJ7hEZmgcBImweCpbHuCQdmX4keJbL4gN4eurbSpjBcRW7R/urWW7VowxmhEl3vxk4CLFJnaRvzkD0W28Z+F7q3up7XxJos0FogkuJI7+JlhQ9GchsKD2Jok8aeFotOhv5PEuiJYTMyxXLX8QjkKkBgrbsEgkZx0yKAPPvhr8RvE3i2S8jTT9EluEtVnW3a9jt2gfeFaKQRy3EvAJ+Zoo+VwVGeLHirxn4u0++1RbRNBgj046bFLBLFNcFpLuURnbKHj+VCc5KZYdlrr9U8ZW1pqVhaWsKXQury3tvNS5jKhZkkdXAUs2MR/xBQc5BODUHhf4g6HrGjaBcX2oabpmp6vaxXMOmzXqed+86BQcM3OQCF5xQBwPiP4oeJdFiFrNDpP2mPULuyl1FolitsxLE0Y2zXUYRn809ZSfkOA3OKjePLnRZtb1Z3s7HUNTm07IdYrm3VmsQ7KJTcQxAccOZcHGACSK9ktvEeiXV4lpbazps127FFgjukZ2YFwQFBySDFIP+AN/dOLK6pYPpz6gl9atYIGZrkTKYlCkhiWzgYIIPpg0AeMxfFTxPeaCdXtoNGhitNCg1e6glt5HaV2uJ4nRGEoCDEIIJD4J71pyeMfEI1abT9GbTIC1xrMryXsU918tq8IQKPOXbnzTkAhRxgDGD1mkfEbw/ftrtxJqulW+kabdx2kepNfxmC4Z4Uk4fhQQXK4yeVP0G1ceKvD1sqtc69pMKtGswMl5GoKMrMr8n7pVHYHoQrHsaAOe1jxjeW3wx0rxLbw20M99FZySPOGaCzWcpvlfBBKIHJPI4HJAyRh6B451/XNc0vS7KfQ5Yrh78HVI7aVoLhLc222SFPN6HznQ/ORlcgkDB7W18b+FLy4gt7TxPoU888nkxRxahEzSScfIoDZLcjgc8ikTxn4fSK3a/1bTtPkuZZIYYrq+gDSskjRnbtchvmXoDkZwQGBAAOf+IvijX9I1n7FoDaXGsWi3uryte28kxbyGiARdsiYz5nU5x6HoeY1T4l+JtIsb4XlvpU86Jps63EEJjitoroTZMglnVW2GELuMkYO8Z29K9pooA8Ei8e3a3S+KNSaxguY9DnjWa2Ed3A3+nRxo+I7goAcjIM2FOctgZrR8L/EjxP4mSyttPbQ4bmS7voHupLYzRMkEcUiMqRXLLlvNwcSsO4PavaqKAPFbH4r6teHSpiukWr3UOmyJpciSNdagLkKZHt2DjCx7iPuP9xtxXrXO+LPiHqfiHwR4isZrnRL2O40rUzcW+nxuJtO8ltiGZjIw+cdAVQ56ZFfRlUtH0uz0bT47HTYfJtY2dlTcWwWYs3JJPJYmgDzDxD8QtZ8Nxaxa6zd6Sl9a3ltBBdRWRELiaJpNrrLdRqhGxvnaVQeOMnFc1e/GnWl8JR6mZfD+mXS6VJfIl7E8g1CZJ5YjFAFmGMeUGPzOR5g6gZP0DWL4h8MaX4haL+10u5okGDAt7NHDIM5xJEjhJBkdHBoA8xv/ilr0PjPVtKitdFgjtJbmJIL+6gtpNscLOk5ZrneUYgE4gwEJO44Ndl8KfFdx4s0e8uLy5s7m4t7jyXazgVIgdithXSedJPvdVfjoVBBrtqKAPCtA+IniVvDMV7bLpQs9P0jS76eK4S4nlmNy8iMqytMSMBMhm3nPXNe60UUAFFFFAHBfHHafhxdbxlft2nZHt9ugridDWG8XyMBIkXy8DjK+3vXefGYK3gOQOoZTqWmgg9x9ugrkLW0h3H7NtWEEEEdj3r0sFK0JI7sJrFlTS9Mt7LalmhRFYsSx+8fetN0lxC0rCTyk8se4ouHQb41xjqhPcCsaTUleY+UxXB9a6vem7s9WFF1NS9er9j0a6m0myhn1Z02q7qCT9fUjsKdpQnTw0lzqkqR3BOCOjYHX2FPZZ7e1guLmQIswyqgcke1Y11dGWVkbcYA2MFeStEfeVjOnhvaO0WP03xRp+o6kLS2uVlCDMtwinYnpz3P0rUvwsxL28sjjbkYTYB9c1Qktba3tlWytUWJzjeE2nPetWO1WHSZLRD5t5cESMOvlrjuacnFNNFyhGklJM57XbSDULSLTBNut2lEtxzkykc4z6VbitW063Jt8wWw+SJR1PqcelBtDbW0hiMbXI4AkbaB+PvRM7zIiL5khAyFB3bT3A9a0vpZPQ6Iay02LNxaXT2EM8UDyJtyHzkPz0Arc0C2jW1Mt1C3mseQVOMfXvVez8P6utpDPNdwW/GRFIfuD0x60o1S6lLJcXcUyD5QNuMfSuaT5lyxZzVZOouWDNG7hNjG91cBHDjCKOgHvWJHdvdyosdrmVeEHp9amZpLtFjknCwL3c4z9KdbXmkWt7b2pvYzNP8AdCHJYjtnsfaiMWlqrsiFqUfe1Ys2n3D3EbTxhpGHCIQSPyqw2k3MwEUETwkdWfjPtSTaukcXmWtpJJlwmX4IGaj1PVJLeMSTpPCmcbDyT7/Sl77aJVSrO1irqFjJYRbp5LeWTIxGJMsT9KSOyTyh9ohIK857Kf8AGs+0W6upJLiGIMmcgsucituyvjdpDp+z7Q27Y0sh2kdwR9OlW7pbmtSU6a1dyGe1jk8oxG3hBOC0jhcmnb5rYC33wMwBz5WG/Wk1u0W3ysrbOhC9R9aNJFlBYyx2kk8s8hG5iuAoHpU3urkNuVPmTuUpNXlM7WnmGNyBsQYVse3+FP8AIl+zCZJUcbwrLnn8ql1DR9Inu4pZJmE5O93YkDI75HSnx6ppCXJt7KC4vrhU3KuwqhHqSau6t7iGq8YpKKNFbpLWJrWGJnfGdyrnJqG50uaR47mZ4YojzKkkKtvx6HGQeantYZbk/aXZILknEcK8YUetV7+2vY7a4mvb0S+UT8ygkbewx3PasOujMGot2vYjumgtVh0zSYZkgVATKGIYjsAOwpLq7ihjjjt3KtE4M0jHO/2z3qTYiRo99LtuJVHy55X6ipZWh0mBpktPtV0jcO/ROOwp6KyW40opqMVqZNp4i07TtSjWXT5DcbiyyyREEEjsanfX9TuEWRLtUG5gYwMEelalhq0+vwy2t7ZRiRh8joudvv7VKfD0UB3GIyTMOEZv8803KCfvrUFOFOTVZa/eUdIuCLS4SC4Ec07Evx0P1qlLHJaTQR2V5PGoBa4O47ZCOfyq2unXK3gXCQRJ1UdSD/OpLrT3M4t1Klx9/nHWi8VItVKfPp1Mhrm5t1iR5yRIDIGUZ4PatDQZ7bUTd2r8XRUNA7n/AFnUECphBFCk0Vwi+Qq7Bngj3FQTaZbxSQTW+5hCBIsgyMc9DTcotWE8RTa5Xo+4yxnZLG6XCieAFpS3dQen50zS0nS7jvpZttrLIfMcgFGAGQMevFXjewWFndxR2/2u9uCGlTGBhucc+1ZYmjtIWFkXmM2Inib7qA98eooSbv5mcZOTbtuaXiNUlfTtcsY3aKdPJfavQdvpzVTV72NIba08osyKDIpXHze9aayfZ7ZFhnYQRgYTbwx9RRboraet5IA9xAfmJTPmgnOPrUxlZK5nGcYW5lsZe66h0+CW1hyUk3Kka4CDB+Y/jWyb6zu7eOWVkhvghjkB4/Os2+vrOOxe2u7x1u3kLkQrygPIU/TpS6TFYQRxySDz/OVg4bqp7H3py1jc0cFKHPJNCX9/l28q5ZU27GUfKGwO3tXN215rdprCTO8cdk4Hmo6gSNj7pU10lw1pbyMUgfLEFS8ZyPpSX39ms6zRmW6vlP3W5Vc9vTirhJRVkioOmntox2ob764hu98qXEsf3BjCHp1p2h2FzeQqyy+XbZyszttJYeg9KzNc1S6nnJSIxSIoAI4I96pRTTXk4DzzNO/BYthRTUHy2NYYeU4N6L8bFv4iQafYeAfFkVtI893Jpl15krHP/LF+noK8Y8Lz48M6SM/8ukQ/8cFej+M7cjwb4kLLKsQ0y7bc2QCfJfH1ya8l8Oz48P6YPS2j/wDQRXjZpL2TjqdeX4BYitKO9l+p03n+9dr8EJPM+Kae2jXf/o+1rzT7RXoHwBk3/FPr00a6/wDR9rXm0K/PUUTozXKvq+EnUttb80fSlFeEePPi54g0Lxx4l0bT00ojTptPgsbeexnc3slwgYo1wJBHCR8xBYcgHrg11mtfGfwvo3itvD96bj7XFcQ2txJG0RSKSToNpcSOB3ZEYDvivRPjj0uivGX+KVxrnxE8EW/hxL+Lw7fz6lDPJLBFt1AwRZHlcmQBXB6hM5HXnHqvhzVf7b0W11H7Bf6f9oUt9lv4fKnj5Iw6ZODxnr0IoA0aKKKAPGPCHwx8RJ4Q0pdR1xdI1m10dNMhWytiptlMsckiyOsxMjHywu5GTGSRgnNPsvhp4g0TVtMbSdWtJ5Wur+7uL67tJJ0gM0UKBQklwZHJ8tvmLt15z3xNK+LHiTUPCF3fXT2VvNc+HL3UbWWPSp7TyrqKPcqRtOzpcjG5iVGBt5zmvRIfiPp8Tql5aakLOKUWc+q+Wn2ZbgRB2TAfzPbITbnjNAFHRPhZDo8mmC21WRobF7BlWSHLMLaKWPBbd/F5uenGMYPbIl+D2oyaZo2mHxbMdP06GzjWFoJgu63dWLKizrH8+0Z3pIV6qRXQx/E+wMERn0XXLe5uY4JbG1kih8y9WZtqGPbIVHPUSMhA64q14H8SXt/4d17U9Zinjaz1C8QW8ojEkUUbHEZ8slSQBjIJz6mgDJ1zwJd2fw//ALJ0KRpdZXVm1C2vY1SIwSS3TOZWDNyEjkZTgksowAMgDotX8GWd54AHhWykNpaxwRQwybA+0xsrKWXjdkqNwyN2T61zejeLvEFvqXguxvrKbU216xn1C5kiEK/ZjuhKohLpmOMSkMSGdhtIydwFLwR8VQfA1hd+KLLVf7QXR01OSfyocXiblR3jVH4+Z14YJ14BoAl1L4V6hqV9capd+I0Gsy34vhLbW09tCv8AoyW5TbFcrJ91AQRKO4ORVyw+FsFnoviCwjvYIzquhpoqtFbORbACcF18yV3IJmB2l/4B8x7aV18RLW0u54bnQ9bjS18r7bMUhKWYlcrGZMS7jkANhAxVSNwU5Aoj4qWsk8cdt4Z8RXAme7S3eNLYLObZykxXdMMAEHG7GegyeKAJ9R+HMV4dTK3yRNeNphBFsD5Ys5VfH3ud+3Hbb79Kop8M722ewOna9HZyW888r3MNtMlw6S3clwY8rOEKjzNuJEkGctgZwILP4mqut6heTW2o3PhqS1024guIoogtmtyDhpAWDnJZOFD4wenfVb4oaWkMtzJpesrY+XcSWt15MbJeCA4cRgOWHQkb1TIBPSgDsNJtr22S5GoX/wBuaS5klibyVi8qJmykXH3to43Hk9TV6vMtR+M3h3TtOsbq6hmU3gleOJb6xb93Ht3P5guPLPLABVcuefl4pNW+I39o3GkJ4Xt797KTVbK1uNS8uH7OVlCOYvmbeWKOvKpgZ+8DQB6dRXH/ABD8f6Z4Et4Z9XhlkhkV3JiuLZGULjOEllRnJzwEDHjp0zVHxM0s6pJbHT9UWyjvVsH1IpF9nWZoVmUf6zzMFWHOzAPXFAHdUV5vJ8UrWewM0Ol6rYLLaxX1rPeW8TpPA88cQdUWcMM+YCA+0gHODjBt3XxQ0q1gu7qbTtWGnRJeNDeeXGY7trVXaVIx5m7OI3xvVQdpwaAO9orz1PijaC6aG78O+ILRIpbWOeaZLcpALllWF22zEkMWx8oJGDkCmz/FvQoNZ1PS5ra8+1WEE9wywS21wZFiIDYWKZmQncCBIE4z0wcAHolFc7oni6w1TwtceICrW2n26SSSM08E+ERdzNugkkQjGeN2eOlYq/E2wXy0u9G1u0uZmtvItpYojJMk7FY3XZIwxlSCCQw7igDvKKhs5nuLSGaW3ltZJEDNBMVLxkj7rFSy5HTgkehNTUAFFFFAHD/Gf/kQpMHB/tHTef8At+grkLe4FtlBHkMCflGQBXZfGCOOXwT5czbIn1PTFdvQG/t8muUntoozMLAymH7iOzfePofau/CNcrR6WBlBJqRSvLVp44PJLyGYl9ijO0D+Va2laPeyyxtDa20QXq7x5/TvWU8uo6XdArDNauQCTjcjfiKtDxNq8v7oMDjqVUDFdUlNr3T05qrKNqbVvU27jSZPtS3Ws30ZRV2hAuNnptFZdzpenyXqOXZYv4wvVqz5rq4mWWeXdPswSM8/l6VtaVqP2nTZYHt1V19cbj9KjllFXOZRnSXMn5E0i2CQLHaReWiISu/t9Pc1kjUZpIM2UAQk7C397HHNXLS+t52eO4tzmM7W3HbkenPWrt1ehJrSGzt7ckNmQEZVV7AY6mkrx0JV4bq5x1raS3VxJFLNhoyfMJXcQBWrHpkrxb7OSVYwex2v7VfvIHuNUme4h8q3Vgyso27hj0+vrU+qz2bWNxcs01v5CjdNG3PPQHPFXKo3axpWxUtEjBFjdyXMaXrSCQnaizPkn6Vsf2eRCPLeKNh/dXOay7B7qRptRa5F3bTKFSYgHCjqFI961bifybZpIFLqq5VRyTVVHJOxhVrTlZRJLaO0gnlOowedaSRFFAG7a2efzrkPD/hHTtH13+0ZBJPbrKZYUm+9GPX/AAr0Dw+FubORZV2zW5OecjLDPH4ViTzK7s0gOWJ6dxmopzkpSj8jGM3doI76KS4EoiCnO5UToKtfZJLydp57fzs42CXPH4VkPf21perbrNFDO2CiOwDn2AroNJeeS8aS5uRuJ+VD1Y/0FE04q6NJLkXNsW2eaaFbN444WOAqRADJ9vSq93psk+2CJ4RLGN2VGAoHbjrTtQnEMbSyt+8jfKjucelZ1zqt7cl3AhgV23YTO7H19aygpbowhzvVbDhpbXMoGoX/AJi/ew6bVB7470kt1ocUjxyagUSI4MUcZBaiO5V3jZpWLN1zz+tMj0K1lvTLB8/94PyDV9feZ0Rqf8/G/kTau+n3+hSQaXm3ndf3eeC/415X4et57bXHC6nJC6nDyOeo9BXrd5ZLYRxzKoZ0GRxjafpWRJZaZ9iuLq+toZpoxuYDhsew71th6yhFpapio1oRv1TLsKWjwr58u9zjM4ck1O/2RI1NjeZVOS5Uvg1meH9V8OamVTR5S0yDm3cgM34GutggS3DxRRJnG4lR8oz296wqPkdmrGc6sU+pgLZz6nNG32qAyoeGC/NiprjRZIsS3dy90zcAZwD7H2qSYXsnmEW8cflnO4dfwxSW0M1yC9zJJFt4Geopc73uae1lunoVY9VkspTHFDEmzqI2wxHrjvWLfa5O42XDOxJADjg7fSrGqaNNJeeao+0lcfMnylfasvxBMmj28cur2c8cRfakuMhT6E1vTjBtd2d1KFGVnLVs1rPXbmTyUihVhEcK5yWwfWte2GZUuWjiR/m3ndgH3NcbptzZak7fYrxQR7/N+IrVihtEAaW+SXHDx8ginUpKL2sFfD0pfDoWpdTgkgmikj859xwepA7kVNbeJNLs7N5prhbXaBveVgq8dOverljJpMUCtp3y3cfIZuS+e30qHxDDYazZMt7p8Mu3I2mMH5j3+tY+63ytaHE40/h5WZcPiHRNQu4mtruCR1YOHV85Geh9q0LuP/ibHUdNISB1xI38LH6fSua0z4ZWH9qSXtrP5Jjj3fZ44sBGxwCT3raXwhdppE8j6iLe+df3Pm8op/2h3rWboprkkWnSjqpeRJcXEglRSytgYCr0FIH1G5hKWdiYYw+TIzn5iP6VLoNtJZ6QZLu4hvbsuY3dI9ojHrg96mjupkuJRKpFpHBukYHh1xkj2NQ3Z6LYmbipNRWqMW00kT34adFmeQktIvUY7Yq1MrWsZEWnSsQdvm4IFR6JcQXmyLTpHcuCUBySQOT83Tiujm0+7WEmb93HEuWZ24P0pznZ2ZMsVNT97UzW0/VLuzW7tY1L55iEnI59+lNgEhvRbyoFnbg7FyOO9XbW/MEm6KXMZOHwOG9xVu2WK5vEkYMJAwIfOCB6D2rNzaTuiJ4mVveRUnVra0dRakRs+HkbG4+1U4LSOS5H9nSLHc5yFdAB+Fat1BdXt7IqIV3kKBnOFHeq+s6bFbzR3Kzozpjyx/EDSjLoTTrX0OX+Ibwv4J8Urql2wvI9KulVMfKT5LYA/GvnvQXA0TTwZAP9Hj7H+6K998dxRP4E8USbTLIdLuiWPO0+S9fPGiH/AIk1j/1wT/0EV42c03JRSPruFq1OliKnN/KvzNguP+eo/I16R+zo274qSfNuxo1z/wCj7avLM16d+zac/FOX/sC3P/o+2rysJRlGsm/60Pa4lxVKpllWMd/d/wDSke9at8P/AAxq8uuyalpSXD64IRqBaWT995IxGRhvkKjuuDSr4D0BNSbULeK/trx1iWWS21O6hM/ljahlCSASkDjL5J75rqKK9s/JzjrD4aeE7DVLXULPTHiuLWWea3UXc5ihaZSspSIvsXcCcgKB+VdB4d0TT/Dmi2mkaLb/AGbT7VSkMW9n2jJPViSeSeprRooAKKKZOZFhkMKh5QpKKxwCccAntQBx1l8MPCdpYmyjsLqS0FrLZJDcajczJDDIux1jDyER5UkZTBx3q7/wgfhz+1RqB08tNv8AN8triUwGTy/L8wwlvLL7ONxXd715Vpvh74jzRanHPHq1hDdR2WIhqrMYpFvI2n8uR7uZ8eTvG4GPcBjYDwbniddT8Kon/CQajqS+GU1a68qJvEItrmeFoIzDi4knR2VXExKGTd04IGKAO5tfAPg0G60yG3aS4jjty6HUp3ntY0Zmh8tjIXhUMrbQhUcHHStTRbHQNDlk8M2CustzHLfyQTSSzNKrMFkdpHLZJZhnLZ5ry3w3pvjq98L6bdXD61c2s1hpDzwrqJhubgKJzcqjNIpjkO+AsxZCwGN3HDz4Y8ereWN8kV4YY7aeKaB9RU3rWzXYdLcXG/iXywPnyRxt3gneAD0XSfBFnbWGhwahPNdz6Huj0+5hlltpI4Mrtjco/wC8G1EDbvlbaCVqb/hAvDX9n29j/Zv+i29j/ZsaefL8tvuVtmd2TyinJ5469a82/wCEf+IbeIdYne61ZY5FvvsvlzgwtG8Ti3jJN5hHUmP5lgzuXlyCWpPG/hzx2lvYw+GYtYluVs4ppL3+2JGY3eRvRka7jjVcKOkcqncRtXuAek33hbwz4i1V9TliW6uYpEhn8i8kWN3hfKrNGjhJCjHo4JFW7Xwlolr9l8iy2/ZTctD+9c7TcOXm6tzuYk89O2K8zHhTxBp02qR2WneIWt5ddkvLk2uteWb2zfeQkJNwDG4dkLEiMsFI3Hoa934T8d3mh3jPda5FfQ6TN/Z0UetMrLcm5laFJWWQCR1iMalmyp5yT1oA9CT4ceF0mtHWwnC20VtCkP22fyWW3AEIeLfsk2YGC4J71NB4B8O293Pc21rdQyyiVVMV/cIIPNbdJ5ID4hLEZJj25riPEHh7xbYrqljosWr6hpkl/DLbySavM88UYt8SFT9qhdgZOqNKoGSQpwBVTRNF8eQ3fhKXVItau7iCKCK/EuoiO2TbK26QtFdKXfYQSHimDYUZGWNAHfL8O/DiRxiK3v4pkkkl+1RandJcs0m3funWQSODsThmI+VfQVLJ4D8PSavHqT2lybtJornP26fY00ahUlaPfsZwFA3MCSByTWL8RfD+u63rO7TLnVILOLRb0RfYtSe1DXxaLyNwV1LcCTk/L69cHnL7w94z0+y1G3sI9W1GC4i05h52sStKkwE32poyLmJuvk/IJEQ5O3oRQB6H4n8F6F4nn87WLaeSQ2z2bNBeTW/mQv8Aejfy3Xep9GyKfF4O0KGMxpYDYb1NQIMrkGdI1jV+W7IijHTjkZzXlFvZ+N7HSvDGlX2p30Os6ybvS7iOS7LyQW4maVbtCJHAdIcpneWzJGCxIr0vxvpOp6ifDdtpU99FaR6krag1tdmFza/Z5lILbgxBcx9DuzhhgjIAOf8ADXwostPvbqXVbmO9tZLZLSCzg+0RRQRpKJVA8yeUjDKmFQoox93k1vzfDzwxNNeyS6c7i8S4jkjN1MYlE4ImMce/bGXBOWQKTk81wFv4R8cXPizUIL7V9btdNlku44bu2uGaMQMjCAZa8yrp+7O4W+4svzMwJJdqmi/EjUPDsN9cy3EOqXF8hvdNs7s4S3jiKDyik8AG6TMrYlQkMoOdu0gHpl14S0S6+1efZbvtRtmm/euNxt3Dw9G42sAeOvfNYGgeDvB14817oqXwNvLd2IaPUbuMW7mXFwkQ8wCPLp1QAcZBrg9Y0X4kvbaNHYx6q9zaww5vTe+WzkTszpNGL7ywRHhdxW4Lg8lT07W2sdS8P/Dfxq1wr2l21xrF9A8cg3BJJZpI3BU8HBU+o9jQB1ej+GtK0jS7rT7O2ZrW7d5LkXE0lw07OAGLvIzM2QAOSeABWbp/gDw3YMjQWMrSJJBKkk95PM6GEkxKrO5IRSThB8vPSvOtE07xo1rbapp0PiBdPVtNuGsb3VlnuLwqzm5ZGaZlRGVk/ds6glei1teF9C8WX/ieK58SNrFnpROoTG3XVPus11E9sjeXJnAjD8A4ABU8MVIB6RrGqWejafJfalN5NrGyKz7S2CzBV4AJ5LAVdr508IaP4s8S+BrC6hTW5re70q1ac6pqguBe3AuYZBLErSt5aiNZM52E5Hyk81txWfxE0XXtX1S4OqXrK139nSIebbXHmEi3G03TeWFJjJK2y4CtuJGWIB7Jpep2mqwSzWEvnRRTSW7OFIHmRsUcDI5wwIyOODVyszw1pEWg6BYaXA7SLawrGZG6yN/E592OSfc1p0AcV8Ys/wDCDnAyf7T0zgf9f9vXOwiwVYzbSTfbAMyLIOGOfSum+K4LeEIwG2E6tpYDen/Ewt+aoa0lvbQs1oyCdl+eTPf29K68NLodeGd/d7keoXFvDaxy30zEPwsKHk+3sK5XxZd3d/p7QaF9ltJCAocrucH196in8ozkmR5M9Tjv7VJBb2scy3NtbSG4T7sk0hIQ+y9K7oQUNT1oYVUUpPV/gQeHdI1qysLFbpllvcYEzrgt3yR6fWuokeCzjdeHu3XawAyB9KoWi3Um5pLudQ3Jx3qZLeJGJLu5HGC1FSXO7yMalVN2b+4qT2UrorSMDnkZOMD61l2mp+ILPXVjtRp9tp0fWR1Mjv8ATniug+wxSj5s8njmoZNIQZZWb15pxqLaWolXjJcsmW47iW8kDfaVlnJJYsBtI7DFTLpTeKPDmp6TqbNBHOvls8XVecgis3TmitpAXiKBmKq5GVJ9K1vtgFrJbxssbE5Up61lNPaJzz00gZmh6F/wjGkQaOd8ltaghLiTA8wk9T2zVqMICSo+UcN3AqbU9Us4kgsb6U3GAA8aDP0yfWo3KWlnvtZI4oz9yB2yWP8AjSbk9ZbscKU7Xlpc5P4iXmqjTdNs/CWn3c5a5EssiLyVU8A+3Wl06/vNWmumltjYGAqjxPx24x611NlqE8N3KssMcj8FWPRPUZFVNQ1BbqbcY4kkUY+RSd3ua3jNxXLy/M6YUZQei+ZyGl+DVTxNBrGqX7T3MTl440A257Zz6V6Csgjj85VDSrwvP6n2rKs7GSZo5EV3aRtqrjGK60aXa+QFlIMgGS2fu1nXrXs5O5hW5IyTm7mEblZVk8yPdM3APYDvVaVYXXKnO04wOce1bL6dIkpJdBG2AWDAHHt709rCyaNFsZhh225znJFZqpFbBKdPoznYbYlGKgkoeD6fhVm301ryWK7kujb/AGU5ZAM+YuKvSNd2SSLFaxLcnmMTP94fQVWgjn2ZuXxM/L+WcL9KrmbV0Q6ujsad48T2sYuTdYOFZ1XA/wDr1WXQ9PmLXVvNukddmXft6EGmRwBQXbc2eBls/pWbeTGPCsjsGb7o4yaiMXtFmULt2i7E1pZaRY3a3Ftbo9ymctH1B9B2q/JPcFJblB9mtx87l24H1rKPmw2gWGIK/U54H0rLu5rkPuYyRluqHkEe4NbKm5PV3OmFLmev4nc2GrxzREuYSGAwVOPzFTMkMpLTHcpHy7T1rg7XfvDpEMZxlm6n2FdBZzXMeEaMlB82R2rKdFLYK2EUdYs2Ejt49u/C8nhzwanuPJuIJEnSOe2cbZEPIIqKG4t9pedSzY9KHuLRoiHVkBHBI/KufU4pQd+pnad4T0fS7w3VmgVHO7axzj6VYvtI06azuWtrcTXMjZYqeSfSqF553H2eIyHGC+7H5VZ057qyZN42B13uHAyOO/vW8udrmctToSmlzRlqZKQCxnWR9PkiCqIxtzgfWttI/Ms282QNGTlSv3lPvUNvr5m8wz2xaNDyU+8B6471dthaXsJvrCf/AEduCScc9856Upt7yRVaUmrTVjGvLu9htEEbPGrtkn+J/c0Br69gWAqs7H+91rU8qC4Sa4aRCseVDHpn2rIku0iG7LD0K1UXfZGMNVZR1LNpoUlkt4cASXKAMC42pj0FMurC1XTymqsk0J+fYpyGI+nUVWa/uZwVDSSIeuRiprD7Ndym0uIn3EZQg/KB702pLWTHKU07yJBqssiR2Wj2jQW+35nRei/7Iqxc6VAliiO9y+R5riR85A7VNbW5s9UsjAylAjR7FOQw/wDrVW1DXUaO6iuYUWQgxrg5yM4z7VGsmuVEyk5O0FoUYJYbzUJI7eWKOONS684yOy1Vg1JDcCVG+VXGEzyBzx70+DS7PULN4dPhk+1Pw0qthVFT6Z4MMFxuvrtY1XkrCSSR9TWzlTSd2aKNNfG2asDG5sNzS7D90gdQOwrMurOOEBjuI9Sev4VtG8sraEW+nxmSXoBgnJ9z3rDe5BdmuVZiSVz2T3xWVO7emhkpWfu7HNeOblB4E8TIAVB0q7HHr5L4r510U/8AEnsf+uCf+givoDxiCPA/id2OcaXdj84XFfPejH/iUWX/AFxT/wBBFRiKHtZo6aON+qTbvuaGa9Q/ZqOfinL/ANgW5/8AR9tXle6vUv2aDn4pzf8AYGuf/R9tXNPCezXMXic1+sUnSvv/AJn1PRRVW11Gyu7q6tbW8tp7m0ZVuIo5VZ4SwyA4BypI5Ge1YnkFqiiigAooooA8R0v4n6lc/DbTDdR31p4jn0+1vUvZ4YPLu0NxDHK8aqTj/WAYZVPzZA711l98WvD2na9qOlags8E1lFPMzpNbThlhALfJFK0iEgggOqk/UEVo6d8NfCun2ZtbfT52g8lLdVnvriby4kdZFjQu5KLuVTtXAOBnNRXXgHwbYLcX1/aLHahZ94ur6Y20Sz587Ebv5aByxzgDk0AZWv8AxAuNK1vw7LqthqWi2N2t0rWV0sEk13IFi8pYxE7/ADFnIC5Bz1GOa3vHGs3+n6Ho11ZiSxnudW062ljkVHZY5bmNJEOCy5KsRlScdj3p5+H/AIckto7e7tLm+hjSSNFv7+4utqyKqsAZXYgYRcY6EZGDzWtc6Dp91ptlY3UUk1tZzQzwiSeRmEkLh42LltzEMoPzE5xzmgDjD8YPD0eo6pYzw3SXNhA05SKW2uTKBKkQVRDM5Vy0iAK+0/N7HFxPiRbtdy6f/wAI9rv9tR3f2T+zcWxlLeQs5YMJvK2hHU5Lg5IGM0s/wu8NpZXUen2XlzSWslpD9qubm4hgR2VyqxGUBV3IrYQoQRwRVbw78LtPs7K6XW7q41G/uL37d9rguLm3kifyliwknnNMBsXBzIc5PbAABLH8UdJmRZrXTtXns444XvLlIowlj5rFVWUM4YkEHOxXwOTS2vxP02d5GfSdahtgt6Ybh4Y2W4NoWEyoqSM+flOMqM/XitA/DrwtvtSmmGNLaOGNYormVIpFibdH5sasFl2k5BcMang8NeG/NXT7VQlzYefMI4LyRZrf7Wzl3yr7l3t5hB7YO3GOADn5vHcmp+HbDxJoySwWEOpwWt1byTWs/nxSukRO6GSTayNIrY3KcqQRg16NXHy+AdOUW8NpJNHanUItRvRcTS3U15JEB5QaWV2barJGcHPCADHNbdvaaT4chvbhWhsYry7+0TySzEK88pVAcscAsdqgDHJAAyaANWiiigAooqC2u7a6e4S2uIZnt5PJmWNwxifaG2tjocMpwecEHvQBPRRRQAUUVBeXlrZLE15cw26yyLDGZXCB3Y4VRnqT2HU0AT0VBJd20d3DaSXEKXUyu8ULOA8irjcVXqQNy5I6bh61PQAUUUUAFFFFAHDfGpingCZl6jUdNI/8DoK4aDz7mQi5kfjkLnge9dn8drkWfw0vblo2lEN7p8hjXq2L2A4H1xXn3w31fWPFaTXTaVa2VnE+FaTJd/zr0sFH93KXY9XA1VTpybXU6K0tAyosVpKw/ikK9ff6VFcxXdnJM8EK7I+C5xtz7Cum/wCEgkjuTa3Fn5DY+VwcjFP82S7uo9kUYEZJznO8VXtJrVrQtYipGV5rQ5az1SQM6zx4bGMfWo55wHdQSCDnFaYt2a7meaLazsSVI6VTktFEoVEySa1Uo3JlUpN3tYl0fffTK1yxhtIDvb+9IegH0q0JH1C9WGEtFEDkseAqjrSatbxafDbIGPmzA7gO6+lZd7c29jpy3V4zvGWx5MZwaVuZ8yIjFT97obGp36x2X2G3gc28R+edU/Ue9V7Gwm1Rle0fy4YmBJPU0ywnF/oausEthYF9xExw8noT/s1ga9qEAgngiupnJwBsGxePpRGD+GO5vRg5e7T0Z0GqaVaW2sKxuY4LZV/fkcvn296ooxvrgpA+IkJZWlOOB/Ea5jSJVWNt8LSMTnk5zXX2cmny6eVh0+YupBaRiMsauUHBWvc7ZRdFK7u9in4i0HUW00Dw9ew3FwctJzj8BWP4Lv8Axfp1+0GoaXb3MWSDvIUhvZsfpXYw6tpmitH5sc6O3zAgDBFU9U8eI0JFpaMu4llZhk/X2ohKo4uHLdPqcE6tSV4JXR1CXks6xsbcwHAz/X8KLq1F7dieIv8ALgKhO1WasXwTql7qcavPNI6Qt84dM7gR0B9RXQwsZdTjlnk27M7I1GAc9/rXFUi6cmux58+aLsczqb6pNNJHPCqzq3ywk8fgfSrWjarbaLpcUWtTRJcuxBI+Yoc9Dj+daWpvNNfpm7SK3VwDs+99CfeuV8V6bbXWoSyxCOGZurNyGP0HetqdqiUZaJnTSiqtoz0Rtajqlvqd1DHp6GadBjzicDB7Ad6sppkpZRdSJH3+UE1y/hHSYroyLdXMsN2r4TnG4eorsf7NhiIVL2Z5lGACd2frU1FGm+WJdaNOi+SLL8dhFHGoQCQ/3jWTcmzW7ZJl3yjnao6Vt2YMaKpxg889qoXlvGLndBguxzgDgfU1zwdnqcEW1Igu9CSe18xGw6ncm8k4rFeGU5knV5VTgvwen17V0WqXTLDFEJFjSQEFm7YHJ/KqWlrZ6tpM1ra3r4GGLhQGQZB/p+tawlJR5uhSlLczZRZs5jhVorhcMS4+Xp0NWrC43xwo2wkyFRnuO4+gqlPIs1zfzhcrkmMt6gcVqQm0SFBNMpYch1HIz1rSbVinLTUl1KRggCbQp+4PQVkiUs770M20ZxnBHvWy6B7MF/mkCcNjqKwZooVeCayn8wSrtEROWz3/AApUrbMuiruxKNUtrIJPesBGCqiQ9Mk8cd6275mbavHmdWb+leYa/wCEtR8SeK9PSR5LPS7ZDO8mfl3gg4P5V6NLf2MwYtcBoUAZmx976etVVhFWcdX1Kmoxd0U9LtpIrW9vHT9zImxFHXJ6kVgzXcnhmzgsrC0fUbS9kMk0szYHPYDsK6zXWxZolsuEdRtIbDAf7I/nWXpl20zTNLGJERlBAPOMcmiDbTk1p2NYydRNy1HXd2L5QUURWyL8kWQBkDvUDKUjjgC5jKrKO+4mte60uCSJpUZPKY9upNUb2NUhBWbawC+WjdwO1EZp7GKb2iRmOVbSGQJxNJsUDkmrRt302yuH3ql/Im1DIeFGe1ZscpukZAsyoGHybeD7A1Nf6V5l0iSucKELHJPA7U3e9myetpM0dOtnhtWk8wIYFYh+rHPWsyw0m11G/ZrwMkBGWUEgufc9qt2l0tnFL5uEiCHcR3Fc1e+K9MjneNLqOM7wiqTyWPQAUoqV3YqLk2+XQ6mbUjCog0uJLWBOAcZJH0qNr5pFZZZGZiKwLuS8LlZE8l+oDVb8Oaal/K8t1dSlIhkxJwGz6n0qnTjGN2U6MUuaTNbTJjDDPNC8ChPvO5yQPTFU9Wmhk8yaIKoY5dQf4j6VZnhtYg0VqkMSMf8AV7s7vUmsm7sEhdhFMrrkj2xSgk3dkRgm73MPxzIsngfxKq4LnSrsn8IXr5w0e626TZjanEKDlR6Cvorx1pbf8ID4jnickDTbolcdAImr5g06fFhbDPSNR+laKSVS67HFmUY+7ys6D7Wf7sf/AHwK9W/Zkm834pz8KMaLc/dXH/Le2rxHz/evYf2U5N/xTu/bRrj/ANH29Tip3pNf1uefQi1URofFXwtql98R/Hl1Bol7PLM+lyadLFo08sk7Rom9YLxfkt+mGY5z04xXSXM3jHQfG/iHV9N0rVLe1vPEeltf+RYm5Mll9mIn2YRi4VsAtGMg+lfQVFeQeifPMvib4qvoNnILfUYll1W+inuTpxWeGBQv2fEa20rbCS2WETE4xletd/4J1PxRc6xoEWvXF64k0eSS7EOkNFaPOJdocyyqkschX/lkUAOSfSvR6KACiiorppltpWtY45LgITGkjlFZscAsASAT3AOPQ9KAPmfwd4L8XWvhzwFb39leLpGmalY38MBVvOjlkkXzRJHjcixbZmyQB+/H901sXd78Qdc0fxDY63b3T+ZaSh7AWUx2yCZNnkOLREI25486UkHI6GvRtA8dajda1c2Wu6Vpumwwal/ZHnQahNcmS5MKTKFH2dQFKuBuZl5GMHIzdu/iZ4UtFVptRnKGJ5y8djcSKsSyNG0jFYyFQOjDecL0OcEEgHB6l4m8d/8ACaalDplprqacqahGsdxZeYiPHC5geNhaquGdV2/vpc7gCATV9W8YJqdhZ6i19q9t52kXZnutMi/cu8kouFUrGAoQKhyfnTd97mul1vx/aReJdF0jR2N1Jcap9gvZDaTNFGBbyyFUmAEZkBRPl3E4J+XuI9Y+Itlst4tF837f/aOn209vqFhcWrrDc3CxbwkqoTxvwwyMjnPSgCj8P7nxj/auiN4hutRurfUNOuZ7uO5sY4UtJ0ljEagpGpUsjPw5OdpIxUWuf8JOfGV3b6QbzTrS71i1hlvrXT4mY232GRnYu8bAgSKi7mztOF74rp/DHipbvwMPEOvSW9pFGZzM6AhFWOV0BwSTnCjjnJPHpXO+Kvibbx/2VaeHGnF9eXzWsputFvZntlWBpiTbKqSsSAu0cZBLchWwAQa/b+IvEPwC1y0v0vZNfltLuEL9nVJp9krqnybcZdFX7oGd2VxkViSQeJYtZ8Qa9oF/4jlKWGmiI3elJG+oEXFwHSSNoFI2Kx4RUOGUk9Ceg8JfFKyutD/tPxDcPD9oMs0NtbaPeb4LdDy8hw29QCuZQFTOR1BrY8R/EjRdK0zWriyF3qc+mWslw62tpO8BZYvMCNcJG0aEjGcnjPIoA5zwbrHji6+Ic9trolg04T3SPbvay+UIgT5LRSC1CZICk7rh85PAPyip8UH8Qahrd3ppGtmxS90uSxtbLTfNtrlBcRPNJNMI2KlCpO0OnCg4YE12lh4tlu9d0JFt2TStZtpTD51tLBPFcRYYqyyAEqybiDtH3M8hhjsKAPCYvEPxQNxrhWCQ3cUN35dlLaSmNWD/ALowuLRUJCgnBnl3ZGBniorbxV4uil0u31nWNatbW7vJUElro8k17sW33bdklhGGG8Z3LCcAkE8Zr3uoZrS3muIJ5reKSe3LGGRkBaMkYJU9RkcHHagDhbjU/FsXwitb+S3nXxMYoDcLFbCSZFMiiR1hAIMgjLNsxjcMYPSvPIrvxlpVtqs2hjXmtL7Xp5Zr+605oruRBZ2wjbyls5CFLK4yIP4ACVOTX0HRQB45cah8QZfDWv3gvL1L+y0e3ns4rTTRturpoX34WWHefm2nZtVg2AcDKm3KPHOna/chda1jUbK11bToI0k06323FvMYxcMzJEDhNzEMpG3B3Fq9YooA8TsdS8W2E/h2FI9VhtXkYT6fYaV5Jy15IN7ubV4gpTaSPMhbAZsksK7vxN/yUbwZ9q/489l95e77v2rZH5f/AALy/tOO/X3rsagvLO1vViW8tobhYpFmjEqBwjqcqwz0I7HqKAPAdQuPHN5epqlsNefxLaaPqo8qXSljtrOcyQGOOBjEBLuVDjc0m7aMY5FbvijxZ40uri/n8OWesQaP9st41kl02SGeOIwuXKI1tK5BkCgkxPj0AO4e0UUAeX+JbfX9d+BF5HetcS65La7n+yWzrJLtkzgRyxI24qBkeWpznaBxWfc614sTWY00+78SXMQls1sEn0UJHexMw+0PdOYE8ll+fAzFwqkK2a9gooAKKKKAM3xFolh4i0ibTNXheazlZHZUleJtyOrqQ6EMCGVTwR0rnI/hj4aiTbGNbRfRdevwP/R1drRTTa2Hc4i4+F/hi5dXuU1qZ1+60mvX7EfnNS2/ww8M23/HuNbi7/u9ev1/lNXbUU+eVrXDmfc41vhv4eYks+vEnufEF/8A/HqaPhl4bByP7cB9Rr9//wDHq7SildhdnFS/DHw1MwaUa25XoW16/OP/ACNSj4ZeGwMD+3Men9v3/wD8ertKKOZ9w5n3ONm+G3h6dNkza9In91/EF+R/6OqqfhN4RPW21U9/+Q3ff/Hq7yimpNbMalJbM4ZfhX4VUYWHWAPQa5ff/Hql/wCFZ+HMY/4nmPT+37//AOPV2lFHM+4c8u5wlx8KPCdyVNzBq0xUbV8zXL5sD0GZqQfCXwiq4W21UL6DW77/AOPV3lFHPLuHPLucZF8NfDsI2wtrsY9F1+/H/tapD8O9CON03iA46Z8Q6h/8frr6KV2xNt7nFy/DPw3L/rf7cf8A3tfvz/7Wpv8Awq/wznO3Ws+v9vX/AP8AHq7aijmfcfM+5xQ+GPhoHga36/8AIev/AP49Ukfw38PxMWjfXkY918QX4/8Aa1djRRd9xOTe7OQPw80I5zP4hOf+ph1D/wCP0i/DrQV+7L4gH08Q6h/8frsKKLiOLm+GnhydCkx1yRDnKvr9+Qfzmplp8LfC9mH+yR6zBv8Av+Vrt8u764m5rt6KfM7WuO7OK/4Vh4a541v5uv8AxPr/AJ/8jUD4Y+Gh0Gtj/uPX/wD8ertaKXM+4XZx4+HWgjpLr44x/wAjDqHT/v8A1FB8MvDcDl4P7cic9WTXr8H9Jq7Wii7C7OPb4d6CyFGm8QFWBBU+IdQwR/3/AKr/APCrfC/H7vWeOB/xPb7j/wAjV3FFCk1swuzjP+Fa+HdyMG13cgwp/t+/yB6D99TE+GHhlJN6Lrav03DXr8H8/OrtqKOZ9w5n3OLPw08OFQpOubV6D+37/A/8jUn/AArHw1uDY1vcOM/29f5/9HV2tFHM+4cz7nHj4daCBgS+IAP+xh1D/wCP00/Dbw6SSW13P/Yfv/8A49XZUUXYXZxMnwv8MSKyyLrTqwwwOvX5BHof31U4fg34Jhl82HTtQjk/vrrF6D+fnV6FRRzPuHM+5xLfDDwyxJZdaJPUnXr/AJ/8jU5fhn4cWMxr/bgRuCo1+/wfw86u0oo5n3C7OIb4X+GGABTWjjpnXb//AOPUD4XeGAMbNawP+o7f/wDx6u3op80u4XZwkvwo8Jy28sEsGrvBMpSSNtcvirqRggjzsEEEgg+tZS/AX4bqoVfD8gA4AGpXfH/kWvUKKXM+4nrueY/8KH+HP/QAl/8ABld//Ha3PB3wz8JeDdVk1Lw5pb2l7JCbdpGu55sxllYjDuwHKLzjPFdlRRzNisgooopDCiiigAooooA4fxT4GF74c8RWWkTFL7Wb+O/M88m37LMohXzIyq5BUQqyg9W6kA8WLz4e6Nc6fdWKNdW9rPow0Ly4WUCO3G7BXKn5/mPJyPauwooA4WX4aadJqCz/ANq6wlql7JqCWKSRLEs8kTxu4Pl+YMiRjjfgE5GKzdC+DPh/RrgT295qDyB7SQnZbRbjbTechby4V3EtwzNlmHfPNemUUAcyfBWlP4JuPCs/nz6XOsqv5jDf87s5OQAOGbjjsM5rL8N/DPR9AutOuLWaUyWN013HstbS2DM0Lw4cQQxhhtkYjPOe+OK7qigDznU/hB4e1Cy0iCR59+mQNbRTS29rcs0bNuwyzwumQehVQeTzitEfDyyWHVbOHVNUh0fVIpI7vTI/IEDmSHymZf3W9CRhsKwXI6Y4rtaKAOPtfCt6mu6JJd6nLeWGkW0ywyzlBcyzSfLlhHGiBUjyBgZO7npk9Homn/2VpFnYfa7y9+zRLF9pvJPMmlwPvO2Blj3NXaKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42630=[""].join("\n");
var outline_f41_40_42630=null;
var title_f41_40_42631="Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)";
var content_f41_40_42631=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/40/42631/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/40/42631/contributors\">",
"     William L Weston, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/40/42631/contributors\">",
"     William Howe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/40/42631/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/40/42631/contributors\">",
"     Robert P Dellavalle, MD, PhD, MSPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/40/42631/contributors\">",
"     Moise L Levy, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/40/42631/contributors\">",
"     Joseph Fowler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/40/42631/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/40/42631/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/40/42631/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atopic dermatitis is a chronic inflammatory skin condition that appears to involve a genetic defect in the proteins supporting the epidermal barrier. Atopy, referring to \"out of place\", describes a group of disorders that include eczema, asthma, and allergic rhinitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/1\">",
"     1",
"    </a>",
"    ]. However such a link between atopic dermatitis and asthma and hay fever has been called into question and is now controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/12/20682?source=see_link&amp;anchor=H8#H8\">",
"     \"Risk factors for asthma\", section on 'Atopy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The terms \"dermatitis\" and \"eczema\" are frequently used interchangeably. When the term \"eczema\" is used alone, it usually refers to atopic dermatitis (atopic eczema). \"Eczematous\" also connotes some crusting, serous oozing, or blister formation as opposed to mere erythema and scale.",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, clinical manifestations, and diagnosis of atopic dermatitis are reviewed here. The treatment of atopic dermatitis, the impact of staphylococcus aureus and other microbes on atopic dermatitis, the role of allergy in atopic dermatitis, and a review of other types of dermatitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/37/10842?source=see_link\">",
"     \"Treatment of atopic dermatitis (eczema)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/26/44457?source=see_link\">",
"     \"Management of severe refractory atopic dermatitis (eczema)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/59/26551?source=see_link\">",
"     \"Role of allergy in atopic dermatitis (eczema)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3721?source=see_link\">",
"     \"Overview of dermatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atopic dermatitis affects approximately 5 to 20 percent of children worldwide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/5\">",
"     5",
"    </a>",
"    ]. The prevalence of atopic dermatitis in the United States is around 11 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of atopic dermatitis appears to be increasing. It may occur in any race or geographic location, although there appears to be a higher incidence in urban areas and developed countries, especially western societies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The vast majority of atopic dermatitis has an onset before age five years, and prevalence data in children show a slight female to male preponderance (1.3 to 1) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two major models currently exist to explain the pathogenesis of atopic dermatitis. The predominant model describes atopic dermatitis as a result of impaired epidermal barrier function due to intrinsic structural and functional abnormalities in the skin. In this model, the disease evolves from the outside in, with an abnormal epidermal barrier as the primary defect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/9\">",
"     9",
"    </a>",
"    ]. The second and traditional model views atopic dermatitis as primarily an immune function disorder in which Langerhans cells, T-cells, and immune effector cells modulate an inflammatory response to environmental factors. While widely accepted for years, there is now little support that atopic dermatitis is the result of allergies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Epidermal permeability barrier",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidermis is the first line of defense between the body and the environment. An intact epidermis keeps environmental irritants, allergens, and microbes from entering the body [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/10\">",
"     10",
"    </a>",
"    ]. Permeability of the epidermis is determined by complex interactions of differentiated keratinocytes on the surface of the skin called corneocytes and groups of structural proteins, such as filaggrin, regulatory enzymes, and lipids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/11\">",
"     11",
"    </a>",
"    ]. Any disruption of these components through inherited defects, trauma, decreased humidity, alteration of pH, and infection can interfere with the ability of the epidermis to function as an effective barrier. Disruption allows antigenic and irritant agents to penetrate the barrier and come into contact with immune cells, leading to the release of proinflammatory mediators [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/11\">",
"     11",
"    </a>",
"    ]. This can then produce the clinical and pathologic findings of dermatitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3092714\">",
"    <span class=\"h3\">",
"     Epidermal hydration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hydration of the epidermis is a key factor in maintaining an intact barrier, and the stratum corneum layer of the epidermis plays a key role in the retention of water in the skin. Water absorption into the stratum corneum occurs as a function of stratum corneum natural moisturizing factor, which consists of a variety of molecules that promote water absorption, including amino acids derived from the proteolysis of epidermal filaggrin, urea, lactate and electrolytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. The stratum corneum also prevents epidermal water loss through the presence of an extracellular lipid barrier composed of ceramides, cholesterol, and free fatty acids.",
"   </p>",
"   <p>",
"    Defects that affect filaggrin, epidermal lipids, or other key components of the stratum corneum can result in the creation of an inadequate epidermal barrier, leading to decreased water content in the epidermis. Increased rates of transepidermal water loss (TEWL) have been detected in skin of patients with atopic dermatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/10,14\">",
"     10,14",
"    </a>",
"    ], and an association between this finding and mutations in the gene for filaggrin have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/15\">",
"     15",
"    </a>",
"    ]. In addition, decreased levels of ceramides in the stratum corneum due to upregulation of sphingomyelin deacylase may contribute to increase TEWL in atopic dermatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Abnormalities in the skin barrier that result in increased water loss likely contribute to the clinical findings in atopic dermatitis. Higher levels of transepidermal water loss in patients with atopic dermatitis have been associated with greater disease severity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/14,16\">",
"     14,16",
"    </a>",
"    ]. In patients with atopic dermatitis, dry skin (xerosis) secondary to decreased epidermal water content may contribute to pruritus and scratching. Resultant cutaneous trauma from scratching can promote the release of proinflammatory mediators and inflammation, thereby worsening pruritus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/17\">",
"     17",
"    </a>",
"    ]. This &ldquo;itch-scratch&rdquo; cycle may play a role in the persistence of symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Filaggrin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Filaggrin is encoded by the FLG gene on the 1q21 epidermal differentiation complex. Filaggrin is a protein produced by differentiating keratinocytes that functions to aggregate keratin filaments into a cytoskeleton that, in combination with other components, comprise the cornified cell envelope [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Filaggrin loss of function mutations (R501X and 2282del4) cause ichthyosis vulgaris, the most common inherited disorder of keratinization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/18\">",
"     18",
"    </a>",
"    ]. The same mutations also are associated with atopic dermatitis and other skin and allergic conditions including atopic dermatitis, irritant contact dermatitis, asthma, and food allergy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/20/29001?source=see_link\">",
"     \"Irritant contact dermatitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/29/10713?source=see_link\">",
"     \"Genetics of asthma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38457?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Clinical features\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Spink 5",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spink 5 is a serine protease inhibitor (Kazal-type 5 serine protease inhibitor) that is deficient in Netherton's syndrome (a rare autosomal recessive disorder characterized by severe atopic dermatitis). Spink 5 inhibits a well characterized protease stratum corneum chymotryptic enzyme (SCCE) that is involved in cleaving the intercellular attachments between corneocytes in normal desquamation process. Decreased Spink 5 results in upregulated SCCE function and increased cleavage of intercellular attachments and reduced corneocyte cohesion and compromised barrier function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/11\">",
"     11",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Epicutaneous sensitization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immune responses to allergens, irritants, and microbes that enter the skin through a defective skin barrier may contribute to the development of local inflammatory responses and the cutaneous findings of atopic dermatitis. Antigen presenting cells in the skin, in particular IgE bearing Langerhans cells, can interact with environmental allergens, leading to the local Th2-mediated inflammatory responses that have been detected in the skin of patients with atopic dermatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Immune hypersensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another theory explaining the pathogenesis of atopic dermatitis proposes that the immune system is responsible for atopic disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/22\">",
"     22",
"    </a>",
"    ]. Atopic dermatitis in this view may represent a cutaneous sign of a systemic disorder that is characterized by food allergy, asthma, and allergic rhinitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The discovery that defects in the filaggrin protein lead to a dysfunctional epidermal barrier and are the primary cause of atopic dermatitis has made this theory less plausible. Emphasis is now placed on the study of the epidermal barrier dysfunction as it relates to the abnormal epidermal architecture and how the immune system responds to the barrier failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum IgE levels vary among patients with atopic dermatitis. Patients with mild to moderate atopic dermatitis typically have much lower (or normal) serum IgE levels compared to patients with severe atopic dermatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/11,24\">",
"     11,24",
"    </a>",
"    ]. This finding suggests that the systemic Th2 driven axis of the immune system detected in atopic dermatitis may be related to epidermal barrier dysfunction and the introduction of environmental antigens, rather than intrinsic immune hypersensitivity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most experts believe that atopic dermatitis has a genetic basis. A genetic basis is suggested by twin studies that have found concordance rates of 80 percent for monozygotic twins compared to 20 percent for dizygotic twins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/25-27\">",
"     25-27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22667005\">",
"    <span class=\"h3\">",
"     Other genes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to filaggrin, many other genes have been proposed as potential contributors to atopic dermatitis, including genes involved in the creation of the skin barrier or immune regulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Linkage on chromosomes 3q21, 1q21, 17q25, and 20p, all of which correspond closely with known psoriasis loci, have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Filaggrin'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In 2009, the first genome-wide association study of atopic dermatitis detected a strong association between atopic dermatitis and an allele on chromosome 11q13.5 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/32\">",
"     32",
"    </a>",
"    ]. The risk of atopic dermatitis was approximately 1.5 times greater in patients who were homozygous for the risk allele than in noncarriers (OR 1.47, 95% CI 1.29-1.68). The results of this genome-wide association study were supported by a subsequent case-control study of 511 children with atopic dermatitis and 1000 controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/33\">",
"     33",
"    </a>",
"    ]. The case-control study implicated the same susceptibility locus as a potential contributor to atopic dermatitis, and found that the effect of the risk allele was independent of and supplementary to filaggrin mutations. A subsequent genome-wide study performed in the Chinese Han population found two new susceptibility loci for atopic dermatitis at 5q22.1 and 20q13.33 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/34\">",
"     34",
"    </a>",
"    ]. However, fine mapping and functional studies of the candidate genes are required to determine their role in the pathogenesis of atopic dermatitis. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Staphylococcus aureus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Staphylococcus aureus colonization is common in patients with atopic dermatitis and may play a role in the exacerbation of this disorder via locally acting staphylococcal superantigens. In normal skin, endogenous antimicrobial peptide (cathelicidin and others) production is upregulated by two cytokines, IL-17 and IL-22, secreted by Th17 T cells. In atopic skin, this effect is abrogated by the presence of Th2 cytokines, resulting in lower levels of antimicrobial peptides, which could be a possible mechanism of staphylococcal superinfection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/37/10842?source=see_link&amp;anchor=H13#H13\">",
"     \"Treatment of atopic dermatitis (eczema)\", section on 'Staphylococcus aureus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atopic dermatitis occurs in the first year of life in 60 percent of cases, and by the age of 5 years in nearly 85 percent of cases. Atopic dermatitis will clear in nearly 40 percent of patients by adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. There are three age-group stages of atopic dermatitis: infantile (from infancy to 2 years old), childhood (from 2 years old to 12 years old) and the adult stage for those older than 12 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/36\">",
"     36",
"    </a>",
"    ]. Virtually all patients report dry skin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/37-39\">",
"     37-39",
"    </a>",
"    ]. Pruritus is characteristic, and secondary changes in the skin due to chronic rubbing or scratching are frequently present.",
"   </p>",
"   <p>",
"    The infantile stage may present with pruritic, red, scaly, and crusted lesions on the extensor surfaces and cheeks or scalp (",
"    <a class=\"graphic graphic_picture graphicRef77457 graphicRef56461 graphicRef77386 \" href=\"mobipreview.htm?28/19/28985\">",
"     picture 1A-C",
"    </a>",
"    ). There is usually sparing of the diaper area (",
"    <a class=\"graphic graphic_picture graphicRef68746 \" href=\"mobipreview.htm?9/41/9875\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/36\">",
"     36",
"    </a>",
"    ]. Acute lesions can include vesicles and there can be serous exudates and crusting in severe cases.",
"   </p>",
"   <p>",
"    The childhood stage is characterized by less exudation and often demonstrates lichenified plaques in a flexural distribution, especially of the antecubital and popliteal fossae, volar aspect of the wrists, ankles, and neck (",
"    <a class=\"graphic graphic_picture graphicRef68215 graphicRef65407 graphicRef52163 graphicRef55424 \" href=\"mobipreview.htm?24/2/24618\">",
"     picture 3A-D",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The adult stage of atopic dermatitis is considerably more localized and lichenified and has a similar distribution to the childhood stage, or may be primarily located on the hands and feet [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/36\">",
"     36",
"    </a>",
"    ]. Adults who no longer have dermatitis in areas present when they were younger are at increased risk for developing hand eczema, especially when the hands are exposed to \"wet-work\" environments. Adult atopic dermatitis is characterized by thickened skin, increased skin markings (lichenification), and excoriated and fibrotic papules (",
"    <a class=\"graphic graphic_picture graphicRef55375 graphicRef64525 \" href=\"mobipreview.htm?31/47/32504\">",
"     picture 4A-B",
"    </a>",
"    ). In adults, the flexural areas (neck, antecubital fossae, and popliteal fossae) are most commonly involved (",
"    <a class=\"graphic graphic_picture graphicRef57982 \" href=\"mobipreview.htm?6/56/7045\">",
"     picture 5",
"    </a>",
"    ); other common sites include the face, wrists, and forearms.",
"   </p>",
"   <p>",
"    In severe cases, any area of the body can be involved, although it is uncommon to see lesions in the axillary, gluteal, or groin area; lesions in these locations should prompt consideration of other diagnoses such as psoriasis. The presence of pustules within areas of dermatitis suggests secondary infection with Staphylococcus aureus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atopic dermatitis is diagnosed by observing its representative clinical features. The United Kingdom working group on atopic dermatitis published criteria for diagnosing atopic dermatitis that include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/37\">",
"     37",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evidence of pruritic skin, including the report by a parent of a child rubbing or scratching.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to itchy skin, three or more of the following are needed to make the diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History of skin creases being involved. These include: antecubital fossae, popliteal fossae, neck, areas around eyes, fronts of ankles.",
"     </li>",
"     <li>",
"      The presence of generally dry skin within the past year.",
"     </li>",
"     <li>",
"      Symptoms beginning in a child before the age of two years. This criterion is not used to make the diagnosis in a child who is under four years old.",
"     </li>",
"     <li>",
"      Visible evidence of dermatitis involving flexural surfaces. For children under four years old, this criterion is met by dermatitis affecting the cheeks or forehead and outer aspects of the extremities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The UK working group's analysis excluded allergy criteria as originally proposed by Hanifin and Rajka. The UK working group data have been validated by investigators from the Netherlands [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42631/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Laboratory testing, including IgE levels, are not used routinely in the evaluation of patients with suspected atopic dermatitis, and are not currently recommended.",
"   </p>",
"   <p>",
"    When the diagnosis is uncertain, we suggest that patients be referred to a specialist (eg, dermatologist, allergist).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of atopic dermatitis includes other eczematous disorders such as contact dermatitis (",
"    <a class=\"graphic graphic_picture graphicRef71913 \" href=\"mobipreview.htm?33/61/34782\">",
"     picture 6",
"    </a>",
"    ), seborrheic dermatitis (",
"    <a class=\"graphic graphic_picture graphicRef59104 \" href=\"mobipreview.htm?27/42/28320\">",
"     picture 7",
"    </a>",
"    ), and drug reactions (",
"    <a class=\"graphic graphic_picture graphicRef76399 \" href=\"mobipreview.htm?28/0/28675\">",
"     picture 8",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3721?source=see_link\">",
"     \"Overview of dermatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In infants, considerations include psoriasis (",
"    <a class=\"graphic graphic_picture graphicRef81412 \" href=\"mobipreview.htm?39/55/40831\">",
"     picture 9",
"    </a>",
"    ), scabies (",
"    <a class=\"graphic graphic_picture graphicRef52588 \" href=\"mobipreview.htm?9/47/9969\">",
"     picture 10",
"    </a>",
"    ), Wiskott-Aldrich syndrome, hyperimmunoglobulin E syndrome (",
"    <a class=\"graphic graphic_picture graphicRef61049 \" href=\"mobipreview.htm?38/24/39302\">",
"     picture 11",
"    </a>",
"    ), nutritional deficiencies, acrodermatitis enteropathica (",
"    <a class=\"graphic graphic_picture graphicRef71329 \" href=\"mobipreview.htm?39/34/40481\">",
"     picture 12",
"    </a>",
"    ) and Netherton's syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27625?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/2/28712?source=see_link\">",
"     \"Scabies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36313?source=see_link\">",
"     \"Wiskott-Aldrich syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/25/32153?source=see_link\">",
"     \"Hyperimmunoglobulin E syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/3/29753?source=see_link\">",
"     \"Zinc deficiency and supplementation in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/30/6626?source=see_link\">",
"       \"Patient information: Eczema (atopic dermatitis) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/23/15730?source=see_link\">",
"       \"Patient information: Atopic dermatitis (eczema) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atopic dermatitis is a chronic inflammatory skin condition that appears to involve genetic defects in the proteins and lipids supporting the epidermal barrier. Disruption of the barrier results in inflammation of the skin. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The diagnosis of atopic dermatitis is generally based on its typical clinical presentation (see",
"    <a class=\"local\" href=\"#H11\">",
"     'Clinical manifestations'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients have manifestations of atopic dermatitis by age five to seven years.",
"     </li>",
"     <li>",
"      In children, acute skin lesions that appear as intensely pruritic erythematous patches with papules and some crusting can be seen on the face, scalp, extremities, or trunk; diaper areas are usually spared.",
"     </li>",
"     <li>",
"      The skin lesions in older individuals with more chronic disease are characterized by thickened skin, increased skin markings (lichenification), and excoriated and fibrotic papules. In adults, the flexural areas (neck, antecubital fossae, and popliteal fossae) are most commonly involved.",
"     </li>",
"     <li>",
"      We suggest not performing routine laboratory testing in patients felt clinically to have atopic dermatitis. When the diagnosis is uncertain, we suggest that patients be referred to a specialist (eg, dermatologist, allergist). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of atopic dermatitis includes other eczematous disorders such as contact dermatitis, seborrheic dermatitis, and drug reactions. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/1\">",
"      Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112:S118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/2\">",
"      Sandilands A, Smith FJ, Irvine AD, McLean WH. Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol 2007; 127:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/3\">",
"      Chan LS. Atopic dermatitis in 2008. Curr Dir Autoimmun 2008; 10:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/4\">",
"      McGrath JA, Uitto J. The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol Med 2008; 14:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/5\">",
"      Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/6\">",
"      Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011; 131:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/7\">",
"      Trepka MJ, Heinrich J, Wichmann HE. The epidemiology of atopic diseases in Germany: an east-west comparison. Rev Environ Health 1996; 11:119.",
"     </a>",
"    </li>",
"    <li>",
"     Kang K, Polster AM, Nedorost St, et al.. Atopic dermatitis. In: Dermatology, Bolognia JL, Jorizzo JL, Rapini RP, et al (Eds), Mosby, New York 2003. p.199.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/9\">",
"      Elias PM, Steinhoff M. \"Outside-to-inside\" (and now back to \"outside\") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008; 128:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/10\">",
"      Grimalt R, Mengeaud V, Cambazard F, Study Investigators' Group. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology 2007; 214:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/11\">",
"      Cork MJ, Robinson DA, Vasilopoulos Y, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006; 118:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/12\">",
"      Verdier-S&eacute;vrain S, Bont&eacute; F. Skin hydration: a review on its molecular mechanisms. J Cosmet Dermatol 2007; 6:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/13\">",
"      Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther 2004; 17 Suppl 1:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/14\">",
"      Flohr C, England K, Radulovic S, et al. Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age. Br J Dermatol 2010; 163:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/15\">",
"      Nemoto-Hasebe I, Akiyama M, Nomura T, et al. Clinical severity correlates with impaired barrier in filaggrin-related eczema. J Invest Dermatol 2009; 129:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/16\">",
"      Gupta J, Grube E, Ericksen MB, et al. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol 2008; 121:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/17\">",
"      Lod&eacute;n M. The skin barrier and use of moisturizers in atopic dermatitis. Clin Dermatol 2003; 21:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/18\">",
"      Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/19\">",
"      van den Oord RA, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009; 339:b2433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/20\">",
"      Rodr&iacute;guez E, Baurecht H, Herberich E, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009; 123:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/21\">",
"      Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000; 105:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/22\">",
"      Boguniewicz M. Atopic dermatitis: beyond the itch that rashes. Immunol Allergy Clin North Am 2005; 25:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/23\">",
"      Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 2009; 9:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/24\">",
"      Flohr C, Johansson SG, Wahlgren CF, Williams H. How atopic is atopic dermatitis? J Allergy Clin Immunol 2004; 114:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/25\">",
"      Weidinger S, Illig T, Baurecht H, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006; 118:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/26\">",
"      Larsen FS, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986; 15:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/27\">",
"      Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993; 28:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/28\">",
"      Guttman-Yassky E, Su&aacute;rez-Fari&ntilde;as M, Chiricozzi A, et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol 2009; 124:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/29\">",
"      Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol 2010; 125:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/30\">",
"      Lee YA, Wahn U, Kehrt R, et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 2000; 26:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/31\">",
"      Cookson WO, Ubhi B, Lawrence R, et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001; 27:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/32\">",
"      Esparza-Gordillo J, Weidinger S, F&ouml;lster-Holst R, et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet 2009; 41:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/33\">",
"      O'Regan GM, Campbell LE, Cordell HJ, et al. Chromosome 11q13.5 variant associated with childhood eczema: an effect supplementary to filaggrin mutations. J Allergy Clin Immunol 2010; 125:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/34\">",
"      Sun LD, Xiao FL, Li Y, et al. Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population. Nat Genet 2011; 43:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/35\">",
"      Macias ES, Pereira FA, Rietkerk W, Safai B. Superantigens in dermatology. J Am Acad Dermatol 2011; 64:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/36\">",
"      Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet 1998; 351:1715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/37\">",
"      Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med 2005; 352:2314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/38\">",
"      Williams HC, Strachan DP. The natural history of childhood eczema: observations from the British 1958 birth cohort study. Br J Dermatol 1998; 139:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42631/abstract/39\">",
"      Brenninkmeijer EE, Schram ME, Leeflang MM, et al. Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol 2008; 158:754.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1729 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-109.230.63.219-5CD169F5DE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42631=[""].join("\n");
var outline_f41_40_42631=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Epidermal permeability barrier",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3092714\">",
"      - Epidermal hydration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Filaggrin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Spink 5",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Epicutaneous sensitization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Immune hypersensitivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22667005\">",
"      - Other genes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Staphylococcus aureus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/1729\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/1729|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/55/23408\" title=\"picture 1A\">",
"      Atopic dermatitis infantile I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/50/28448\" title=\"picture 1B\">",
"      Atopic dermatitis infantile II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?36/35/37428\" title=\"picture 1C\">",
"      Atopic dermatitis infant 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/41/9875\" title=\"picture 2\">",
"      Atopic dermatitis infant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/7/2163\" title=\"picture 3A\">",
"      Atopic dermatitis popliteal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/31/42482\" title=\"picture 3B\">",
"      Severe atopic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/57/28575\" title=\"picture 3C\">",
"      Flexural atopic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/17/6418\" title=\"picture 3D\">",
"      Atopic dermatitis papular",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/10/42147\" title=\"picture 4A\">",
"      Adult atopic dermatitis 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/31/24051\" title=\"picture 4B\">",
"      Adult atopic dermatitis 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/56/7045\" title=\"picture 5\">",
"      Atopic dermatitis antecubit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/61/34782\" title=\"picture 6\">",
"      Allergic contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/42/28320\" title=\"picture 7\">",
"      Seborrheic dermatitis face 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?28/0/28675\" title=\"picture 8\">",
"      Phototoxic eruption 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/55/40831\" title=\"picture 9\">",
"      Plaque type psoriasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/47/9969\" title=\"picture 10\">",
"      Scabies infant trunk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/24/39302\" title=\"picture 11\">",
"      Severe eczema hyper IgE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/34/40481\" title=\"picture 12\">",
"      Acrodermatitis enteropathica",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/29/10713?source=related_link\">",
"      Genetics of asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/25/32153?source=related_link\">",
"      Hyperimmunoglobulin E syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/20/29001?source=related_link\">",
"      Irritant contact dermatitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/26/44457?source=related_link\">",
"      Management of severe refractory atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3721?source=related_link\">",
"      Overview of dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/23/15730?source=related_link\">",
"      Patient information: Atopic dermatitis (eczema) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/30/6626?source=related_link\">",
"      Patient information: Eczema (atopic dermatitis) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38457?source=related_link\">",
"      Peanut, tree nut, and seed allergy: Clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/12/20682?source=related_link\">",
"      Risk factors for asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/59/26551?source=related_link\">",
"      Role of allergy in atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/2/28712?source=related_link\">",
"      Scabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/37/10842?source=related_link\">",
"      Treatment of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36313?source=related_link\">",
"      Wiskott-Aldrich syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/3/29753?source=related_link\">",
"      Zinc deficiency and supplementation in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_40_42632="Drug interactions with thyroid hormones";
var content_f41_40_42632=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Drug interactions with thyroid hormones",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/40/42632/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/40/42632/contributors\">",
"     Martin I Surks, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/40/42632/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/40/42632/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/40/42632/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/40/42632/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/40/42632/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 26, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients whose thyroid function is evaluated also take medications for a variety of nonthyroidal illnesses. As a result, clinicians must be aware of the interactions between various drugs and thyroid function, including measurements of serum thyroid hormones and thyrotropin (TSH).",
"   </p>",
"   <p>",
"    Issues relating to the major drug-induced or drug-related abnormalities in thyroid hormone secretion, transport, and metabolism will be reviewed here (",
"    <a class=\"graphic graphic_table graphicRef50439 \" href=\"mobipreview.htm?21/19/21820\">",
"     table 1",
"    </a>",
"    ). Many of these interactions are discussed in detail separately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     THYROID HORMONE METABOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before discussing the different drug interactions with thyroid hormones, it is helpful to review briefly thyroid hormone metabolism and the pathways that may be affected by the administration of drugs.",
"   </p>",
"   <p>",
"    Thyroidal synthesis and secretion of thyroxine (T4) and triiodothyronine (T3) are dependent on TSH (",
"    <a class=\"graphic graphic_figure graphicRef76931 \" href=\"mobipreview.htm?26/29/27088\">",
"     figure 1",
"    </a>",
"    ). Under the influence of TSH, thyroid follicular cells sequentially perform the following functions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Transport of iodide from serum into the cells",
"     </li>",
"     <li>",
"      Oxidation of iodide and iodination of tyrosine residues",
"     </li>",
"     <li>",
"      Synthesis of T4 and T3",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The latter two steps occur within thyroglobulin at the interface between the follicular cells and the lumen of the thyroid follicles. The thyroglobulin subsequently reenters the cell and is hydrolyzed to its constituent amino acids, including the thyroid hormones. The hormones are then secreted into the circulation, where they are tightly bound to serum binding proteins, mostly thyroxine-binding globulin (TBG) but also transthyretin and albumin. Most of the secreted hormone is T4; by comparison, serum T3 is mainly produced by deiodination of T4 in extrathyroidal tissues.",
"   </p>",
"   <p>",
"    The principal pathway of thyroid hormone metabolism is progressive deiodination to inert metabolites. However, 20 percent of thyroid hormones are conjugated either with glucuronide or sulfate and excreted into the bile [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/1\">",
"     1",
"    </a>",
"    ]. In the gut, some of these conjugates are hydrolyzed by bacterial enzymes and the freed hormones are then reabsorbed into the circulation.",
"   </p>",
"   <p>",
"    The thyroid gland requires thyrotropin (TSH) for synthesis and secretion of thyroid hormones. In normal subjects, the serum concentrations of thyroid hormones and TSH are intimately related by a delicate negative feedback system by which serum thyroid hormones inhibit TSH secretion (",
"    <a class=\"graphic graphic_figure graphicRef75399 \" href=\"mobipreview.htm?10/24/10629\">",
"     figure 2",
"    </a>",
"    ). In the absence of hypothalamic or pituitary disease, the serum TSH concentration is the most valuable guide to the assessment of thyroid function and the most sensitive index of thyroid hormone action. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3608?source=see_link\">",
"     \"Laboratory assessment of thyroid function\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Drugs can affect any aspect of the thyroid hormone system, including TSH secretion, thyroidal production of T4 and T3, their transport in serum, and their metabolism. The result may be either overt thyroid dysfunction or biochemical abnormalities that do not result in clinically important thyroid dysfunction but may be misinterpreted as indicating its presence. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3608?source=see_link\">",
"     \"Laboratory assessment of thyroid function\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/39/44663?source=see_link\">",
"     \"Thyroid function in nonthyroidal illness\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DRUGS THAT AFFECT TSH SECRETION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several drugs inhibit TSH secretion. They include the following (",
"    <a class=\"graphic graphic_table graphicRef50439 \" href=\"mobipreview.htm?21/19/21820\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pharmacologic doses of glucocorticoids (more than 20 mg per day of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      or its equivalent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/2,3\">",
"       2,3",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       Dobutamine",
"      </a>",
"      in high doses [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/4\">",
"       4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Dopamine (more than 1",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per minute) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The somatostatin analogue",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"       octreotide",
"      </a>",
"      (more than 100",
"      <span class=\"nowrap\">",
"       mcg/day)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/10/31904?source=see_link\">",
"       Bexarotene",
"      </a>",
"      , a retinoid X receptor ligand [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/9\">",
"       9",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The administration of these drugs may confound the interpretation of serum TSH concentrations depending upon the degree of sensitivity of the serum TSH assay. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the serum TSH assay in use has a sensitivity in the range of 0.05 to 0.1",
"      <span class=\"nowrap\">",
"       mcU/mL",
"      </span>",
"      <span class=\"nowrap\">",
"       (mU/L),",
"      </span>",
"      the administration of these may result in an \"undetectable\" serum TSH concentration, similar to that in patients with hyperthyroidism.",
"     </li>",
"     <li>",
"      If a more sensitive assay that detects 0.01",
"      <span class=\"nowrap\">",
"       mcU/mL",
"      </span>",
"      is used, the serum TSH values in patients being given these drugs are usually in the range of 0.08 to 0.4",
"      <span class=\"nowrap\">",
"       mcU/mL.",
"      </span>",
"      These values can easily be distinguished from the suppressed values in patients with hyperthyroidism (&lt;0.01",
"      <span class=\"nowrap\">",
"       mcU/mL).",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one report,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    caused suppression of serum TSH concentrations to subnormal levels in four hypothyroid patients receiving a stable dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"     levothyroxine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/10\">",
"     10",
"    </a>",
"    ]. This was not associated with an increase in free T4; the mechanism is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DRUGS THAT CAUSE HYPERTHYROIDISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several drugs can cause hyperthyroidism, many of which can also cause hypothyroidism (",
"    <a class=\"graphic graphic_table graphicRef50439 \" href=\"mobipreview.htm?21/19/21820\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Iodine and iodide containing drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;High doses of iodides or drugs that contain iodide (",
"    <a class=\"graphic graphic_table graphicRef60901 \" href=\"mobipreview.htm?18/26/18861\">",
"     table 2",
"    </a>",
"    ) may cause hyperthyroidism. The effect of iodide administration in patients with abnormal thyroid glands differs from that in normal subjects and depends upon the underlying disease process. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20568?source=see_link\">",
"     \"Iodine-induced thyroid dysfunction\"",
"    </a>",
"    .) As an example, iodide administration may result in hyperthyroidism in patients with endemic goiter and iodine deficiency and, in areas of iodide sufficiency, in euthyroid patients with nodular goiters containing autonomous nodules. These nodules probably function autonomously (independent of TSH); however, they do not secrete excessive amounts of thyroid hormones in the absence of exposure to high concentrations of iodide.",
"   </p>",
"   <p>",
"    Administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    and radiocontrast agents are the most common causes of hyperthyroidism. Patients who receive radiographic contrast agents, which contain as much as 50 percent iodine by weight, may develop hyperthyroidism within several weeks after exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     Amiodarone",
"    </a>",
"    can cause hyperthyroidism by two mechanisms (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/30/25065?source=see_link\">",
"     \"Amiodarone and thyroid dysfunction\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Iodide-loading in patients with autonomous nodules [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The induction of thyroiditis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/14\">",
"       14",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     Amiodarone",
"    </a>",
"    -induced hyperthyroidism tends to increase with time. In one report, 12.1 percent of amiodarone-treated patients in an iodine-sufficient area became hyperthyroid after a mean duration of therapy of 21 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    -induced hyperthyroidism who have an underlying thyroid adenoma or toxic nodular goiter can be treated with a thionamide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/15\">",
"     15",
"    </a>",
"    ]. However, this approach is ineffective in patients with thyroiditis, who respond best to glucocorticoid therapy. In one report, as an example, 12 patients with amiodarone-induced thyroiditis (eight of whom had failed to respond to thionamides) were treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (initial dose 40",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    for three months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/15\">",
"     15",
"    </a>",
"    ]. Normal serum T3 concentrations were achieved after an average of eight days. Four patients relapsed as the prednisone dose was tapered. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/30/25065?source=see_link\">",
"     \"Amiodarone and thyroid dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Lithium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although better known as a cause of hypothyroidism,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    has been associated with hyperthyroidism. This is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/29/42453?source=see_link\">",
"     \"Lithium and the thyroid\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interferon-alfa and interleukin-2 have been associated with the same two types of hyperthyroidism (Graves' disease and painless thyroiditis) in a few patients, presumably by initiating or exacerbating thyroid autoimmune disease. Hyperthyroidism after",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/57/918?source=see_link\">",
"     denileukin diftitox",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/52/19270?source=see_link\">",
"     ipilimumab",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/25/26008?source=see_link\">",
"     alemtuzumab",
"    </a>",
"    has also been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DRUGS THAT CAUSE HYPOTHYROIDISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several drugs can cause hypothyroidism (",
"    <a class=\"graphic graphic_table graphicRef50439 \" href=\"mobipreview.htm?21/19/21820\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Iodine",
"    </span>",
"    &nbsp;&mdash;&nbsp;High doses of iodine can cause hypothyroidism. Normal thyroid follicular cells have several autoregulatory functions that protect against a sudden increase in iodide availability. Upon exposure to high concentrations of iodide, thyroid cells decrease the oxidation of iodide and thyroid hormone formation (the Wolff-Chaikoff effect) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/8\">",
"     8",
"    </a>",
"    ]. The efficiency of iodine transport decreases over a few weeks, thereby restoring the intrathyroidal iodide pool and thyroid hormone production toward normal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20568?source=see_link\">",
"     \"Iodine-induced thyroid dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, in normal subjects, exposure to high serum iodide concentrations causes only a small and transient decrease in serum T4 and T3 concentrations. However, in euthyroid patients who have Hashimoto's disease, have previously been treated with radioactive iodine, or have had thyroid surgery, escape from the Wolff-Chaikoff effect is impaired and therefore they may become hypothyroid when given high doses of iodide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar considerations apply to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    . In one report, as an example, hypothyroidism developed in 6.9 percent of patients treated with amiodarone for a mean of 21 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/13\">",
"     13",
"    </a>",
"    ]. This complication primarily occurred in patients with preexisting thyroid disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Lithium",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    may cause hypothyroidism. A serum lithium concentration in the therapeutic range results in an increase in thyroid size in approximately 50 percent of patients and causes mild hypothyroidism in about 20 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Some of the patients with hypothyroidism have antithyroid antibodies. If hypothyroidism develops, appropriate treatment is the administration of T4, not cessation of lithium therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/29/42453?source=see_link\">",
"     \"Lithium and the thyroid\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H63808039\">",
"    <span class=\"h2\">",
"     Tyrosine kinase inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral tyrosine kinase inhibitors (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/10/44200?source=see_link\">",
"     sunitinib",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/45/9944?source=see_link\">",
"     sorafenib",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/1/17434?source=see_link\">",
"     imatinib",
"    </a>",
"    , motesanib) used for the treatment of gastrointestinal stromal tumors, renal cell carcinoma, hepatocellular cancer, chronic myeloid leukemia, and in other cancers can cause hypothyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/16\">",
"     16",
"    </a>",
"    ]. Hypothyroidism may occur in patients with previously normal thyroid function, and may be preceded by a destructive thyroiditis and transient suppression of TSH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/20\">",
"     20",
"    </a>",
"    ]. In patients with preexisting hypothyroidism, thyroid hormone requirements may increase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/16,21,22\">",
"     16,21,22",
"    </a>",
"    ]. Sorafenib treatment is associated with increased type 3 deiodination, which increases the metabolism of T4 and T3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/23\">",
"     23",
"    </a>",
"    ]. This finding may explain, in part, the increased thyroid hormone requirements in patients taking these drugs.",
"   </p>",
"   <p>",
"    Of the kinase inhibitors,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/10/44200?source=see_link\">",
"     sunitinib",
"    </a>",
"    appears to cause thyroid dysfunction most frequently, with subclinical hypothyroidism reported in 30 to 80 percent of patients treated with sunitinib [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/24\">",
"     24",
"    </a>",
"    ]. It is possible that kinase inhibitors like sunitinib that broadly target tyrosine kinases, specifically vascular endothelial growth factor (VEGF) receptors, are more likely to cause hypothyroidism by causing capillary regression and thyroid ischemia. Other possible mechanisms include a destructive thyroiditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/20,25\">",
"     20,25",
"    </a>",
"    ], impaired iodine uptake [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/26\">",
"     26",
"    </a>",
"    ], reduced thyroid peroxidase activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/27\">",
"     27",
"    </a>",
"    ], or decreased clearance of thyrotropin (TSH) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43882?source=see_link&amp;anchor=H1651229244#H1651229244\">",
"     \"Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects\", section on 'Thyroid dysfunction'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/47/42744?source=see_link&amp;anchor=H13#H13\">",
"     \"Disorders that cause hypothyroidism\", section on 'Drugs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Interferon-alfa, interleukin-2, and denileukin diftitox",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interferon-alfa and interleukin-2 can cause both permanent and transient hypothyroidism. The thyroid injury is apparently due to the ability of these substances to induce or exacerbate thyroid autoimmune disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Aminoglutethimide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aminoglutethimide, which is used to reduce adrenal secretion in patients with Cushing's disease and adrenal, breast, or prostatic cancer, can cause hypothyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. One report, as an example, evaluated 29 men with prostatic cancer treated with 1000 mg daily: 31 percent had clinical or biochemical evidence of hypothyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many other drugs, such as sulfonamides and sulfonylureas, have been implicated as causes of hypothyroidism in occasional patients (",
"    <a class=\"graphic graphic_table graphicRef50439 \" href=\"mobipreview.htm?21/19/21820\">",
"     table 1",
"    </a>",
"    ). However, evidence for a cause-and-effect relationship is poor with these drugs.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/10/31904?source=see_link\">",
"     Bexarotene",
"    </a>",
"    has been reported to cause central hypothyroidism, as well as an increase in non-deiodinase metabolism of thyroid hormone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/31\">",
"     31",
"    </a>",
"    ].&nbsp;Hypophysitis and panhypopituitarism, including central hypothyroidism, may also occur as a complication of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/52/19270?source=see_link\">",
"     ipilimumab",
"    </a>",
"    (anti-CTLA-4) immunotherapy used for the treatment of metastatic melanoma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/6/18536?source=see_link\">",
"     \"Central hypothyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/28/2506?source=see_link&amp;anchor=H177442801#H177442801\">",
"     \"Advanced melanoma: anti-CTLA-4 antibodies and other immune checkpoint strategies\", section on 'Endocrinopathies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cases of hypothyroidism have also been described with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/62/29673?source=see_link\">",
"     thalidomide",
"    </a>",
"    therapy, although the mechanism for this effect is unknown [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DRUGS THAT INTERFERE WITH THYROID HORMONE TRANSPORT AND METABOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many drugs and hormones affect T4 and T3 transport (binding) in serum. In addition, some drugs interfere with the absorption or metabolism of thyroid hormones (eg, T4).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Drugs that influence thyroid hormone binding in serum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drugs may increase or decrease serum thyroxine-binding globulin (TBG) concentrations, thereby causing parallel changes in serum total, but not free, T4 and T3 concentrations (",
"    <a class=\"graphic graphic_table graphicRef50439 \" href=\"mobipreview.htm?21/19/21820\">",
"     table 1",
"    </a>",
"    ). Serum TSH concentrations are unchanged. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/53/856?source=see_link\">",
"     \"Euthyroid hyperthyroxinemia and hypothyroxinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among those that raise serum TBG, the most important are estrogen or SERMs (including oral contraceptives,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"       tamoxifen",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/15/6390?source=see_link\">",
"       raloxifene",
"      </a>",
"      ),",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/32/33280?source=see_link\">",
"       fluorouracil",
"      </a>",
"      . Thyroid hormone doses may need to be adjusted in hypothyroid women who initiate estrogen replacement therapy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=see_link\">",
"       \"Treatment of hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Among those that lower serum TBG, the most important are androgens, anabolic steroids, and glucocorticoids.",
"     </li>",
"     <li>",
"      Several other drugs, such as salicylates,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/14/5350?source=see_link\">",
"       salsalate",
"      </a>",
"      , fenclofenac and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/63/41976?source=see_link\">",
"       mefenamic acid",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      , lower serum T4 and T3 concentrations by blocking hormone binding to TBG [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/33-36\">",
"       33-36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       Heparin",
"      </a>",
"      , even when administered subcutaneously, may cause an acute and transient increase in serum free T4 concentrations. This increase occurs because of generation of free fatty acids by heparin stimulation of lipoprotein lipase that displace T4 from binding proteins; this effect requires that the serum triglyceride concentration be greater than about 180",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (2",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      It is primarily an in vitro phenomenon [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Drugs that affect gastrointestinal absorption of thyroid hormone",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bile acid binding resins used in the treatment of hypercholesterolemia,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/33/36374?source=see_link\">",
"     cholestyramine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/26/12710?source=see_link\">",
"     colestipol",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/57/35734?source=see_link\">",
"     colesevelam",
"    </a>",
"    , bind thyroid hormones and decrease their absorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. In euthyroid patients without thyroid disease, the administration of these resins has no adverse effects. However, hypothyroidism may occur in the following situations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The concomitant administration of bile acid binding-resins and T4 in patients with hypothyroidism. If both are required, T4 should not be taken until several hours after administration of the bile acid-binding resin.",
"     </li>",
"     <li>",
"      Although not yet reported in the literature, euthyroid patients with limited thyroid reserve due to subclinical thyroid disease or treatment with radioactive iodine would also seem to be at risk for the development of hypothyroidism during treatment with bile acid binding resins.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Normal gastric acid secretion appears to be necessary for normal thyroid hormone absorption.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/62/26601?source=see_link\">",
"     Omeprazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/41\">",
"     41",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/14/3305?source=see_link\">",
"     lansoprazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/42\">",
"     42",
"    </a>",
"    ], and presumably other medications that reduce gastric acid secretion may interfere with thyroid hormone absorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/32/42504?source=see_link\">",
"     Calcium carbonate",
"    </a>",
"    also reduces the absorption of exogenous T4. In a prospective cohort study of 20 hypothyroid patients taking 1200 mg of elemental calcium as calcium carbonate for three months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/43\">",
"     43",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mean serum free and total T4 concentrations fell significantly during co-administration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/32/42504?source=see_link\">",
"       calcium carbonate",
"      </a>",
"      by 8 percent and 7 percent, respectively.",
"     </li>",
"     <li>",
"      The mean serum TSH concentration increased by 69 percent (1.6",
"      <span class=\"nowrap\">",
"       mU/L",
"      </span>",
"      to 2.7",
"      <span class=\"nowrap\">",
"       mU/L,",
"      </span>",
"      p = 0.008), and 20 percent of patients had serum TSH concentrations above the normal range (highest 7.8",
"      <span class=\"nowrap\">",
"       mU/L).",
"      </span>",
"     </li>",
"     <li>",
"      All changes resolved after",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/32/42504?source=see_link\">",
"       calcium carbonate",
"      </a>",
"      was discontinued.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/15/6390?source=see_link\">",
"     Raloxifene",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    administered at the same time as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"     levothyroxine",
"    </a>",
"    reproducibly interfered with the absorption of levothyroxine in one patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/44\">",
"     44",
"    </a>",
"    ], and two patients, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/45\">",
"     45",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/29/29141?source=see_link\">",
"     Sucralfate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/11/37046?source=see_link\">",
"     ferrous sulfate",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/16/27910?source=see_link\">",
"     aluminum hydroxide",
"    </a>",
"    can also bind T4 in the gut, but their effect is smaller and also less consistent than those described above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. Sevelemer,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/37/28244?source=see_link\">",
"     lanthanum carbonate",
"    </a>",
"    , and chromium have been shown to reduce thyroxine absorption in a formal six-hour absorption test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/40,49\">",
"     40,49",
"    </a>",
"    ]. It is prudent to separate the administration of these drugs and T4 by several hours.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Drugs that affect thyroid hormone metabolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/40/29321?source=see_link\">",
"     Phenobarbital",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    increase the metabolism of T4 and T3. As a result, T4-treated hypothyroid patients may need a higher dose when treated with any of these drugs. Conversely, the doses of these drugs may need adjustment because their metabolism varies according to thyroid status.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/40/29321?source=see_link\">",
"     Phenobarbital",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    augment the rate of deiodination of T4 and T3, principally by stimulation of the hepatic drug-metabolizing enzyme system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. The hypothalamic-pituitary system in normal subjects compensates for an increase in hormone metabolism by augmenting thyroid hormone production and secretion. In the steady state, therefore, serum T4, T3, and TSH concentrations remain within the normal range. However, patients with subclinical or overt hypothyroidism who are treated with phenobarbital or rifampin cannot augment thyroid hormone production and secretion, thereby exacerbating the hypothyroidism.",
"   </p>",
"   <p>",
"    By comparison, the interactions of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    on the thyroid system are more complex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. These drugs both augment the rate of thyroid hormone metabolism (similar to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/40/29321?source=see_link\">",
"     phenobarbital",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    ) and displace thyroid hormones from the serum binding proteins, principally TBG. As a result, serum total T4 and free T4 concentrations decrease about 40 percent; the decrease in serum T3 is smaller but TSH concentrations remain within the normal range. The decrease in free T4 is an artifact in most free T4 assays.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/25/40344?source=see_link\">",
"     Oxcarbazepine",
"    </a>",
"    , an antiepileptic that has less of an effect on the hepatic P-450 enzyme system, nonetheless is still associated with low serum T4 concentrations and normal TSH levels suggesting a possible central effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Drugs that affect T3 production",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most serum T3 is produced by extrathyroidal monodeiodination of T4, a reaction catalyzed by 5'-monodeiodinase. Drugs that inhibit the action of this enzyme decrease T3 production and cause a fall in serum T3 concentrations. Drugs known to inhibit extrathyroidal T3 production include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/12\">",
"     12",
"    </a>",
"    ], high doses of glucocorticoids (eg, more than 4",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/56-60\">",
"     56-60",
"    </a>",
"    ], beta-adrenergic antagonists [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/61-64\">",
"     61-64",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/9/5271?source=see_link\">",
"     propylthiouracil",
"    </a>",
"    (which is only given to treat hyperthyroidism), and the iodinated contrast agents (ipodate and iopanoic acid) used for oral cholecystography.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     Amiodarone",
"    </a>",
"    , as noted above, may cause hypothyroidism or hyperthyroidism by different mechanisms in susceptible patients. It also inhibits T4 conversion to T3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/12\">",
"     12",
"    </a>",
"    ]. As a result, patients treated with amiodarone who do not develop hypothyroidism or hyperthyroidism often have low serum T3 concentrations, while serum total and free T4 concentrations are raised to just above the upper limit of the normal range. Serum TSH concentrations are usually normal but may be slightly high during the first few months of treatment.",
"   </p>",
"   <p>",
"    High doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    or related drugs may inhibit T3 production from T4. In one study, some patients treated with more than 160 mg per day of propranolol had slightly high serum T4 and slightly low serum T3 concentrations, with normal serum TSH concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. In hyperthyroid patients,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/46/30440?source=see_link\">",
"     atenolol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39417?source=see_link\">",
"     metoprolol",
"    </a>",
"    , and alprenolol also decrease serum T3 concentrations slightly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42632/abstract/63,64\">",
"     63,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum T3 concentrations fall by about 30 percent for four to six days after single oral doses of sodium ipodate or iopanoic acid given for cholecystography. This effect has been used for the treatment of hyperthyroidism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/57/37779?source=see_link\">",
"     \"Iodinated radiocontrast agents in the treatment of hyperthyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H106739105\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Drugs can affect any aspect of thyroid hormone production, including TSH secretion, thyroidal production of T4 and T3, their transport in serum, and their metabolism. The result may be either overt thyroid dysfunction or biochemical abnormalities that do not result in clinically important thyroid dysfunction but may be misinterpreted as indicating its presence (",
"      <a class=\"graphic graphic_table graphicRef50439 \" href=\"mobipreview.htm?21/19/21820\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Thyroid hormone metabolism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Drugs that in high doses may inhibit TSH secretion include glucocorticoids,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      , dopamine,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"       octreotide",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/10/31904?source=see_link\">",
"       bexarotene",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Drugs that affect TSH secretion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Iodine (or iodide containing drugs),",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      , interferon-alpha, and interleukin-2 may cause hyperthyroidism or hypothyroidism. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Drugs that cause hyperthyroidism'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Drugs that cause hypothyroidism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some drugs may increase or decrease serum thyroxine-binding globulin (TBG) concentrations, thereby causing parallel changes in serum total, but not free, T4 and T3 concentrations (",
"      <a class=\"graphic graphic_table graphicRef50439 \" href=\"mobipreview.htm?21/19/21820\">",
"       table 1",
"      </a>",
"      ). Serum TSH concentrations are unchanged, and these drugs do not result in clinically important thyroid dysfunction but may be misinterpreted as indicating its presence. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Drugs that influence thyroid hormone binding in serum'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/53/856?source=see_link\">",
"       \"Euthyroid hyperthyroxinemia and hypothyroxinemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Several drugs can interfere with the absorption of T4, including bile acid resins, proton pump inhibitors,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/32/42504?source=see_link\">",
"       calcium carbonate",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/11/37046?source=see_link\">",
"       ferrous sulfate",
"      </a>",
"      . It is prudent to separate the administration of these drugs and T4 by several hours. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Drugs that affect gastrointestinal absorption of thyroid hormone'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=see_link&amp;anchor=H5#H5\">",
"       \"Treatment of hypothyroidism\", section on 'Timing of dose'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/40/29321?source=see_link\">",
"       Phenobarbital",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      increase the metabolism of T4 and T3. As a result, T4-treated hypothyroid patients may need a higher dose when treated with any of these drugs. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Drugs that affect thyroid hormone metabolism'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/1\">",
"      Curran PG, DeGroot LJ. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev 1991; 12:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/2\">",
"      Brabant G, Brabant A, Ranft U, et al. Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J Clin Endocrinol Metab 1987; 65:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/3\">",
"      Brabant G, Prank K, Hoang-Vu C, et al. Hypothalamic regulation of pulsatile thyrotopin secretion. J Clin Endocrinol Metab 1991; 72:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/4\">",
"      Lee E, Chen P, Rao H, et al. Effect of acute high dose dobutamine administration on serum thyrotrophin (TSH). Clin Endocrinol (Oxf) 1999; 50:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/5\">",
"      Cooper DS, Klibanski A, Ridgway EC. Dopaminergic modulation of TSH and its subunits: in vivo and in vitro studies. Clin Endocrinol (Oxf) 1983; 18:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/6\">",
"      Agner T, Hagen C, Andersen AN, Djursing H. Increased dopaminergic activity inhibits basal and metoclopramide-stimulated prolactin and thyrotropin secretion. J Clin Endocrinol Metab 1986; 62:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/7\">",
"      Bertherat J, Brue T, Enjalbert A, et al. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. J Clin Endocrinol Metab 1992; 75:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/8\">",
"      Braverman LE. Iodine induced thyroid disease. Acta Med Austriaca 1990; 17 Suppl 1:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/9\">",
"      Sherman SI, Gopal J, Haugen BR, et al. Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med 1999; 340:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/10\">",
"      Vigersky RA, Filmore-Nassar A, Glass AR. Thyrotropin suppression by metformin. J Clin Endocrinol Metab 2006; 91:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/11\">",
"      Martin FI, Tress BW, Colman PG, Deam DR. Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly. Am J Med 1993; 95:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/12\">",
"      Figge HL, Figge J. The effects of amiodarone on thyroid hormone function: a review of the physiology and clinical manifestations. J Clin Pharmacol 1990; 30:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/13\">",
"      Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991; 91:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/14\">",
"      Bartalena L, Grasso L, Brogioni S, et al. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1994; 78:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/15\">",
"      Bartalena L, Brogioni S, Grasso L, et al. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 1996; 81:2930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/16\">",
"      Hamnvik OP, Larsen PR, Marqusee E. Thyroid dysfunction from antineoplastic agents. J Natl Cancer Inst 2011; 103:1572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/17\">",
"      Philippou G, Koutras DA, Piperingos G, et al. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement. Clin Endocrinol (Oxf) 1992; 36:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/18\">",
"      Spaulding SW, Burrow GN, Bermudez F, Himmelhoch JM. The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients. J Clin Endocrinol Metab 1972; 35:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/19\">",
"      Perrild H, Heged&uuml;s L, Baastrup PC, et al. Thyroid function and ultrasonically determined thyroid size in patients receiving long-term lithium treatment. Am J Psychiatry 1990; 147:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/20\">",
"      Shinohara N, Takahashi M, Kamishima T, et al. The incidence and mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma. Br J Cancer 2011; 104:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/21\">",
"      de Groot JW, Zonnenberg BA, Plukker JT, et al. Imatinib induces hypothyroidism in patients receiving levothyroxine. Clin Pharmacol Ther 2005; 78:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/22\">",
"      Brassard M, Neraud B, Trabado S, et al. Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancer. J Clin Endocrinol Metab 2011; 96:2741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/23\">",
"      Abdulrahman RM, Verloop H, Hoftijzer H, et al. Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination. J Clin Endocrinol Metab 2010; 95:3758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/24\">",
"      Makita N, Iiri T. Tyrosine kinase inhibitor-induced thyroid disorders: a review and hypothesis. Thyroid 2013; 23:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/25\">",
"      Desai J, Yassa L, Marqusee E, et al. Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med 2006; 145:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/26\">",
"      Mannavola D, Coco P, Vannucchi G, et al. A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake. J Clin Endocrinol Metab 2007; 92:3531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/27\">",
"      Wong E, Rosen LS, Mulay M, et al. Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity. Thyroid 2007; 17:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/28\">",
"      Verloop H, Smit JW, Dekkers OM. Sorafenib therapy decreases the clearance of thyrotropin. Eur J Endocrinol 2013; 168:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/29\">",
"      Dowsett M, Mehta A, Cantwell BM, Harris AL. Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. Eur J Cancer 1991; 27:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/30\">",
"      Figg WD, Thibault A, Sartor AO, et al. Hypothyroidism associated with aminoglutethimide in patients with prostate cancer. Arch Intern Med 1994; 154:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/31\">",
"      Smit JW, Stokkel MP, Pereira AM, et al. Bexarotene-induced hypothyroidism: bexarotene stimulates the peripheral metabolism of thyroid hormones. J Clin Endocrinol Metab 2007; 92:2496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/32\">",
"      Badros AZ, Siegel E, Bodenner D, et al. Hypothyroidism in patients with multiple myeloma following treatment with thalidomide. Am J Med 2002; 112:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/33\">",
"      Stockigt JR, Lim CF, Barlow JW, et al. Interaction of furosemide with serum thyroxine-binding sites: in vivo and in vitro studies and comparison with other inhibitors. J Clin Endocrinol Metab 1985; 60:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/34\">",
"      Faber J, Waetjen I, Siersbaek-Nielsen K. Free thyroxine measured in undiluted serum by dialysis and ultrafiltration: effects of non-thyroidal illness, and an acute load of salicylate or heparin. Clin Chim Acta 1993; 223:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/35\">",
"      McConnell RJ. Abnormal thyroid function test results in patients taking salsalate. JAMA 1992; 267:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/36\">",
"      Samuels MH, Pillote K, Asher D, Nelson JC. Variable effects of nonsteroidal antiinflammatory agents on thyroid test results. J Clin Endocrinol Metab 2003; 88:5710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/37\">",
"      Jaume JC, Mendel CM, Frost PH, et al. Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artifactual elevations in the serum-free thyroxine concentration as measured by equilibrium dialysis. Thyroid 1996; 6:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/38\">",
"      Harmon SM, Seifert CF. Levothyroxine-cholestyramine interaction reemphasized. Ann Intern Med 1991; 115:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/39\">",
"      Witztum JL, Jacobs LS, Schonfeld G. Thyroid hormone and thyrotropin levels in patients placed on colestipol hydrochloride. J Clin Endocrinol Metab 1978; 46:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/40\">",
"      Weitzman SP, Ginsburg KC, Carlson HE. Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine. Thyroid 2009; 19:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/41\">",
"      Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 2006; 354:1787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/42\">",
"      Sachmechi I, Reich DM, Aninyei M, et al. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr Pract 2007; 13:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/43\">",
"      Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA 2000; 283:2822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/44\">",
"      Siraj ES, Gupta MK, Reddy SS. Raloxifene causing malabsorption of levothyroxine. Arch Intern Med 2003; 163:1367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/45\">",
"      Cooper JG, Harboe K, Frost SK, Skadberg &Oslash;. Ciprofloxacin interacts with thyroid replacement therapy. BMJ 2005; 330:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/46\">",
"      Liel Y, Sperber AD, Shany S. Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. Am J Med 1994; 97:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/47\">",
"      Campbell NR, Hasinoff BB, Stalts H, et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med 1992; 117:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/48\">",
"      Campbell JA, Schmidt BA, Bantle JP. Sucralfate and the absorption of L-thyroxine. Ann Intern Med 1994; 121:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/49\">",
"      John-Kalarickal J, Pearlman G, Carlson HE. New medications which decrease levothyroxine absorption. Thyroid 2007; 17:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/50\">",
"      Oppenheimer JH, Bernstein G, Surks MI. Increased thyroxine turnover and thyroidal function after stimulation of hepatocellular binding of thyroxine by phenobarbital. J Clin Invest 1968; 47:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/51\">",
"      Cavlieri RR, Sung LC, Becker CE. Effects of phenobarbital on thyroxine and triiodothyronine kinetics in Graves' disease. J Clin Endocrinol Metab 1973; 37:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/52\">",
"      Isley WL. Effect of rifampin therapy on thyroid function tests in a hypothyroid patient on replacement L-thyroxine. Ann Intern Med 1987; 107:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/53\">",
"      Smith PJ, Surks MI. Multiple effects of 5,5'-diphenylhydantoin on the thyroid hormone system. Endocr Rev 1984; 5:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/54\">",
"      Surks MI, DeFesi CR. Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. A paradox resolved. JAMA 1996; 275:1495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/55\">",
"      Miller J, Carney P. Central hypothyroidism with oxcarbazepine therapy. Pediatr Neurol 2006; 34:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/56\">",
"      LoPresti JS, Eigen A, Kaptein E, et al. Alterations in 3,3'5'-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man. J Clin Invest 1989; 84:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/57\">",
"      Degroot LJ, Hoye K. Dexamethasone suppression of serum T3 and T4. J Clin Endocrinol Metab 1976; 42:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/58\">",
"      Gamstedt A, J&auml;rnerot G, K&aring;gedal B. Dose related effects of betamethasone on iodothyronines and thyroid hormone-binding proteins in serum. Acta Endocrinol (Copenh) 1981; 96:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/59\">",
"      Duick DS, Warren DW, Nicoloff JT, et al. Effect of single dose dexamethasone on the concentration of serum triiodothyronine in man. J Clin Endocrinol Metab 1974; 39:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/60\">",
"      Chopra IJ, Williams DE, Orgiazzi J, Solomon DH. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3). J Clin Endocrinol Metab 1975; 41:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/61\">",
"      Kristensen BO, Weeke J. Propranolol-induced increments in total and free serum thyroxine in patients with essential hypertension. Clin Pharmacol Ther 1977; 22:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/62\">",
"      Cooper DS, Daniels GH, Ladenson PW, Ridgway EC. Hyperthyroxinemia in patients treated with high-dose propranolol. Am J Med 1982; 73:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/63\">",
"      Perrild H, Hansen JM, Skovsted L, Christensen LK. Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism. Clin Endocrinol (Oxf) 1983; 18:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42632/abstract/64\">",
"      Reeves RA, From GL, Paul W, Leenen FH. Nadolol, propranolol, and thyroid hormones: evidence for a membrane-stabilizing action of propranolol. Clin Pharmacol Ther 1985; 37:157.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7845 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-D3B5B19E3F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42632=[""].join("\n");
var outline_f41_40_42632=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H106739105\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      THYROID HORMONE METABOLISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DRUGS THAT AFFECT TSH SECRETION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DRUGS THAT CAUSE HYPERTHYROIDISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Iodine and iodide containing drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Lithium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DRUGS THAT CAUSE HYPOTHYROIDISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Iodine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Lithium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H63808039\">",
"      Tyrosine kinase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Interferon-alfa, interleukin-2, and denileukin diftitox",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Aminoglutethimide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DRUGS THAT INTERFERE WITH THYROID HORMONE TRANSPORT AND METABOLISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Drugs that influence thyroid hormone binding in serum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Drugs that affect gastrointestinal absorption of thyroid hormone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Drugs that affect thyroid hormone metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Drugs that affect T3 production",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H106739105\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7845\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7845|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/29/27088\" title=\"figure 1\">",
"      Thyroid hormone synthesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/24/10629\" title=\"figure 2\">",
"      Regulation thyroid hormone production",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7845|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/19/21820\" title=\"table 1\">",
"      Drugs and thyroid function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?18/26/18861\" title=\"table 2\">",
"      Sources of iodine",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/28/2506?source=related_link\">",
"      Advanced melanoma: anti-CTLA-4 antibodies and other immune checkpoint strategies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/30/25065?source=related_link\">",
"      Amiodarone and thyroid dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/6/18536?source=related_link\">",
"      Central hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/47/42744?source=related_link\">",
"      Disorders that cause hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/53/856?source=related_link\">",
"      Euthyroid hyperthyroxinemia and hypothyroxinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/57/37779?source=related_link\">",
"      Iodinated radiocontrast agents in the treatment of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20568?source=related_link\">",
"      Iodine-induced thyroid dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3608?source=related_link\">",
"      Laboratory assessment of thyroid function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/29/42453?source=related_link\">",
"      Lithium and the thyroid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/39/44663?source=related_link\">",
"      Thyroid function in nonthyroidal illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43882?source=related_link\">",
"      Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=related_link\">",
"      Treatment of hypothyroidism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_40_42633="Normal growth patterns in infants and prepubertal children";
var content_f41_40_42633=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Normal growth patterns in infants and prepubertal children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/40/42633/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/40/42633/contributors\">",
"     Julie A Boom, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/40/42633/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/40/42633/contributors\">",
"     Teresa K Duryea, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/40/42633/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/40/42633/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/40/42633/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal growth is the progression of changes in height, weight, and head circumference that are compatible with established standards for a given population. The progression of growth is interpreted within the context of the genetic potential for a particular child [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/1\">",
"     1",
"    </a>",
"    ]. Normal growth is a reflection of overall health and nutritional status. Understanding the normal patterns of growth enables the early detection of pathologic deviations (eg, poor weight gain due to a metabolic disorder, short stature due to inflammatory bowel disease) and can prevent the unnecessary evaluation of children with acceptable normal variations in growth.",
"   </p>",
"   <p>",
"    A review of normal growth patterns during infancy and childhood will be provided below. Growth during puberty is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/25/1434?source=see_link\">",
"     \"Normal puberty\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DETERMINANTS OF NORMAL GROWTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Somatic growth and biologic maturation are influenced by several factors that act independently and in concert to modify a child's genetic growth potential. The influence of maternal nutrition and intrauterine environment are reflected primarily in the growth parameters at the time of birth and during the first month of life, whereas genetic factors have a later influence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/2\">",
"     2",
"    </a>",
"    ]. The correlation coefficient between length and adult height is only 0.25 at birth, but increases to 0.8 at two years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although primarily reflected in the growth parameters at birth, long-term influences of maternal nutrition and intrauterine environment on subsequent growth and pubertal development have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Studies in various populations have demonstrated an association between catch-up growth or rapid growth in infancy or early childhood and subsequent obesity, suggesting that mechanisms that signal and regulate catch-up growth in the postnatal period may play a role in the development of obesity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/5/32858?source=see_link&amp;anchor=H14#H14\">",
"     \"Definition; epidemiology; and etiology of obesity in children and adolescents\", section on 'Metabolic programming'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     NORMAL PATTERNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most healthy infants and children grow in a predictable fashion, following a typical pattern of progression in weight, length, and head circumference. Normal human growth is pulsatile; periods of rapid growth (\"growth spurts\") are separated by periods of no measurable growth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. Growth is also seasonal, with growth velocities increased during the spring and summer months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Growth velocity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Growth velocity, the change in growth over time, is a more sensitive index of growth than is a single measurement. Current growth points should be compared to previous growth points, if possible, to determine the interval growth velocity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Twins",
"    </span>",
"    &nbsp;&mdash;&nbsp;After birth, the growth velocity of twins is increased compared to singletons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/11\">",
"     11",
"    </a>",
"    ]. Nonetheless, their weight, length, and body mass index (BMI) usually are less than those of singletons during the first 2.5 years of life, even after correcting for gestational age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. By age four years, the weight, height, and BMI of twins are comparable to those of their nontwin siblings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Weight gain",
"    </span>",
"    &nbsp;&mdash;&nbsp;General guidelines regarding weight gain during infancy and childhood for infants with growth parameters that were appropriate for gestational age at birth include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Term neonates may lose up to 10 percent of their birth weight in the first few days of life and typically regain their birth weight by 10 to 14 days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/13-15\">",
"       13-15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Newborns gain approximately 30",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      (1",
"      <span class=\"nowrap\">",
"       oz/day)",
"      </span>",
"      until three months of age",
"     </li>",
"     <li>",
"      Infants gain approximately 20",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      (0.67",
"      <span class=\"nowrap\">",
"       oz/day)",
"      </span>",
"      between three and six months of age and approximately 10",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      between 6 and 12 months",
"     </li>",
"     <li>",
"      Infants double their birth weight by four months of age and triple their birth weight by one year",
"     </li>",
"     <li>",
"      Children gain 2",
"      <span class=\"nowrap\">",
"       kg/year",
"      </span>",
"      (4.4",
"      <span class=\"nowrap\">",
"       lbs/year)",
"      </span>",
"      between two years and puberty",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A prepubertal child whose weight velocity is &lt;1",
"    <span class=\"nowrap\">",
"     kg/year",
"    </span>",
"    (&lt;2.2",
"    <span class=\"nowrap\">",
"     lbs/year)",
"    </span>",
"    should be monitored closely for progressive nutritional deficits. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/21/38233?source=see_link\">",
"     \"Poor weight gain in children older than two years of age\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The growth patterns of preterm infants, small-for-gestational-age infants, and large-for-gestational-age infants are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/22/23912?source=see_link&amp;anchor=H6#H6\">",
"     \"Growth management in preterm infants\", section on 'Growth chart'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/23/9593?source=see_link&amp;anchor=H22#H22\">",
"     \"Small for gestational age infant\", section on 'Physical growth'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/21/20823?source=see_link&amp;anchor=H23#H23\">",
"     \"Large for gestational age newborn\", section on 'Potential long-term effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Method of feeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pattern of weight gain during infancy varies depending upon the method of feeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/16-22\">",
"     16-22",
"    </a>",
"    ]. Compared with formula-fed infants, breastfed infants gain weight relatively rapidly during the first three to four months of life and relatively slowly thereafter.",
"   </p>",
"   <p>",
"    When exclusively breastfed infants are plotted on the Centers for Disease Control and Prevention National Center for Health Statistics",
"    <span class=\"nowrap\">",
"     (CDC/NCHS)",
"    </span>",
"    growth charts (which are derived from a sample of predominantly formula-fed infants), their normal and appropriate weight gain may appear to be too rapid in the first three months of life, and too slow thereafter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. Although the weights of breastfed and formula-fed infants are similar by 12 to 23 months of age, the typical pattern of slowed weight gain after three to four months among breastfed infants may lead to early introduction of solid foods or cessation of breastfeeding if the slowed weight gain is perceived as lactational inadequacy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/24,26\">",
"     24,26",
"    </a>",
"    ]. The use of a weight chart derived from a population of breastfed infants may prevent this misperception. Such a curve has been developed for international use by the World Health Organization (WHO) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'WHO growth charts'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In 2010, the CDC recommended that the WHO growth charts be used in the United States for infants and children &lt;24 months of age, regardless of the method of feeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/28\">",
"     28",
"    </a>",
"    ]. When using the WHO growth charts for formula-fed infants, normal and appropriate weight gain may appear to be too slow in the first three months of life, and too rapid thereafter (",
"    <a class=\"graphic graphic_figure graphicRef51959 \" href=\"mobipreview.htm?12/5/12370\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Linear growth",
"    </span>",
"    &nbsp;&mdash;&nbsp;General guidelines regarding length or height gain during infancy and childhood include the following (",
"    <a class=\"graphic graphic_figure graphicRef70382 \" href=\"mobipreview.htm?6/6/6253\">",
"     figure 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The average length at birth for a term infant is 20 inches (50 cm)",
"     </li>",
"     <li>",
"      Infants grow 10 inches (25 cm) during the first year of life",
"     </li>",
"     <li>",
"      Toddlers grow 4 inches (10 cm) between 12 and 24 months, 3 inches (7.5 cm) between 24 and 36 months, and 3 inches (7.5 cm) between 36 and 48 months",
"     </li>",
"     <li>",
"      Children reach one-half of their adult height by 24 to 30 months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/1\">",
"       1",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Children grow 2",
"      <span class=\"nowrap\">",
"       inches/year",
"      </span>",
"      (5",
"      <span class=\"nowrap\">",
"       cm/year)",
"      </span>",
"      between age four years and puberty",
"     </li>",
"     <li>",
"      There is a normal deceleration of height velocity before the pubertal growth spurt (",
"      <a class=\"graphic graphic_figure graphicRef66909 graphicRef74573 \" href=\"mobipreview.htm?32/1/32792\">",
"       figure 3A-B",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The linear growth rate shifts during the first two years of life in nearly two-thirds of normal infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Approximately one-third of infants cross one major percentile line (eg, 10th, 25th, 50th, 75th, 90th), one-fourth cross two major percentile lines, and one-tenth cross three major percentile lines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/29\">",
"     29",
"    </a>",
"    ]. The shift may be an increase or decrease from the growth rate of the first six months, during which growth is influenced primarily by the intrauterine environment. After the period of shift, the child's growth typically proceeds along the same channel of growth between two and nine years. This can be used to predict adult height. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Predicted height'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Prepubertal growth is a nonlinear process, comprised of growth spurts lasting an average of eight weeks, separated by periods of slow growth, which last an average of 18 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Height velocity",
"    </span>",
"    &nbsp;&mdash;&nbsp;A period of at least six months is necessary for reliable calculation of height velocity in children older than two years. Average normal length or height velocities are as follows (",
"    <a class=\"graphic graphic_figure graphicRef70382 \" href=\"mobipreview.htm?6/6/6253\">",
"     figure 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      0 to 6 months &ndash; One inch (2.5 cm) per month",
"     </li>",
"     <li>",
"      7 to 12 months &ndash; One-half inch (1.25 cm) per month",
"     </li>",
"     <li>",
"      12 to 24 months &ndash; Usually &gt;4 inches (10 cm) per year",
"     </li>",
"     <li>",
"      24 to 36 months &ndash; 3 inches (8 cm) per year",
"     </li>",
"     <li>",
"      36 to 48 months &ndash; 2.75 inches (7 cm) per year",
"     </li>",
"     <li>",
"      4 to 10 years &ndash; 2 to 2.4 inches (5 to 6 cm) per year",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A prepubertal child whose height velocity is &lt;2",
"    <span class=\"nowrap\">",
"     inches/year",
"    </span>",
"    (&lt;5",
"    <span class=\"nowrap\">",
"     cm/year)",
"    </span>",
"    should be monitored closely. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/18/10537?source=see_link\">",
"     \"Causes of short stature\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/60/18376?source=see_link\">",
"     \"Diagnostic approach to short stature\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Variants of normal",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two most common causes of short stature beyond the first year or two of life are variants of normal growth: familial short stature and delayed (constitutional) growth. Growth velocity is normal in each of these conditions, but there are other characteristic features (",
"    <a class=\"graphic graphic_table graphicRef51582 \" href=\"mobipreview.htm?24/15/24827\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/18/10537?source=see_link&amp;anchor=H4#H4\">",
"     \"Causes of short stature\", section on 'Patterns of abnormal growth'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Predicted height",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adult height can be predicted by projecting the child's current growth channel to the value at 18 to 20 years or by calculating the midparental height.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Projected height &ndash; The projected height for a child older than two years is determined by extrapolating the child's growth along the current channel to the 18- to 20-year mark (",
"      <a class=\"graphic graphic_figure graphicRef64811 \" href=\"mobipreview.htm?3/8/3204\">",
"       figure 4",
"      </a>",
"      ). The projected height can be compared with the calculated midparental height to determine if the child's growth is consistent with genetic potential.",
"      <br/>",
"      <br/>",
"      For children with delayed or accelerated growth, using the skeletal age (bone age) rather than the chronologic age to determine the projected height channel provides more accurate assessment of projected height (",
"      <a class=\"graphic graphic_figure graphicRef77625 \" href=\"mobipreview.htm?10/48/11012\">",
"       figure 5",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/60/18376?source=see_link\">",
"       \"Diagnostic approach to short stature\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/53/10073?source=see_link\">",
"       \"The child with tall stature or abnormally rapid growth\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Skeletal age generally is obtained by assessing the appearance and shape of the bones of the hand and wrist from a radiograph. The methods used most commonly for determining skeletal age are the Greulich and Pyle Atlas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/31\">",
"       31",
"      </a>",
"      ] and the Tanner-Whitehouse (TW2) method [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Midparental height &ndash; Although the precise contribution of heredity cannot be quantitated, an estimate of a child's adult height potential can be obtained by calculation of the midparental height, adjusted for the sex of the child (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?30/3/30769?source=see_link\">",
"       calculator 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/33\">",
"       33",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For girls, 13 cm is subtracted from the father's height and averaged with the mother's height",
"     </li>",
"     <li>",
"      For boys, 13 cm is added to the mother's height and averaged with the father's height. The 13 cm represents the average difference in height of men and women.",
"     </li>",
"     <li>",
"      For both girls and boys, 8.5 cm on either side of this calculated value (target height) represents the 3rd to 97th percentiles for anticipated adult height.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Head growth",
"    </span>",
"    &nbsp;&mdash;&nbsp;General guidelines regarding head growth, a reflection of brain growth, include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The average head circumference at birth is 13.7 inches (35 cm)",
"     </li>",
"     <li>",
"      Head circumference usually is 0.4 to 0.8 inches (1 to 2 cm) larger than chest circumference at birth",
"     </li>",
"     <li>",
"      Head circumference increases approximately 0.4",
"      <span class=\"nowrap\">",
"       inches/month",
"      </span>",
"      (1",
"      <span class=\"nowrap\">",
"       cm/month)",
"      </span>",
"      during the first year of life, with the most rapid growth occurring during the first six months, with an increase of 0.8 inches (2 cm) in the first month and 2.7 inches (6 cm) in the first four months.",
"     </li>",
"     <li>",
"      Brain weight doubles by four to six months of age and triples by one year of age",
"     </li>",
"     <li>",
"      The majority of head growth is complete by four years of age",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     EVALUATION OF GROWTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of growth in children focuses on historical features related to growth, accurate measurement of growth parameters, determination of growth percentiles for age and sex (including assessment of proportionality), and assessment of the growth trajectory. The laboratory and radiologic evaluation of nutritional status and measurement of body composition in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/55/22391?source=see_link\">",
"     \"Laboratory and radiologic evaluation of nutritional status in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/38/6760?source=see_link\">",
"     \"Measurement of body composition in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The accurate measurement and charting of growth may prevent unnecessary evaluation or intervention in a child who has a normal pattern of growth (eg, a child whose length channel shifts toward the channel of the midparental height in the first 12 to 15 months; a child with familial short stature whose growth velocity is normal). (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Method of feeding'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/18/10537?source=see_link&amp;anchor=H5#H5\">",
"     \"Causes of short stature\", section on 'Intrinsic shortness'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The weight, length, and head circumference at birth",
"     </li>",
"     <li>",
"      Prenatal history: maternal infection, intrauterine exposures (cigarettes, drugs, alcohol, and other toxins)",
"     </li>",
"     <li>",
"      Interval growth points",
"     </li>",
"     <li>",
"      Past medical history",
"     </li>",
"     <li>",
"      Dietary history (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/61/28631?source=see_link&amp;anchor=H2#H2\">",
"       \"Dietary history and recommended dietary intake in children\", section on 'Dietary history'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Developmental history",
"     </li>",
"     <li>",
"      Review of systems for symptoms of systemic disease (particularly vomiting or diarrhea)",
"     </li>",
"     <li>",
"      Family history, including parental heights, parental growth patterns, and timing of pubertal onset in parents",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Measurement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination should include careful measurements of weight, length, and head circumference. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/30/19943?source=see_link&amp;anchor=H7#H7\">",
"     \"The pediatric physical examination: General principles and standard measurements\", section on 'Standard measurements'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Growth charts",
"    </span>",
"    &nbsp;&mdash;&nbsp;To determine the child's growth percentiles, weight and length (or height) should be plotted on the appropriate growth chart at each well-child visit and as indicated at interval visits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/37\">",
"     37",
"    </a>",
"    ]. Head circumference and weight-for-length should be plotted between birth and two years of age, and BMI after two years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/37\">",
"     37",
"    </a>",
"    ]. When a growth point deviates from the normal percentile range or from the patient's growth trajectory, the clinician should repeat the measurement to verify its accuracy.",
"   </p>",
"   <p>",
"    In 2010, the CDC recommended that the WHO growth charts be used for children &lt;24 months and the",
"    <span class=\"nowrap\">",
"     CDC/NCHS",
"    </span>",
"    growth charts be used for children ages 2 through 19 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/28\">",
"     28",
"    </a>",
"    ]. When using the WHO charts, fewer United States children will be identified as underweight, but gaining weight more rapidly than is indicated on the WHO chart may be an early sign of being overweight. Additional differences between the WHO and CDC charts are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/14/31976?source=see_link&amp;anchor=H31542395#H31542395\">",
"     \"Measurement of growth in children\", section on 'Recommended growth charts'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The incorporation of the WHO curves into routine clinical practice may be delayed due to lack of provider knowledge of the existence of the new curves and difficulties in integrating the WHO data into currently used electronic medical records.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     CDC growth charts",
"    </span>",
"    &nbsp;&mdash;&nbsp;The growth charts traditionally used by most pediatric healthcare providers in the United States are published by the CDC based on data from the National Center for Health Statistics (NCHS). The",
"    <span class=\"nowrap\">",
"     CDC/NCHS",
"    </span>",
"    growth charts were revised in 2000 to include a more ethnically diverse population and more breastfed infants. The",
"    <span class=\"nowrap\">",
"     CDC/NCHS",
"    </span>",
"    charts were derived primarily from data from the National Health and Nutrition Examination Survey, which has periodically collected height, weight, and other health information on the United States population since the early 1960s. As such, the CDC charts are reference charts, which describe the growth of children in the United States during an approximately 30-year period (1963 to 1994) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The CDC growth charts are available at the CDC Web site (",
"    <a class=\"external\" href=\"file://www.cdc.gov/growthcharts/\">",
"     www.cdc.gov/growthcharts/",
"    </a>",
"    ). The CDC recommends that the",
"    <span class=\"nowrap\">",
"     CDC/NCHS",
"    </span>",
"    growth charts be used for children ages 2 through 19 years, but that the WHO charts be used for children younger than two years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/28\">",
"     28",
"    </a>",
"    ]. The CDC charts for children older than two years are reproduced below; they can be printed out for clinical use.",
"   </p>",
"   <p>",
"    For boys aged 2 to 20 years:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Weight-for-age (",
"      <a class=\"graphic graphic_figure graphicRef71721 \" href=\"mobipreview.htm?13/61/14291\">",
"       figure 6",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Height-for-age (",
"      <a class=\"graphic graphic_figure graphicRef63399 \" href=\"mobipreview.htm?43/1/44050\">",
"       figure 7",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?21/47/22262?source=see_link\">",
"       calculator 2",
"      </a>",
"      )",
"      <br/>",
"      <br/>",
"      Charts combining these curves are also available and may be most practical for clinical use:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.cdc.gov/growthcharts/data/set1clinical/cj41c021.pdf\">",
"       Weight-for-age and stature-for-age boys",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Body mass index-for-age (",
"      <a class=\"graphic graphic_figure graphicRef60784 \" href=\"mobipreview.htm?37/23/38257\">",
"       figure 8",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?35/14/36070?source=see_link\">",
"       calculator 3",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For girls aged 2 to 20 years:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Weight-for-age (",
"      <a class=\"graphic graphic_figure graphicRef53325 \" href=\"mobipreview.htm?41/7/42098\">",
"       figure 9",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Height-for-age (",
"      <a class=\"graphic graphic_figure graphicRef77249 \" href=\"mobipreview.htm?29/10/29858\">",
"       figure 10",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?22/7/22646?source=see_link\">",
"       calculator 4",
"      </a>",
"      )",
"      <br/>",
"      <br/>",
"      Charts combining these curves are also available and may be most practical for clinical use:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.cdc.gov/growthcharts/data/set1clinical/cj41c022.pdf\">",
"       Weight-for-age and stature-for-age girls",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Body mass index-for-age (",
"      <a class=\"graphic graphic_figure graphicRef68478 \" href=\"mobipreview.htm?40/2/40993\">",
"       figure 11",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?34/60/35782?source=see_link\">",
"       calculator 5",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     WHO growth charts",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO growth charts are based upon data from the Multicentre Growth Reference Study, which combined longitudinal data from birth to 24 months and cross-sectional data from 18 to 71 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/27\">",
"     27",
"    </a>",
"    ]. The study population included 8440 healthy breastfed infants and young children from diverse ethnic backgrounds and cultural settings (Brazil, Ghana, India, Norway, Oman, United States). The study population was chosen to reflect a standard for children living under optimal environmental conditions.",
"   </p>",
"   <p>",
"    The WHO growth charts are growth standards that describe how healthy children should grow under optimal conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/28\">",
"     28",
"    </a>",
"    ]. &nbsp;They are intended to be used for all children, regardless of ethnicity, socioeconomic status, and type of feeding. However, they may not be suitable for all populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 2010, the United States Centers for Disease Control and Prevention recommended that the WHO growth charts be used for children younger than 24 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/28\">",
"     28",
"    </a>",
"    ]. The WHO growth charts are available at the CDC Web site (",
"    <a class=\"external\" href=\"file://www.cdc.gov/growthcharts/who_charts.htm\">",
"     www.cdc.gov/growthcharts/who_charts.htm",
"    </a>",
"    ) and the WHO Web site (",
"    <a class=\"external\" href=\"file://www.who.int/childgrowth/standards/en\">",
"     www.who.int/childgrowth/standards/en",
"    </a>",
"    ). The weight, length, head circumference, and weight-for-length charts for boys and girls aged zero to two years are reproduced here; they can be printed out for use in clinical practice.",
"   </p>",
"   <p>",
"    For boys aged zero to two years:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Weight-for-age (",
"      <a class=\"graphic graphic_figure graphicRef50006 \" href=\"mobipreview.htm?39/52/40770\">",
"       figure 12",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?11/46/12003?source=see_link\">",
"       calculator 6",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Length-for-age (",
"      <a class=\"graphic graphic_figure graphicRef67950 \" href=\"mobipreview.htm?30/44/31426\">",
"       figure 13",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?9/51/10035?source=see_link\">",
"       calculator 7",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Head circumference-for-age (",
"      <a class=\"graphic graphic_figure graphicRef58632 \" href=\"mobipreview.htm?32/32/33281\">",
"       figure 14",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?34/31/35315?source=see_link\">",
"       calculator 8",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Weight-for-length (",
"      <a class=\"graphic graphic_figure graphicRef53474 \" href=\"mobipreview.htm?40/13/41171\">",
"       figure 15",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?22/54/23398?source=see_link\">",
"       calculator 9",
"      </a>",
"      )",
"      <br/>",
"      <br/>",
"      Charts combining these curves are also available and may be most practical for clinical use:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.cdc.gov/growthcharts/data/who/GrChrt_Boys_24LW_9210.pdf\">",
"       Weight-for-age and length-for-age boys",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.cdc.gov/growthcharts/data/who/GrChrt_Boys_24HdCirc-L4W_rev90910.pdf\">",
"       Weight-for-length and head circumference-for-age boys",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For girls aged zero to two years:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Weight-for-age (",
"      <a class=\"graphic graphic_figure graphicRef63877 \" href=\"mobipreview.htm?38/6/39010\">",
"       figure 16",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?11/46/12003?source=see_link\">",
"       calculator 6",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Length-for-age (",
"      <a class=\"graphic graphic_figure graphicRef80511 \" href=\"mobipreview.htm?29/51/30514\">",
"       figure 17",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?9/51/10035?source=see_link\">",
"       calculator 7",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Head circumference-for-age (",
"      <a class=\"graphic graphic_figure graphicRef74503 \" href=\"mobipreview.htm?35/3/35889\">",
"       figure 18",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?34/31/35315?source=see_link\">",
"       calculator 8",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Weight-for-length (",
"      <a class=\"graphic graphic_figure graphicRef73036 \" href=\"mobipreview.htm?41/25/42387\">",
"       figure 19",
"      </a>",
"      ) (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?22/54/23398?source=see_link\">",
"       calculator 9",
"      </a>",
"      )",
"      <br/>",
"      <br/>",
"      Charts combining these curves are also available and may be most practical for clinical use:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.cdc.gov/growthcharts/data/who/GrChrt_Girls_24LW_9210.pdf\">",
"       Weight-for-age and length-for-age girls",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.cdc.gov/growthcharts/data/who/GrChrt_Girls_24HdCirc-L4W_9210.pdf\">",
"       Weight-for-length and head-circumference-for-age girls",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The WHO growth charts show a faster rate of growth for the first three months of life than the CDC growth charts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/28\">",
"     28",
"    </a>",
"    ]. When plotted on the WHO growth charts, formula-fed infants typically appear to have slow weight gain during this time period (",
"    <a class=\"graphic graphic_figure graphicRef51959 \" href=\"mobipreview.htm?12/5/12370\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Method of feeding'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The WHO growth charts for children from birth to four years of age have been adopted for use in the United Kingdom (UK-WHO growth charts). UK-WHO growth charts and supporting educational materials can be downloaded from",
"    <a class=\"external\" href=\"file://www.growthcharts.rcpch.ac.uk/\">",
"     www.growthcharts.rcpch.ac.uk",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/40\">",
"     40",
"    </a>",
"    ]. When using the UK-WHO growth charts for weight, fewer children will be less than the 2nd percentile, and more children will be greater than the 98th percentile after the age of six months than when using the former UK90 growth charts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     CDC versus WHO growth charts",
"    </span>",
"    &nbsp;&mdash;&nbsp;A comparison of the",
"    <span class=\"nowrap\">",
"     CDC/NCHS",
"    </span>",
"    and WHO growth charts is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/14/31976?source=see_link&amp;anchor=H31542395#H31542395\">",
"     \"Measurement of growth in children\", section on 'Recommended growth charts'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Premature infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most clinicians use standard growth charts to monitor the growth of preterm infants after discharge from the neonatal intensive care unit. Corrections for gestational age should be made for weight through 24 months of age, for stature through 40 months of age, and for head circumference through 18 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/22/23912?source=see_link\">",
"     \"Growth management in preterm infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Other growth charts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Special growth charts have been developed for a variety of conditions that are associated with altered patterns of growth. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Turner syndrome (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33449?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Down syndrome (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/15/26874?source=see_link\">",
"       \"Clinical features and diagnosis of Down syndrome\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Williams syndrome (available at:",
"      <a class=\"external\" href=\"file://pediatrics.aappublications.org/cgi/content/full/107/5/1192\">",
"       pediatrics.aappublications.org/cgi/content/full/107/5/1192",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/42\">",
"       42",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Achondroplasia (available at",
"      <a class=\"external\" href=\"file://pediatrics.aappublications.org/cgi/content/full/116/3/771\">",
"       pediatrics.aappublications.org/cgi/content/full/116/3/771",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/43\">",
"       43",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Proportionality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proportionality is the degree to which individual growth parameters correlate with each other. Measures of proportionality are useful as screens of nutritional status, to diagnose overweight and obesity, and in generating a differential diagnosis for short or tall stature. Assessment of proportionality is particularly useful when growth parameters are abnormal. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'Abnormal patterns of growth'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Weight-for-length",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weight-for-length should be plotted in children between zero and two years of age (",
"    <a class=\"graphic graphic_figure graphicRef53474 \" href=\"mobipreview.htm?40/13/41171\">",
"     figure 15",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef73036 \" href=\"mobipreview.htm?41/25/42387\">",
"     figure 19",
"    </a>",
"    ) (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?22/54/23398?source=see_link\">",
"     calculator 9",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/37\">",
"     37",
"    </a>",
"    ]. A weight-for-length between the 2.3rd and 97.7th percentile reflects normal variation, whereas a weight-for-length less than the 2.3rd percentile or greater than the 97.7th percentile may indicate undernutrition or obesity, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/28\">",
"     28",
"    </a>",
"    ]. Rapid increases in weight-for-length from zero to six months of age are associated with an increased risk of obesity at age three years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8378?source=see_link\">",
"     \"Clinical evaluation of the obese child and adolescent\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/12/14538?source=see_link&amp;anchor=H6#H6\">",
"     \"Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years\", section on 'Terminology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The weight-for-length (or weight-for-height) typically is normal in children who have constitutional growth delay or familial short stature. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Variants of normal'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     BMI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The body mass index (BMI) characterizes the relative proportion between the child's weight and the height squared. The BMI should be calculated for children older than two years (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?35/14/36070?source=see_link\">",
"     calculator 3",
"    </a>",
"    and",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?34/60/35782?source=see_link\">",
"     calculator 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/37\">",
"     37",
"    </a>",
"    ]. BMI is a valid predictor of adiposity and the best clinical standard for defining obesity. The BMI percentile can be used as a screening tool for undernutrition and to diagnose overweight and obesity (",
"    <a class=\"graphic graphic_figure graphicRef60784 \" href=\"mobipreview.htm?37/23/38257\">",
"     figure 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef68478 \" href=\"mobipreview.htm?40/2/40993\">",
"     figure 11",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/14/31976?source=see_link&amp;anchor=H10#H10\">",
"     \"Measurement of growth in children\", section on 'Body mass index (BMI)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A child with a BMI less than the 15th percentile is \"at risk\" for undernutrition. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/21/38233?source=see_link&amp;anchor=H20#H20\">",
"       \"Poor weight gain in children older than two years of age\", section on 'Growth parameters'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A child with BMI between the 85th and 95th percentiles is overweight, and a child with BMI &ge;95th percentile is obese. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/5/32858?source=see_link\">",
"       \"Definition; epidemiology; and etiology of obesity in children and adolescents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8378?source=see_link\">",
"       \"Clinical evaluation of the obese child and adolescent\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At the extremes (&gt;97th percentile or &lt;3rd percentile), small differences in percentiles represent clinically important differences in BMI. At these extremes, the z-score is a more precise reflection of how far the measurement deviates from the mean and is a useful tool for tracking changes (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?35/14/36070?source=see_link\">",
"     calculator 3",
"    </a>",
"    and",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?34/60/35782?source=see_link\">",
"     calculator 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Ideal body weight",
"    </span>",
"    &nbsp;&mdash;&nbsp;The percent of ideal body weight (IBW) is another method to assess proportionality and nutritional status. There are several methods by which to calculate IBW, each of which provides similar results for children younger than eight years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/45\">",
"     45",
"    </a>",
"    ]. One method is to plot the child's height on the height curve; draw a horizontal line from the height to the 50 percent height line, then draw a vertical line to the 50 percent weight line; the intersection with the 50 percent weight line is the IBW [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/46\">",
"     46",
"    </a>",
"    ]. Another method is to determine the weight percentile that is proportionate to the height percentile for chronologic age using standard growth charts (",
"    <a class=\"graphic graphic_figure graphicRef57059 \" href=\"mobipreview.htm?11/5/11353\">",
"     figure 20",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Percent IBW = actual weight divided by IBW x 100. The assessment of nutritional status according to percent IBW is as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      &gt;120 &ndash; Obese",
"     </li>",
"     <li>",
"      110 to 120 &ndash; Overweight",
"     </li>",
"     <li>",
"      90 to 110 &ndash; Normal variation",
"     </li>",
"     <li>",
"      80 to 90 &ndash; Mild wasting",
"     </li>",
"     <li>",
"      70 to 80 &ndash; Moderate wasting",
"     </li>",
"     <li>",
"      &lt;70 &ndash; Severe wasting",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Body proportions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proportions of the body change during fetal and postnatal growth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/47\">",
"     47",
"    </a>",
"    ]. The most commonly used descriptors of body proportions are the ratio of the upper body segment to the lower body segment and the ratio of arm span to height.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Upper segment to lower segment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The upper segment to lower segment ratio",
"    <span class=\"nowrap\">",
"     (US/LS",
"    </span>",
"    ratio) is helpful in distinguishing among causes of short or tall stature and in distinguishing disproportionate growth from immaturity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lower segment is measured from the top of the symphysis pubis to the plantar surface of the foot. The upper segment is calculated by subtracting the lower segment from the child's height. Approximate normal ratios are as follows [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/47\">",
"     47",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Birth &ndash; 1.7",
"     </li>",
"     <li>",
"      3 years &ndash; 1.33",
"     </li>",
"     <li>",
"      5 years &ndash; 1.17",
"     </li>",
"     <li>",
"      10 years &ndash; 1.0",
"     </li>",
"     <li>",
"      &gt;10 years &ndash; &lt;1.0",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     US/LS",
"    </span>",
"    ratio is increased in children with rickets, achondroplasia, and Turner syndrome (because of decreased limb length) and decreased in those with Marfan syndrome (because of increased limb length). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/21/26967?source=see_link\">",
"     \"Overview of rickets in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33449?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/3/20538?source=see_link\">",
"     \"Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Arm span to height",
"    </span>",
"    &nbsp;&mdash;&nbsp;The arm span is the distance between the tips of the middle fingers when the arms are raised to a horizontal position [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/49\">",
"     49",
"    </a>",
"    ]. At birth, the arm span is typically less than length (by at least 2.5 cm) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/47\">",
"     47",
"    </a>",
"    ]. By approximately 10 years of age in boys and 12 years of age in girls, the arm span exceeds height [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/47,50\">",
"     47,50",
"    </a>",
"    ]. Arm span is 0 to 5 cm greater than height in approximately three-fourths of healthy children, 5 to 10 cm greater in approximately one-fourth, and &ge;10 cm greater in approximately 1 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The arm span-to height ratio is helpful in identifying conditions with a disproportion between the limbs and the trunk (eg, Marfan syndrome, in which the arm span usually exceeds height by at least 5 cm) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/3/20538?source=see_link\">",
"     \"Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     ABNORMAL PATTERNS OF GROWTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Growth can be slowed or accelerated by a variety of conditions. Changes in growth may be the first sign of a pathologic condition (eg, inflammatory bowel disease, hypercortisolism, thyroid dysfunction) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/51-53\">",
"     51-53",
"    </a>",
"    ]. The evaluation and management of abnormal growth patterns in children are discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Poor weight gain (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32248?source=see_link\">",
"       \"Malnutrition in developing countries: Clinical assessment\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/21/38233?source=see_link&amp;anchor=H3#H3\">",
"       \"Poor weight gain in children older than two years of age\", section on 'Definition'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/16/30985?source=see_link&amp;anchor=H3#H3\">",
"       \"Management of failure to thrive (undernutrition) in children younger than two years\", section on 'Initial management'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/12/14538?source=see_link&amp;anchor=H3#H3\">",
"       \"Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years\", section on 'Patterns of growth'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Obesity (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/5/32858?source=see_link\">",
"       \"Definition; epidemiology; and etiology of obesity in children and adolescents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8378?source=see_link\">",
"       \"Clinical evaluation of the obese child and adolescent\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/50/37674?source=see_link\">",
"       \"Comorbidities and complications of obesity in children and adolescents\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Short stature (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/18/10537?source=see_link\">",
"       \"Causes of short stature\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/60/18376?source=see_link\">",
"       \"Diagnostic approach to short stature\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Tall stature (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/53/10073?source=see_link\">",
"       \"The child with tall stature or abnormally rapid growth\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Microcephaly and macrocephaly (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/51/36665?source=see_link\">",
"       \"Etiology and evaluation of microcephaly in infants and children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/54/3946?source=see_link&amp;anchor=H6#H6\">",
"       \"Etiology and evaluation of macrocephaly in infants and children\", section on 'Etiology'",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     COMMUNICATING WITH PARENTS ABOUT GROWTH CHARTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although some parents may appreciate viewing their child's growth and hearing their healthcare provider's interpretation of the graphic information, the usefulness of the growth curve as an education tool for parents is questionable. The general population may not easily understand growth chart data, as illustrated below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/54-56\">",
"     54-56",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a survey of 1000 parents (demographically representative of the United States population), nearly two-thirds responded that it was important to see their child's growth chart [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/55\">",
"       55",
"      </a>",
"      ]. However, 36 percent incorrectly determined a child's weight when shown a point plotted on a growth chart, 32 percent incorrectly identified the percentile associated with a plotted point, and up to 77 percent inaccurately interpreted data plotted on combined height and weight graphs.",
"     </li>",
"     <li>",
"      In another survey of 279 parents who were asked to rank six growth charts, almost one-half selected the curve with consistent growth along the 10th percentile as \"least healthy\" and 29 percent chose growth patterns along the 90th percentile or trending upward to the 90th percentile as the \"healthiest\" [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/40/42633/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pediatric healthcare providers who choose to share growth chart information with parents must recognize the limitations of using growth charts as an educational tool.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normal human growth is pulsatile. Periods of rapid growth are separated by periods of no measurable growth. Growth is also seasonal, with growth velocities increased during the spring and summer months. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Normal patterns'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Growth velocity, the change in growth over time, is a more sensitive index of growth than is a single measurement. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Growth velocity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Compared with formula-fed infants, breastfed infants gain weight relatively rapidly during the first three to four months of life and relatively slowly thereafter. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Method of feeding'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Weight and height should be plotted on the appropriate growth chart at each well-child visit. Head circumference and weight-for-length should be plotted for children younger than two years of age and body mass index for children older than two years. The accurate charting of growth may prevent the unnecessary evaluation or intervention of a child who has a normal pattern of growth. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Growth charts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The World Health Organization growth charts should be used for infants and children &lt;24 months of age, regardless of method of feeding. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'WHO growth charts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The growth of premature infants can be plotted on the standard growth charts. However, corrections for gestational age should be made for weight through 24 months of age, for stature through 40 months of age, and for head circumference through 18 months of age. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Premature infants'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Assessment of proportionality is useful as a screen of nutritional status, to diagnose overweight and obesity, and in generating a differential diagnosis for short or tall stature. Assessment of proportionality is particularly useful when growth parameters are abnormal. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Proportionality'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Lifshitz F, Cervantes CD. Short stature. In: Pediatric Endocrinology, Lifshitz F (Ed), Marcel Dekker, New York 1996. p.3.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/2\">",
"      Touwslager RN, Gielen M, Derom C, et al. Determinants of infant growth in four age windows: a twin study. J Pediatr 2011; 158:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/3\">",
"      HEALY MJ, LOCKHART RD, MACKENZIE JD, et al. Aberdeen growth study. I. The prediction of adult body measurements from measurements taken each year from birth to 5 years. Arch Dis Child 1956; 31:372.",
"     </a>",
"    </li>",
"    <li>",
"     Tanner JM. Fetus into Man: Physical Growth from Conception to Maturity, Harvard University Press, Cambridge 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/5\">",
"      Ong KK, Ahmed ML, Emmett PM, et al. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ 2000; 320:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/6\">",
"      Adair LS. Size at birth predicts age at menarche. Pediatrics 2001; 107:E59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/7\">",
"      Lampl M, Johnson ML, Frongillo EA Jr. Mixed distribution analysis identifies saltation and stasis growth. Ann Hum Biol 2001; 28:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/8\">",
"      Lampl M, Veldhuis JD, Johnson ML. Saltation and stasis: a model of human growth. Science 1992; 258:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/9\">",
"      Thalange NK, Foster PJ, Gill MS, et al. Model of normal prepubertal growth. Arch Dis Child 1996; 75:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/10\">",
"      Gelander L, Karlberg J, Albertsson-Wikland K. Seasonality in lower leg length velocity in prepubertal children. Acta Paediatr 1994; 83:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/11\">",
"      van Dommelen P, de Gunst M, van der Vaart A, et al. Growth references for height, weight and body mass index of twins aged 0-2.5 years. Acta Paediatr 2008; 97:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/12\">",
"      Estourgie-van Burk GF, Bartels M, Boomsma DI, Delemarre-van de Waal HA. Body size of twins compared with siblings and the general population: from birth to late adolescence. J Pediatr 2010; 156:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/13\">",
"      Crossland DS, Richmond S, Hudson M, et al. Weight change in the term baby in the first 2 weeks of life. Acta Paediatr 2008; 97:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/14\">",
"      Macdonald PD, Ross SR, Grant L, Young D. Neonatal weight loss in breast and formula fed infants. Arch Dis Child Fetal Neonatal Ed 2003; 88:F472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/15\">",
"      Wright CM, Parkinson KN. Postnatal weight loss in term infants: what is normal and do growth charts allow for it? Arch Dis Child Fetal Neonatal Ed 2004; 89:F254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/16\">",
"      Whitehead RG, Paul AA. Growth charts and the assessment of infant feeding practices in the western world and in developing countries. Early Hum Dev 1984; 9:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/17\">",
"      Dewey KG, Heinig MJ, Nommsen LA, et al. Growth of breast-fed and formula-fed infants from 0 to 18 months: the DARLING Study. Pediatrics 1992; 89:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/18\">",
"      Hediger ML, Overpeck MD, Ruan WJ, Troendle JF. Early infant feeding and growth status of US-born infants and children aged 4-71 mo: analyses from the third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2000; 72:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/19\">",
"      Kramer MS, Guo T, Platt RW, et al. Feeding effects on growth during infancy. J Pediatr 2004; 145:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/20\">",
"      Dewey KG, Peerson JM, Brown KH, et al. Growth of breast-fed infants deviates from current reference data: a pooled analysis of US, Canadian, and European data sets. World Health Organization Working Group on Infant Growth. Pediatrics 1995; 96:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/21\">",
"      Cole TJ, Paul AA, Whitehead RG. Weight reference charts for British long-term breastfed infants. Acta Paediatr 2002; 91:1296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/22\">",
"      Dewey KG. Growth patterns of breastfed infants and the current status of growth charts for infants. J Hum Lact 1998; 14:89.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Nutrition American Academy of Pediatrics. Breastfeeding. In: Pediatric Nutrition Handbook, 6th ed, Kleinman, RE (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.29.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/24\">",
"      Mei Z, Ogden CL, Flegal KM, Grummer-Strawn LM. Comparison of the prevalence of shortness, underweight, and overweight among US children aged 0 to 59 months by using the CDC 2000 and the WHO 2006 growth charts. J Pediatr 2008; 153:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/25\">",
"      van Dijk CE, Innis SM. Growth-curve standards and the assessment of early excess weight gain in infancy. Pediatrics 2009; 123:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/26\">",
"      Whitehead RG. The importance of diet-specific growth charts. Acta Paediatr 2003; 92:137.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. The WHO child growth standards. Available at: www.who.int/childgrowth/standards/en/. (Accessed on February 21, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/28\">",
"      Grummer-Strawn LM, Reinold C, Krebs NF, Centers for Disease Control and Prevention (CDC). Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/29\">",
"      Smith DW, Truog W, Rogers JE, et al. Shifting linear growth during infancy: illustration of genetic factors in growth from fetal life through infancy. J Pediatr 1976; 89:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/30\">",
"      Mei Z, Grummer-Strawn LM, Thompson D, Dietz WH. Shifts in percentiles of growth during early childhood: analysis of longitudinal data from the California Child Health and Development Study. Pediatrics 2004; 113:e617.",
"     </a>",
"    </li>",
"    <li>",
"     Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist, Stanford University Press, Stanford 1950.",
"    </li>",
"    <li>",
"     Tanner JM, Whitehouse RH, Cameron N, et al. Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method), Academic Press, London 1983.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/33\">",
"      Tanner JM, Goldstein H, Whitehouse RH. Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child 1970; 45:755.",
"     </a>",
"    </li>",
"    <li>",
"     Swaiman, KF. Neurologic examination of the term and preterm infant. In: Pediatric Neurology: Principles and Practice, 4th ed, Swaiman, KF, Ashwal, S, Ferriero, DM (Eds), Mosby, St. Louis 2006. p.48.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/35\">",
"      Fujimura M, Seryu JI. Velocity of head growth during the perinatal period. Arch Dis Child 1977; 52:105.",
"     </a>",
"    </li>",
"    <li>",
"     Hall, JG, Froster-Iskenius, UG, Allanson, JE. Head circumference (occipitofrontal circumference, OFC). In: Handbook of Physical Measurements. Oxford University Press, New York 2007. p.72.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/37\">",
"      Recommendations for preventive pediatric health care. Pediatrics 2007; 120:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/38\">",
"      Hui LL, Schooling CM, Cowling BJ, et al. Are universal standards for optimal infant growth appropriate? Evidence from a Hong Kong Chinese birth cohort. Arch Dis Child 2008; 93:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/39\">",
"      Wright C, Lakshman R, Emmett P, Ong KK. Implications of adopting the WHO 2006 Child Growth Standard in the UK: two prospective cohort studies. Arch Dis Child 2008; 93:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/40\">",
"      Wright CM, Williams AF, Elliman D, et al. Using the new UK-WHO growth charts. BMJ 2010; 340:c1140.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Nutrition American Academy of Pediatrics. Failure to thrive. In: Pediatric Nutrition Handbook, 6th, Kleinman RE (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.601.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/42\">",
"      Committee on Genetics. American Academy of Pediatrics: Health care supervision for children with Williams syndrome. Pediatrics 2001; 107:1192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/43\">",
"      Trotter TL, Hall JG, American Academy of Pediatrics Committee on Genetics. Health supervision for children with achondroplasia. Pediatrics 2005; 116:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/44\">",
"      Taveras EM, Rifas-Shiman SL, Belfort MB, et al. Weight status in the first 6 months of life and obesity at 3 years of age. Pediatrics 2009; 123:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/45\">",
"      Phillips S, Edlbeck A, Kirby M, Goday P. Ideal body weight in children. Nutr Clin Pract 2007; 22:240.",
"     </a>",
"    </li>",
"    <li>",
"     Olsen, IE, Mascarenhas, MR, Stallings, VA. Clinical assessment of nutritional status. In: Nutrition in Pediatrics Basic Science and Clinical Applications, 3rd ed, Walker, WA, Watkins, JB, Duggan, C (Eds), BC Decker Inc, Hamilton, Ontario 2003. p.6.",
"    </li>",
"    <li>",
"     Hall, JG, Froster-Iskenius, UG, Allanson, JE. Proportional growth and normal variants. In: Handbook of Physical Measurements. Oxford University Press, New York 2007. p.13.",
"    </li>",
"    <li>",
"     Hall, JG, Froster-Iskenius, UG, Allanson, JE. Limbs. In: Handbook of Physical Measurements. Oxford University Press, New York 2007. p.240.",
"    </li>",
"    <li>",
"     Dimeglio, A. Biometric measurements. In: Lovell and Winter's Pediatric Orthopaedics, 6th ed, Morrissy, RT, Weinstein, SL (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.35.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/50\">",
"      Jarzem PF, Gledhill RB. Predicting height from arm measurements. J Pediatr Orthop 1993; 13:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/51\">",
"      Kanof ME, Lake AM, Bayless TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology 1988; 95:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/52\">",
"      Magiakou MA, Mastorakos G, Oldfield EH, et al. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 1994; 331:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/53\">",
"      Schlesinger S, MacGillivray MH, Munschauer RW. Acceleration of growth and bone maturation in childhood thyrotoxicosis. J Pediatr 1973; 83:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/54\">",
"      Ben-Joseph EP, Dowshen SA, Izenberg N. Public understanding of growth charts: a review of the literature. Patient Educ Couns 2007; 65:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/55\">",
"      Ben-Joseph EP, Dowshen SA, Izenberg N. Do parents understand growth charts? A national, Internet-based survey. Pediatrics 2009; 124:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/40/42633/abstract/56\">",
"      Laraway KA, Birch LL, Shaffer ML, Paul IM. Parent perception of healthy infant and toddler growth. Clin Pediatr (Phila) 2010; 49:343.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2845 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-14B9D587E9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42633=[""].join("\n");
var outline_f41_40_42633=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DETERMINANTS OF NORMAL GROWTH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      NORMAL PATTERNS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Growth velocity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Twins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Weight gain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Method of feeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Linear growth",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Height velocity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Variants of normal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Predicted height",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Head growth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      EVALUATION OF GROWTH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Measurement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Growth charts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - CDC growth charts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - WHO growth charts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - CDC versus WHO growth charts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Premature infants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Other growth charts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Proportionality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Weight-for-length",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - BMI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Ideal body weight",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Body proportions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Upper segment to lower segment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Arm span to height",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      ABNORMAL PATTERNS OF GROWTH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      COMMUNICATING WITH PARENTS ABOUT GROWTH CHARTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/2845\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2845|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/5/12370\" title=\"figure 1\">",
"      Comparison of WHO and CDC weight-for-age charts 0 to 24 months",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?6/6/6253\" title=\"figure 2\">",
"      Normal growth rate in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/37/4692\" title=\"figure 3A\">",
"      Height velocity in boys",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?16/0/16387\" title=\"figure 3B\">",
"      Height velocity in girls",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/8/3204\" title=\"figure 4\">",
"      Projected height A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/48/11012\" title=\"figure 5\">",
"      Projected height B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?13/61/14291\" title=\"figure 6\">",
"      CDC weight for age boys 2 to 20 years",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?43/1/44050\" title=\"figure 7\">",
"      CDC stature for age boys 2 to 20 years",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/23/38257\" title=\"figure 8\">",
"      CDC BMI for age boys 2 to 20 years",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/7/42098\" title=\"figure 9\">",
"      CDC weight for age girls 2 to 20 years",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?29/10/29858\" title=\"figure 10\">",
"      CDC stature for age girls 2 to 20 years",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/2/40993\" title=\"figure 11\">",
"      CDC BMI for age girls 2 to 20 years",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?39/52/40770\" title=\"figure 12\">",
"      WHO weight for age boys 0 to 24 months",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?30/44/31426\" title=\"figure 13\">",
"      WHO length for age boys 0 to 24 months",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?32/32/33281\" title=\"figure 14\">",
"      WHO head circumference for age boys 0 to 24 months",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/13/41171\" title=\"figure 15\">",
"      WHO weight for length boys 0 to 24 months",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?38/6/39010\" title=\"figure 16\">",
"      WHO weight for age girls 0 to 24 months",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?29/51/30514\" title=\"figure 17\">",
"      WHO length for age girls 0 to 24 months",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/3/35889\" title=\"figure 18\">",
"      WHO head circumference for age girls 0 to 24 months",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/25/42387\" title=\"figure 19\">",
"      WHO weight for length girls 0 to 24 months",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?11/5/11353\" title=\"figure 20\">",
"      Percent ideal body weight",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2845|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/15/24827\" title=\"table 1\">",
"      Short stature v delay of growth",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?30/3/30769?source=related_link\" title=\"calculator 1\">",
"      Calculator: Mid-parental target height prediction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?21/47/22262?source=related_link\" title=\"calculator 2\">",
"      Calculator: CDC height for age percentiles for boys (2 to 20 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?35/14/36070?source=related_link\" title=\"calculator 3\">",
"      Calculator: Body Mass Index (BMI) percentiles for boys (2 to 20 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?22/7/22646?source=related_link\" title=\"calculator 4\">",
"      Calculator: CDC height for age percentiles for girls (2 to 20 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?34/60/35782?source=related_link\" title=\"calculator 5\">",
"      Calculator: Body Mass Index (BMI) percentiles for girls (2 to 20 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?11/46/12003?source=related_link\" title=\"calculator 6\">",
"      Calculator: WHO Infant Weight for Age Percentiles (&lt; 24 months)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?9/51/10035?source=related_link\" title=\"calculator 7\">",
"      Calculator: WHO Infant Length for Age Percentiles (&lt; 24 months)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?34/31/35315?source=related_link\" title=\"calculator 8\">",
"      Calculator: WHO Infant Head Circumference for Age Percentiles (&lt; 24 months)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?22/54/23398?source=related_link\" title=\"calculator 9\">",
"      Calculator: WHO Infant Weight for Length Percentiles (&lt; 24 months)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/18/10537?source=related_link\">",
"      Causes of short stature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8378?source=related_link\">",
"      Clinical evaluation of the obese child and adolescent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/15/26874?source=related_link\">",
"      Clinical features and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33449?source=related_link\">",
"      Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/50/37674?source=related_link\">",
"      Comorbidities and complications of obesity in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/5/32858?source=related_link\">",
"      Definition; epidemiology; and etiology of obesity in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/60/18376?source=related_link\">",
"      Diagnostic approach to short stature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/61/28631?source=related_link\">",
"      Dietary history and recommended dietary intake in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/12/14538?source=related_link\">",
"      Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/54/3946?source=related_link\">",
"      Etiology and evaluation of macrocephaly in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/51/36665?source=related_link\">",
"      Etiology and evaluation of microcephaly in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/3/20538?source=related_link\">",
"      Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/22/23912?source=related_link\">",
"      Growth management in preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/55/22391?source=related_link\">",
"      Laboratory and radiologic evaluation of nutritional status in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/21/20823?source=related_link\">",
"      Large for gestational age newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32248?source=related_link\">",
"      Malnutrition in developing countries: Clinical assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/16/30985?source=related_link\">",
"      Management of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/38/6760?source=related_link\">",
"      Measurement of body composition in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/14/31976?source=related_link\">",
"      Measurement of growth in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/25/1434?source=related_link\">",
"      Normal puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/21/26967?source=related_link\">",
"      Overview of rickets in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/21/38233?source=related_link\">",
"      Poor weight gain in children older than two years of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/23/9593?source=related_link\">",
"      Small for gestational age infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/53/10073?source=related_link\">",
"      The child with tall stature or abnormally rapid growth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/30/19943?source=related_link\">",
"      The pediatric physical examination: General principles and standard measurements",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_40_42634="Adeno CA lung Light I";
var content_f41_40_42634=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F71512%7EPULM%2F50555%7EPULM%2F67385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F71512%7EPULM%2F50555%7EPULM%2F67385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Adenocarcinoma of the lung",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 284px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High-powered photomicrograph demonstrating the typical acinar pattern of glandular differentiation observed in adenocarcinoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Adenocarcinoma of the lung",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 284px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photomicrograph of a hematoxylin and eosin-stained section of solid adenocarcinoma of the lung.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intracytoplasmic mucin",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A mucicarmine stain illustrates intracytoplasmic mucin (arrow), which appears as a dark pink intracytoplasmic globule within the neoplastic cells of a solid lung adenocarcinoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42634=[""].join("\n");
var outline_f41_40_42634=null;
var title_f41_40_42635="Tachy mediated CM treatment";
var content_f41_40_42635=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59233&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59233&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Tachycardia-mediated cardiomyopathy: Improvement with treatment",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Associated arrhythmia",
"       </td>",
"       <td class=\"subtitle1\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle1\">",
"        Treatment",
"       </td>",
"       <td class=\"subtitle1\">",
"        Evidence for improvement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atrial fibrillation",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        AV node ablation and pacer",
"       </td>",
"       <td>",
"        Increased EF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atrial fibrillation",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        Cardioversion",
"       </td>",
"       <td>",
"        Increased EF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atrial fibrillation",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        Rate control or conversion",
"       </td>",
"       <td>",
"        Increased EF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ectopic atrial tachycardia",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        Surgical ablation",
"       </td>",
"       <td>",
"        Increased EF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AVRT",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        Medications",
"       </td>",
"       <td>",
"        Increased EF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        RVOT VT",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        Ablation",
"       </td>",
"       <td>",
"        Increased EF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LV VT",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        Ablation",
"       </td>",
"       <td>",
"        Increased EF",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AVRT: atrioventricular reentrant tachycardia mediated by an accessory pathway; EF: ejection fraction; RVOT VT: right ventricular outflow tract ventricular tachycardia; LV VT: idiopathic left ventricular tachycardia.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42635=[""].join("\n");
var outline_f41_40_42635=null;
var title_f41_40_42636="Risk score versus physician-rated KPS chemo toxicity";
var content_f41_40_42636=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F60649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F60649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Ability of risk score versus physician-rated Karnofsky performance status (KPS) to predict chemotherapy toxicity",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"16%\">",
"     </colgroup>",
"     <colgroup span=\"4\" width=\"9%\">",
"     </colgroup>",
"     <colgroup span=\"3\" width=\"16%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Risk strata",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        No toxicity",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Toxicity",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Total",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        p",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        ROC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        No.",
"       </td>",
"       <td class=\"subtitle2\">",
"        Percent",
"       </td>",
"       <td class=\"subtitle2\">",
"        No.",
"       </td>",
"       <td class=\"subtitle2\">",
"        Percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"8\">",
"        By total score",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0-5 (low)",
"       </td>",
"       <td class=\"centered\">",
"        89",
"       </td>",
"       <td class=\"centered\">",
"        70",
"       </td>",
"       <td class=\"centered\">",
"        39",
"       </td>",
"       <td class=\"centered\">",
"        30",
"       </td>",
"       <td class=\"centered\">",
"        128",
"       </td>",
"       <td class=\"centered\" rowspan=\"3\">",
"        &lt;0.001",
"       </td>",
"       <td class=\"centered\" rowspan=\"3\">",
"        0.72*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        6-9 (mid)",
"       </td>",
"       <td class=\"centered\">",
"        110",
"       </td>",
"       <td class=\"centered\">",
"        48",
"       </td>",
"       <td class=\"centered\">",
"        117",
"       </td>",
"       <td class=\"centered\">",
"        52",
"       </td>",
"       <td class=\"centered\">",
"        227",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        10-19 (high)",
"       </td>",
"       <td class=\"centered\">",
"        19",
"       </td>",
"       <td class=\"centered\">",
"        17",
"       </td>",
"       <td class=\"centered\">",
"        90",
"       </td>",
"       <td class=\"centered\">",
"        83",
"       </td>",
"       <td class=\"centered\">",
"        109",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"8\">",
"        By physician-rated KPS (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        90-100",
"       </td>",
"       <td class=\"centered\">",
"        125",
"       </td>",
"       <td class=\"centered\">",
"        49",
"       </td>",
"       <td class=\"centered\">",
"        128",
"       </td>",
"       <td class=\"centered\">",
"        51",
"       </td>",
"       <td class=\"centered\">",
"        253",
"       </td>",
"       <td class=\"centered\" rowspan=\"3\">",
"        0.19",
"       </td>",
"       <td class=\"centered\" rowspan=\"3\">",
"        0.53*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        80",
"       </td>",
"       <td class=\"centered\">",
"        73",
"       </td>",
"       <td class=\"centered\">",
"        49",
"       </td>",
"       <td class=\"centered\">",
"        76",
"       </td>",
"       <td class=\"centered\">",
"        51",
"       </td>",
"       <td class=\"centered\">",
"        149",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &le;70",
"       </td>",
"       <td class=\"centered\">",
"        33",
"       </td>",
"       <td class=\"centered\">",
"        38",
"       </td>",
"       <td class=\"centered\">",
"        53",
"       </td>",
"       <td class=\"centered\">",
"        62",
"       </td>",
"       <td class=\"centered\">",
"        86",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ROC: receiver operating characteristic; KPS: Karnofsky performance status.",
"     <br/>",
"     * Risk score and physician-rated KPS were treated as continuous to calculate the ROC.",
"    </div>",
"    <div class=\"reference\">",
"     From: Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011; 29:3457. Reprinted with permission. Copyright &copy; 2011 American Society of Clinical Oncology. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42636=[""].join("\n");
var outline_f41_40_42636=null;
var title_f41_40_42637="Dx workup FM";
var content_f41_40_42637=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F56396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F56396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Recommended diagnostic workup for fibromyalgia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 295px; height: 296px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Establishing the diagnosis is an essential component of FM management. Diagnostic criteria for FM include the ACR and the Canadian Consensus Guidelines. A complete history, physical exam, and laboratory testing should be done to exclude diseases that may mimic or complicate FM. Each patient should be assessed for a &ge;3-month history of chronic widespread pain; patient self-report should be used as an index of pain. The presence of tender points should be confirmed. However, tenderness is subjective and depends upon the examiner's strength of palpation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Goldenberg, DL, Burckhardt, C, Crofford, L. Management of fibromyalgia syndrome. JAMA 2004; 292:2388.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42637=[""].join("\n");
var outline_f41_40_42637=null;
var title_f41_40_42638="Urinary tract tuberculosis";
var content_f41_40_42638=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F64772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F64772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Urinary tract tuberculosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 184px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Intravenous pyelogram in urinary tract tuberculosis. Both upper and lower tract involvement are present on the left side as manifested by blunting of the calyces (caliectasis) and two long ureteral strictures (arrows). Although the caliceal changes can be seen in other disorders (such as reflux nephropathy), the concurrent ureteral abnormalities are virtually diagnostic of tuberculosis. A normal pelvic right kidney is also present but is not well visualized.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Rose, BD, Pathophysiology of Renal Disease, 1st ed, McGraw-Hill, New York, 1981.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42638=[""].join("\n");
var outline_f41_40_42638=null;
var title_f41_40_42639="Flexible bronchoscope tip";
var content_f41_40_42639=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F79391&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F79391&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 477px\">",
"   <div class=\"ttl\">",
"    Diagram of a flexible bronchoscope's distal tip (ie, working tip)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 457px; height: 606px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_40_42639=[""].join("\n");
var outline_f41_40_42639=null;
